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Introduction Neurogenesis, the development of new neurons, starts soon after the
formation of the neural tube and is largely completed by birth. Development of the brain
after birth is mainly reliant on the formation of new connections between surviving neurons.
However, adult neurogenesis does continue in the subgranular zone of the hippocampus from
quiescent adult neural stem cells. Traditionally neural stem cells were cultured as
neurospheres, a heterogeneous agglomeration of neural cells at various stages of
differentiation. This heterogeneity prevented accurate quantitative analysis. In 2008 Sun et
al produced the first non-immortalised human foetal neural stem (NS) cell line from nine
week old human foetal cortex. These cells are cultured as monolayers, have a radial glia like
appearance, self renew and form all three neural cell types, neurons, astrocytes and
oligodendrocytes upon differentiation. More recently human foetal neuroepithelial like (NES)
stem cells have been produced from five week old human foetal hind-brain, they resemble
neuroepithelial cells, with characteristic rosettes, upon differentiation they appear to form a
pure population of neurons. These homogeneous monolayer cultures enable quantitative
proteomic analysis, to increase our understanding of early brain development
Methods Three NES and two NS cell lines were available for analysis. They proliferate by
stimulation from FGF and EGF, removal of these growth factors results in spontaneous
differentiation. Proliferating NES and NS cells were compared using SILAC labelling. In
addition, each cell line was differentiated for 12 days, 6 timepoints were taken and compared
using label free quantitation.
Results 4677 proteins were quantitated with 473 differentially expressed, revealing
fundamental differences between NES and NS cells. NES cells are less differentiated,
expressing SOX2 and LIN28, have active cell cycle processes, DNA elongation, histone
modification and miRNA mediated gene silencing. Whereas NS cells are more
developmentally defined, express multiple membrane proteins, have activated focal adhesion,
thereby increasing their binding and interaction with their environment. NS metabolism is
more oxidative, utilises lipid metabolism, the pentose phosphate pathway and produces
creatine phosphate. Upon differentiation the cell cycle processes are downregulated and
neurogenic and gliogenic processes increased.
Conclusion This work represent a detailed in vitro characterisation of non immortalised
human foetal neural stem cells, it describes the regulatory, metabolic and structural changes
occurring within neural stem cells in early brain development. The information herein points
towards de-differentiation potentially through LIN28-let7, as a means to produce more
neurogenic neural stem cells in vitro thus aiding regenerative therapies, as well as provides a
wealth of information for better understanding neurological developmental disorders.
Keywords neural stem cells, neuroepithelia, radial glia
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Introduction
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Chapter 1
Nervous system development
1.1 Background
Neurogenesis, the development of new neurons, starts soon after the formation of the neural
tube and in humans is largely completed by birth.169 Development of the brain after birth is
mainly reliant on the formation of new connections between surviving neurons, rather than
the formation of new neurons. In 1965 it was discovered that neurogenesis continues into
adult life.16 Even though neural stem cell are found throughout the adult brain, they develop
primarily into glial cells due to strict neurogenic inhibition. Adult neurogenesis is restricted
to defined neurogenic niches,194 within which neurons are allowed to form from neural stem
cells.99,194 Elsewhere in the brain neural stem cells are only able to differentiate into glial cells.
In addition to taking place continuously in the neurogenic niches, neurogenesis may also be
initiated in response to traumatic brain injury.130,246 The discovery of adult neurogenesis has
initiated much research into the neurogenic niches and the cells living in them.
Recently two homogeneous non-immortalised neural stem cells have been produced by the
Smith lab at the Wellcome trust-medical research council stem cell institute in Cambridge UK
(Smith lab) from five and nine week old human foetal hind-brain. These cells self renew and
can be differentiated into neurons, astrocytes or oligodendrocytes.206,211 These cells offer the
ability to quantitatively study the developing brain in an in vitro model.
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Proteins are the building blocks and functional components of all cells. Proteomics, the
study of global protein expression and state, allows us to quantitatively compare the proteins
changes occurring within a biological system. Thus enabling an assessment of the critical
components within neural stem cells and the changes they undergo as they differentiate.
An increased understanding of neurogenesis is hoped to aid in the development of therapies
for brain degenerative disorders.137 Currently there are two distinct approaches to neurogenesis
related therapies: through the activation of endogenous neural stem cells239 by infusion of
growth factors into damaged regions of the brain, alternatively, neural stem cells produced
in vitro may be transplanted into damaged areas of the brain.126,153 In both approaches it is
hoped that integration of new neurons into damaged areas of the brain would return some of
the functionality to those areas.
The focus of this Thesis is to use proteomics to contribute to the understanding of the
intracellular mechanisms controlling neurogenesis.
1.2 Development
The eight totipotent stem cells of the morula have the potential to form an entire human
body. Their DNA methylation and histone modification have largely been stripped besides
for a few imprinted genes.91,175,191 Their DNA does not hold any epigenetic marks specifying
them towards any predetermined fate. The morula undergoes compaction, where the 8 cells
are drawn close together, increasing cell surface contact.105 This compaction is the start of cell
distinction. The cells inside the morula are specified to form the inner cell mass, while those on
the outside go on to form the trophectoderm. The morula continues to divide maintaining the
polarity of the cells. Liquid is pumped into the blastocoel, creating a cavity, the blastocyst then
contracts and hatches from its glycoprotein outer layer, the zona pellucida. The blastocyst
then implants, and the embryo begins to develop, encapsulated within the blastocyst. A body
of cells, the inner cell mass will go on to form the epiblast and then the embryo, while the
main portion of the blastocyst the trophectoderm develops in the uterine sac.
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Soon after implantation the embryo undergoes gastrulation, the development of the three
tissue layers; the endoderm, mesoderm and ectoderm. At this point cells are becoming increas-
ingly specified, and begin expressing markers specific for their tissue layers. They lose their
pluripotency and become multipotent, restricted to form only the tissue later found within
their respective layer. Cells in the embryo do not grow in isolation, as in tissue culture, but
rather in intimate contact with the cells around them. Their position within the embryo is
specified by their direct interactions with the cells around them and by the diffusion of growth
factors from distant cells in the embryo. The embryo is largely symmetric along sagittal plane,
left and right. The dorso ventral planes are specified by the secretion and diffusion gradients
of SHH and bone morphogenetic proteins (BMPs).
The first eight weeks of human development is divided into 23 Carnegie stages. Carnegie
stages describe the maturity of an embryo based on its external features. The stages are
determined by multiple physical properties, not by age or size of the embryo and are therefore
applicable across species (Figure 1.1). Within species post-ovulatory age is used to describe
the age of the embryo, since the time of ovulation can be calculated and fertilisation should
have occurred soon after ovulation.96,190
4
Figure 1.1: Carnegie Stages are morphologically characterised embryonic devel-
opmental stages used to make comparisons between the embryonic development of
different species. These stages are correlated to the embryonic ages within species,
since embyonic age, calculated from the time of ovulation, commonly used to track
development within a single specie. The cells used in this work, human foetal
neuroepithelial-like stem cell lines (hfNES cells) and human foetal neural stem cell-
like cell lines (hfNS cells), originated from Carnegie Stages 15 and 22 respectively.
96
1.3 Developmental neurogenesis
The focus of this Thesis was on neurogenesis, so the description of development will continue
in the direction of the nervous tissue, disregarding the rest of the body. In gastrulation,
the epiblast separates into three layers, through a process of tissue and cell movement. The
ectoderm has two potential fates. BMP4 induces the ectoderm to form epidermis. If BMP4
signalling is inhibited the ectoderm defaults to nervous tissue. The notocord is the most dorsal
layer of the mesoderm. It produces BMP inhibitors, NOG , CHRD and FST thereby causing
the formation of neuro-ectoderm. Nervous tissue is the default state for ectodermal cells. In
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fact, if embryonic stem cell (ESC) are dissociated in vitro, without growth factor stimulation,
for several hours they begin forming neural tissue.95
Figure 1.2: Overview of the central nervous system (CNS) development taken
from Stiles and Jernigan, 2010 202 (A,B) Initial development of the neural tube,
(C,D) closure of the neural tube, (E) formation of the three main divisions of the
brain, and the (F) subdivisions within these regions.
At three weeks (Carnegie stage 9) the neuroectoderm folds along the antero-posterior axis,
the sides of the folds connect and fuse forming the neural tube (Figure 1.2 A). The neural tube
zips closed from the centre rostrally and caudally, eventually forming the brain and spinal cord
respectively. The anterior neuropore (caudal) and the posterior neuropore (rostral) close at
embryonic day 25 and 27 respectively,183 (Carnegie stage 11). The cells connecting the neural
tube to the epidermis become neural crest cells, which go on to form the peripheral nervous
system and the melanocytes in the skin. Nervous system patterning occurs through a complex
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interaction of growth factor gradients and patterning genes.168
The neuroepithelial cells, which make-up the neural tube initially divide symmetrically,
producing identical neuroepithelial cells thus expanding the pool of cells prior to neurogenesis.
They are the only proliferating cells in the early brain and they are connected to the apical
lumen of the ventricles forming the ventricular zone thus stimulated by growth factors from the
cerebro-spinal fluid (CSF). During the cell cycle the nucleus of neuroepithelial cells migrates
between the apical to basal membranes, called interkinetic movement,75 During the DNA
synthesis phase of the cell cycle (S phase) the nucleus is furthest way from the neural tube
lumen and the cells appear columnar. During the second growth phase of the cell cycle (G2
phase) the nucleus migrates towards the lumen. Changes in cell adherence during interkinetic
movement allows the cells to become rounded before mitosis. Initially the columnar epithelial
cells in S phase and the rounded cells undergoing mitosis were thought to be two different cells.
Through 3H-Thymadine (3H-dT) labelling it was shown that there is only one homogeneous
population of neuroepithelial cells in the early neural tube.76,77
Cells incorporate 3H-dT during S phase, after a couple of hours the rounded mitotic cells
also appear labelled. These labelled cells later loose contact with the lumen, migrate and
differentiate as neurons. Varying the time of labelling made it possible to identify and study
neurons born at different times.
Neuroepithelial cells initially divide symmetrically producing identical daughter neuroep-
ithelial cell, but later go on to divide asymmetrically forming the first neurons of the preplate
and deep brain layers.183
As development progresses a sequence of different neurons are produced in the cortex to
make up the six layers of the brain. Cell fate switching appears to trigger intrinsic changes,
as early neural progenitors are able to form superficial layer neurons, but late progenitors are
unable to form deep brain layers.170
During development neuroepithelial cells gradually transform into radial glia (RG), this
process most likely happens through ”major differentiation” processes.74,78,87 RG are initially
neurogenic, but later become gliogenic.
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RG start off as apical RG that undergo interkinetic movement during their cell cycle. If
mitosis occurs when the nucleus is at the apical membrane, apical RG divide symmetrically
producing additional apical RG. If the nucleus is at the basal membrane during mitosis, basal
RG are formed, which loose their connection to the ventricle. These basal RG continue to
proliferate forming secondary germinal zones, (i.e the subventricular zone of the lateral ven-
tricles (SVZ), lateral to the lateral ventricles). The secondary germinal layers are responsible
for gyrification or folding of the brain beginning in the first six months of gestation in humans.
The surface of the brain is smooth in most animals, but gyrification occurs in some other
primates, dolphins, elephants and pigs.37,115,216
Basal RG and apical RG also divide asymmetrically, producing daughter cells that differ
from each other. Asymmetric division can be either proliferative, producing one identical
daughter cell and another lineage restricted progenitor cell, or consumptively where only lineage
restricted progenitor cells are produced. Lineage restricted progenitor cells may divide once
or twice more but ultimately go on to terminally differentiate.219
Differentiating neurons migrate away from the germinal zone in three ways. Early in brain
development differentiating cells migrate by stromal migration. They form a connection to
the pial surface of the brain, the nucleus then migrates towards the pial surface and loses it’s
connection to the apical ventricle. Once the brain has become sufficiently thick, differentiating
cells migrate radially along the radial glia which maintain contact between the ventricle or
germinal zone and the pial surface. Differentiating neurons usually migrate to the superficial
layers of the brain. The brain is therefore formed from the inside out. Neurons can also migrate
tangentially, across the brain layers, rather than through them, directed by locally secreted
trophic factors.183.
1.3.1 Cerebellum development
The rostral part of the neural tube is initially divided into three sections the prosencephalon
(fore-brain), the mesencephalon (mid-brain) and the rhombencephalon (hind-brain) (Figure 1.2
E). These section are compartmentalised by constrictions in the neural tube. Fluid pressure
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build up due to the constrictions causes swelling of these areas. As development continues the
three main brain regions are further subdivided into functional areas, specification of these
areas is largely controlled by homeobox (HOX) genes. HOX genes specify the anterio-posterior
axis in zones from the anterior to posterior of the embryo, and are numbered accordingly.84
Since the cells studied in this work originate from the hind-brain, the discussion of devel-
opment will move in that direction. The hind-brain is separated from the mid-brain by the
isthmus or the midbrain-hindbrain boundary (MHB). FGF8 is expressed caudally of the MHB
and WNT1 is expressed rostrally.
The areas of the brain are separated by gene expression, OTX2 is required for fore-brain
and mid-brain development and forms the rostral boundary of the hind-brain. OTX2 negative
and GBX2 positive areas develop into hind-brain, with homeobox cluster B (HOX2) forming
the caudal boundary.
GBX2 appears to play a repressive role on OTX2 rather than a inductive role on gene
expression.39 FGF8 expressed rostrally in the hind-brain is important for progenitor expansion,
but its expression needs to be reduced in order to initiate maturation.39
The hind-brain divides into 8 transverse swellings or rhombomeres (R1 to R8). R1-R3
metencephalons forms the pons and the cerebellum, while R4-R8 forms the meyencephalon
which forms the medulla oblongata (Figure 1.2 F).
Cerebellar cellular development occurs in waves, with each new wave inducing changes
which brings about the induction of the next wave. There is no known molecular clock and
the exact mechanism of this timing is still unknown. The ventricular zone, a germinal layer
surrounding the ventricles is the first germinal layer. The first neurons to emerge from the ven-
tricular zone are nuclear neurons of the cerebellar cortex.86 Subsequent cells migrate through
existing layers of differentiated cells. After the nuclear and Purkinje cells have finished divid-
ing, a second germinal layer, the external granular layer (EGL) forms from the rhombic lip
which extends from the roof of the forth ventricle.
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1.3.2 The mature brain
Upon completion of the formation of the central nervous system, the brain consists of 100 billion
neurons and one trillion glial cells. The survival of a neuron is dependent on its integration into
a functional neural network. Survival is controlled by neurotrophins, which act on electrically
active neurons and are released by the target cells of neurons. An activated target cell therefore
ensures the survival of the cell that activated it.151 Once the brain has matured few new neurons
are formed. Additional complexity and learning mainly occurs through the the formation of
new connections between the surviving neurons and adjustment to the excitability of these
connections.
Long term potentiation (LTP) increases the excitability of neurons, and through long term
depression (LTD) the excitability of neurons is decreased. LTP is triggered by rapid firing
of the neurons, causing the release of excess glutamate, which hyper-depolarises the post
synaptic membrane, causing opening of N-methyl-D-aspartate (NMDA) receptors by lifting the
inhibition of magnesium. Open NMDA receptors allow calcium into the post synaptic synapse,
which induces the insertion of more glutamate receptors into the post synaptic membrane.
Long term gene expression changes due to LTP cause morphological changes, most markedly
the growth of dendritic spines.234 The synapses become more excitable, and thereby potentially
store memory. This has been shown in vivo in a mouse model using high frequency stimulation.
When neurons were excited with low frequency the process was reversed.142
1.4 Adult neurogenesis
Until recently it was thought that once the brain had matured no new neurons could be
produced. This inhibition of neurogenesis is due to strict inhibitory signals within the adult
brain. Adult neural stem cells are found throughout the brain and they have the potential to
form neurons but are forced to become glial cells.
Through BrdU labeling experiments of rat brains, it was discovered that new neurons were
being formed in the adult brains of rats.16 These neurons were shown to survive for long pe-
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riods of time,110 receive synaptic input,109 extend axonal projections200 and enhance brain
function.152 Subsequently adult neurogenesis has been discovered in other vertebrates, mam-
mals, primates and humans.67 Furthermore is has been shown that human adult neurogenesis
declines with increased age35,66 and even more so in brain degenerative conditions35 such as
Alzheimer’s disease.138
Neurogenesis has been shown to continue throughout life in two defined regions of the
brain, the SVZ lateral to the lateral ventricles and the subgranular zone of the dentate gyrus
in the hippocampus (SGZ).137,194 These neurogenic niches consist of quiescent neural stem
cells, often called RG, regulated by niche astrocytes specific to these regions.99,194
Niche astrocytes maintain the neurogenic environment through growth factors48,107,122 and
the cell to cell contacts.106,123
Rat studies have shown that neurogenesis in the SGZ produces new hippocampal granule
cells. Which are involved in memory and learning.11,167,187,189 Newly formed hippocampal gran-
ule cells have been shown to be electrically active, form synapses and integrate into existing
networks, thus potentially aid in the formation of new memories.63 New neurons formed in the
SVZ migrate down the rostral migratory stream and become functionally integrated into the
olfactory bulb.53,63,89 These neurons survive for long periods of time, and may enhance the acu-
ity of smell in rodents. Maternal SVZ neurogenesis has been shown to increase in anticipation
of birth, enhancing a mothers ability to imprint on her young’s smell.186 Neurogenesis in the
SVZ is also increased due to a number of different stimuli such as exercise in rats, caffeine231
and anti-depressants.228
In animals neurogenesis can be induced outside of the neurogenic niches through traumatic
brain injury or ischemia,130,246 LIF , released by astrocytes surrounding a site of injury in
mice, has been shown to induce proliferation of adult neural stem cells.21 Some of these newly
formed neural stem cells form new neurons18,159 but most form glial cells. The adult brain’s
strict inhibition of neurogenesis11 prevents large numbers of new neurons being formed.26 The
result of traumatic brain injury is thus the formation of a glial scar.
New neurons being formed after injury to the brain18,131,144,159, shows that the brain has
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the potential to partially regenerate itself, even if this capacity is greatly attenuated.
Animal studies involving cell transplantation, have increased understanding into the in-
duction of neurogenesis and the role of the neurogenic niches. Neural stem cells transplanted
out of the neurogenic niches are inhibited from forming neurons. Neural stem cells from non
neurogenic brain areas such as the cortex, transplanted into neurogenic niches are induced to
form neurons.204 Niche astrocytes transplanted into non neurogenic niches induce neural stem
cell from these areas to form new neurons.107 Transfusion of growth factors such as SHH 10,107
and BDNF 162 have also been shown to induce neurogenesis in non neurogenic brain regions.
Transplantation of neural stem cells derived from ESC grown in culture and later transplanted
into non neurogenic regions of rat brains have been shown to differentiate, integrate and survive
within existing neural networks.136, 211
Human brain tissue is only accessible post mortem, so most work on neurogenesis is either
done in vitro or in animals, due the ease of access to these materials. Studies on the human
brain therefore needs to be done in indirect ways. In the 1950s large quantities of Carbon-14
isotopes (14Cs) were produced during extensive above ground testing of atomic bombs. The
levels of atmospheric 14C have been decreasing ever since the suspension of testing in 1963.
This 14C has a half life of 11 years.196 14C is absorbed by plants consumed by humans and
incorporated into DNA when cells divide. Comparison of atmospheric and cellular 14C levels
can therefore enable the birth dating of cells. Extensive study of cell nuclei isolated from brains
of cadavers has allowed the determination of the rate and location of neurogenesis in the adult
human brain.196 In animals there is clear evidence for neurogenesis both in the SVZ and SGZ.
Using 14C birth dating young neurons were observed in the SGZ in humans,29 but not in the
SVZ.195 All neurons in the SVZ and olfactory bulb originate at birth. No new neurons have
been observed in other areas of the human brain including after ischaemic stroke.
Neurogenesis is thought to be inhibited in the adult brain due to its potentially disruptive
effect on cognitive function.203 Despite inhibition, induced neurogenesis is still a promising
treatment for neuro-degenerative disorders. These new neurons may be produced from en-
dogenous or transplanted neural stem cells. It is hoped that induced neurogenesis may aid
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healing by increasing the number of neurons in damaged areas of the brain.18 In order to
accomplish neurogenic healing a detailed understanding of neural stem cells and the effects
of the factors required to induce neurogenesis is necessary. In a review, Conti and Cattaneo
stated with regards to in vivo neural stem cells ”no direct and thorough comparison of their
biological and molecular properties or of their physiological relevance and possible relationship
to endogenous neural stem cells has yet been carried out”, thus highlighting the importance
for detailed study of these cells.50
1.5 Stem cells
1.5.1 Embryonic stem cells
ESCs are derived from the inner cell mass and are pluripotent, able to form all the cells of the
body, but not a whole blastocyst. These cells can be cultured virtually indefinitely. Mouse ESC
differ from human ESC in that human ESC require FGF2 and TGFB1 /Activin to proliferate
while mouse ESC can be cultured with only inhibitors for GSK3B and TGFB1 .
Human ESC are similar to epiblast cells while mouse ESC are similar to the developmentally
earlier inner cell mass cells. Human ESC and can be developmentally reverted to resemble
inner cell mass cells by a short induced expression of NANOG and KLF2 , taking them one
step back in the differentiation process.215
ESCs are pluripotent, therefore able to self renew and differentiate into the three primary
germ cell layers. They proliferate on mouse fibroblast feeder layers. They can be induced
to differentiate spontaneously through the removal of the pluripotent-dependent factors that
stimulate self renewal,81 forming embryoid bodies, which contain ESCs partially differentiated
into all three germ cell layers and a central cavity of dead cells. They can also be induced
to differentiate directly, through the addition of exogenous chemicals and factors. Neural
progenitors are easily formed from ESC through their removal from feeder layers and sparse
culture in the presence of fibroblast growth factor (FGF).95
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1.5.2 Induced pluripotent stem cells
Recent advances in inducing pluripotency in adult cells has resulted in the development of ro-
bust techniques for turning adult fibroblasts into induced pluripotent stem cells (iPSCs), such
as the insertion of the four main pluripotency factors POU5F1, SOX2, MYC and KLF4 by
adeno-virus. Expression of these exogenous genes induces expression of their endogenous coun-
terparts. These genes induce pluripotency and embryoid bodies form from fibroblasts, which
are harvested for expansion and validation. iPSC are initially slightly different to ESCs,249
but the longer they are cultured, the more closely they begin to resemble ESCs, morphologi-
cally, transcriptionally and epi-genetically. Like ESCs, iPSCs can be directed to differentiate
into a variety of different cells. Certain cell types, like neuronal tissue is fairly easy to pro-
duce. Cardiac myocytes also appear readily, and begin rhythmically contracting within cell
cultures.Unfortunately most differentiation results in a heterogeneous mixture of cells. With-
out the highly specific 3D environment found within the developing embryo it is hard to specify
cells perfectly. Differentiation of pluripotent stem cells into specific fates is thus an active field
of research. iPSCs offer the opportunity to produce pluripotent cells from any adult patient
and they are currently being used to study diseases. Cell models are produced for specific
genetic disorders, and are used to increase understanding of the biochemistry involved. Thus
enabling the identification and characterisation of the consequences of a faulty gene. Treat-
ments can also be tested on these cells before going into clinical trials. In the near future
iPSCs are hoped to be used to produce patient derived cells, or tissues, required to regenerate
diseased, or damaged areas of the body.
1.5.3 Neural stem cells
Neural stem cell are proliferating cells of the nervous system which are able to self renew and
can form all three nervous tissue cells; neurons, astrocytes and oligodendrocytes.9 They are
routinely cultured in vitro. Whether or not the neural stem cells cultured in vitro are artefacts
of cell culture or are representative of endogenous neural stem cell in the brain is still under
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some debate.9,206
Neurospheres
Figure 1.3: (A) Neurospheres generated from adult rat hippocampus. (B) Im-
munoreactive for nestin (red) and nuclei stained with DAPI (blue). (C) After be-
ing differentiated for two days they display positive immunoreactivity for TUBB3
(green) and GFAP (red).205
Neural stem cells are routinely cultured in vitro in the presence of FGF2 and EGF as floating
neurospheres (Figure 1.3).50,145,146,209 Neurospheres are spherical agglomerations of nervous
tissue cells at various stages of differentiation. Due to the spherical nature of neurospheres,
a declining growth factor gradient is produced towards the interior of neurospheres.36 Cells
on the interior of the neurosphere are more differentiated than the peripheral cells. Removal
of growth factors and transferral to adherent culture conditions induces differentiation and
migration of the cells out of neurospheres.8
A neurosphere can be formed from either a neural stem cell or a neural progenitor cell.207
Neural progenitors are neural stem cells that have become more restricted in their differenti-
ation potential becoming bi-potent or uni-potent. Neurospheres cultured for long periods of
time gradually lose the ability to generate neurons upon differentiation.235 This may be due
to a gradual transition of neurospheres containing neural stem cells to those containing glial
progenitors.
One of the difficulties in studying neurospheres is that the heterogeneity of the neuro-
spheres prevents accurate analysis of the discrete cells forming the neurospheres.206 Quanti-
tative changes occurring in neural stem cell within neurospheres are obscured by the hetero-
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geneity of cells within neurospheres and the heterogeneity across neurospheres within the same
culture. In order to quantitatively measure changes in neural stem cells a homogeneous culture
of neural stem cells that maintains long term tri-potency is required.206
Additional source of neural stem cells
A homogeneous adherent population of neural stem cells can be produced through either
immortalisation of neural stem cells40,55 or by deriving neural stem cells from pluripotent stem
cells.58,185 Immortalisation requires the insertion and constant expressions of genes such as
MYC into neural stem cells. These constantly expressed immortalisation genes may alter
both regulation of the cell cycle and the cells differentiation potential. Neural stem cells can
also be derived from ESCs or iPSCs, through directed or spontaneous differentiation, but will
potentially be affected by the artificial in vitro environment in which they are derived. Both
immortalisation and generation of neural stem cells from pluripotent stem cells runs the risk
of creating a cell which mimics, but is not a true neural stem cell.
(a) (b)
Figure 1.4: Human foetal hind-brain neural stem cells cultured as monolayers
from (a) Carnegie Stage 15 and (b) 22.211
Homogeneous non-immortalised human neural stem cell In 2008, Sun et al. from the
Smith lab produced the first non immortalised human neural stem cell line from nine week old
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human foetal cortex (Carnegie Stage 22). The group used a serum free medium containing
FGF2 and EGF and alternated the use of laminin and gelatine as the substrate upon which
the human foetal neural stem cells proliferated. These culture conditions allowed only the
survival of neural stem cells, thus effectively separating them from differentiated progenitor
cells. These hfNS cells self renew and are genetically stable for up to 100 generations. They are
tri-potent, thus able to form all three neural tissue cells. This homogeneous population of hfNS
cells may provide an accessible population of cells which can be used to model neurogenesis
in vitro. hfNS cells resemble in vivo RG cells in morphology, cell marker expression and
differentiation potential. Upon differentiation hfNS cells form a heterogeneous mixture of
neurons and astrocytes with few oligodendrocytes, they can however be induced to form greater
proportions of these cells through stimulation by BDNF , GDNF and platelet-derived growth
factor (PDGF) respectively.
Neuroepithelial Stem Cells In 2013, Tailor et al. also from the Smith lab, produced an-
other neural stem cell line, this time from five week old human foetal hind-brain (Carnegie
Stage 15) using the same procedure as Sun et al. These cells have a epithelial cell like mor-
phology and produce neural tube characteristic rosettes . They were thus named, hfNES cells.
These cells self renew, proliferating more rapidly than hfNS cells. They are karyotypically
stable for multiple generations and can be clonally cultured with conditioned media. Upon
differentiation they form an almost pure population of neurons, both GABAergic and glu-
taminergic neurons. In vitro differentiated neurons from hfNES cells were shown to mature
over two months, but became synaptically active within two weeks, as measured by electro-
physiology. Proliferating hfNES cells are easily transformed to express exogenous proteins such
as green fluorescent protein (GFP). Tailor et al. transplanted hfNES cells into adult and em-
bryonic mouse brains, and showed they were able to functionally integrate. hfNES cells like
cells called lt-NES have also been produced directly from ESC64,65,83,247 and iPSC.68 .
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Chapter 2
Proteomics
2.1 Introduction
Genomics is the of study the of genomes, the entire genetic sequence of organisms. Sequenc-
ing of the human genome has enabled the identification of 20258 protein transcribing genes
(Uniprot). Transcriptomics is the study of the rates at which these genes are expressed or
transcribed into messenger RNA (mRNA). The mRNA is then translated into proteins, the
main functional components of cells. Knowing the sequence of the genes has allowed accurate
high throughput identification and quantification of the proteins produced by these genes,
spawning proteomics, which is the study of all proteins produced by an cell, tissue or organ-
ism’s genome.225 A cell’s transcriptome and proteome is under constant flux as it responds to
environmental changes. Genes within the genome are identified in vitro, where there is physical
evidence for their existence; mRNA or proteins produced by the genes have been identified.
Genes are also identified in silico, where their sequence have characteristics similar to other
known genes. Many of the genes identified in silico have been verified, some may not exist at
all. The latest protein level count is 17694.155
Gene expression levels do not always correlate with protein abundances resulting in the
proteome often differing from the transcriptome. The difference is due at least in part to
post transcriptional regulation of protein synthesis and degradation. Protein abundance may
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however be more conserved across species than gene expression levels.116 This makes sense since
proteins are the functional components and RNA is a messenger. Even though the message
may differ slightly, the end result and goal may be maintained.
Measuring global changes in proteins, i.e. proteomics, is however more complex than
measuring transcriptomic changes. mRNA has a simple chemistry, four RNA base-pairs with
similar chemical properties forming long polymers. mRNA is easily enriched and can be ampli-
fied, thus increasing the overall quantity, without changing the differences between individual
mRNA molecules too significantly.
Proteins are produced as linear chains of twenty different amino acids, each with a different
chemical property. They can be acidic, basic, polar or non-polar. As proteins are synthesised
the chemical properties of the amino acids cause them to fold into specific 3D conformations.
The chemical environment of the cytoplasm in which most proteins are produced, affects their
folding. Specific environments created within the endoplasmic reticulum, the Golgi apparatus
and by protein chaperones induce additional protein conformations. The final conformation is
an energetic folded minima, thus stabilising the final structure. The amino acids exposed on
the surface of a protein molecule determine how it interacts with its surroundings. The 3D
structure and surface chemistry produce the diverse functions of proteins required in a cell.
A protein’s affect is influenced by both it’s abundance and post-translational state. Phos-
phorylation for instance usually turns phosphoprotein activity on. There are hundreds of
protein post-translation modifications which change the conformation, surface chemistry and
activity of proteins. The diversity in protein chemistries influences the extraction, purification
and fractionation of proteins. No single extraction and purification is sufficient for all the
proteins in the proteome.
Unlike mRNA, proteins cannot be amplified in vitro. Protein quantity is therefore often
a limiting factor in many studies. Cells are usually lysed in detergents or chaotropic agent
to maintain protein solubility. Proteins can then be enriched through precipitation or filter
aided sample preparation (FASP). Differential detergent and differential centrifugation allow
access to different cellular compartments. Nano-scale liquid chromatography (LC) allows the
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proteome to be separated into minute fractions. Mass spectrometer (MS) allows detection of
proteins at femtomolar concentrations within these fractions.
The 20258 protein transcribing human genes produce roughly 70 000 protein isoforms and
up to 1 million different post-translationally modified proteins. Proteins are expressed across
5 to 8 orders of magnitude in a single cell.51 A few high abundant proteins constitute the
bulk of cellular protein and obscure the identification of numerous low abundant proteins.135
Currently half of the proteins, not including post-translational modifications, of simple mul-
ticellular organisms as can be covered by proteomic analysis27 and this proteome coverage is
constantly being increased. Many post-translational modifications such as phosphorylation
can be detected by MS. An pre-enrichment of the modified proteins or peptides is usually
required. Metabolic and chemical labelling and recent advances in label free quantification
allows absolute and relative quantification between samples.
The are a considerable number of challenges in accessing the complete proteomic. Pro-
teomics however offers a more detailed picture of the functioning of cells than transcriptomics.
mRNA merely hints at the potential abundance of proteins, whereas proteomics is able to
measure protein abundance and state.
History
Traditionally, proteins have been studied by a variety of molecular biology techniques. Usually
these techniques study only a few proteins at a time. Proteins can be individually visualised
using antibodies conjugated to fluorophores. Individual proteins can be quantitated using
western blotting or localised through immunohistochemistry. Proteins can be isolated and
their activity kinetics defined in a test tube. Although this is hugely important, the process
is time and labour intensive. Individual proteins need to be selected based on pre-existing
knowledge. Proteomics enables the study of proteins without any pre-defined selection. The
hypotheses produced by proteomics then need to be validated using traditional molecular
biology techniques.
The origin of proteomics is in two dimensional gel electrophoresis (2D gel). Proteins were
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separated by iso-electric focusing (IEF) and then by size on SDS polyacrylamide gel elec-
trophoresis (SDS-PAGE). The gels were then silver stained, to visualise the proteins as dark
spots. Initially gels were run separately and then visually overlaid. Differences in abundance
of proteins could be deduced from the intensity of the spots. Spots were excised and analysed
by MS to identify them. Each spot usually contained multiple proteins, the most abundant
contributing the majority of the spot. 2D gels provided information on differences in protein
abundance. Post translational modification causes changes in protein mass and charge, thus
shifting the spots. Due to large variability in the gels, numerous replicates were required for
accurate measurements.
Figure 2.1: Differential gel electrophoresis (DIGE).177
In differential gel electrophoresis (DIGE) samples are labelled with up to three size and
charge matched fluorescent dyes (Figure 2.1). This allows different conditions to be run on
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the same gel. A reference sample can be run as the 3rd sample enabling better comparisons
between gel replicates. 2D-DIGE is still routinely used but suffers from low resolution with the
potential of only being able to identify 10-100s of proteins compared to thousands with liquid
chromatography coupled to tandem mass spectrometry (LC/MS/MS). It however is still the
only proteomics technique from which protein quantitation can be directly deduced.
2.2 Tandem mass spectrometry
2.2.1 Liquid chromatography
LC/MS/MS is now the cornerstone of proteomics. In LC a sample suspended in a mobile
phase flows through an absorbent material called the stationary phase. The difference in
interaction of the analytes within the mobile phase to the stationary phase affects their flow
rate. The interaction can further be manipulated by changing the solvent composition of the
mobile phase. Analytes are therefore separated as fractions in time, and can thus be analysed
sequentially by MS.
In proteomics high performance liquid chromatography (HPLC) is generally coupled di-
rectly to a MS. HPLC columns are generally produced by filling narrow borosilicate glass
capillaries with stationary phase silica beads. The most commonly used stationary phases in
proteomics are reverse phase (RP), normal phase and strong cation exchange (SCX). They sep-
arate analytes based on hydrophobicity, hydrophilicity and positive charge respectively. The
length and diameter of the column together with the size of the beads affects the resolving
power of the column.
Sample is loaded onto the column, in the equilibration mobile phase, most of the analytes
will bind to the stationary phase. Mobile phase continually flows through the column. Reverse
phase separates analytes based on hydrophobicity, so increasing the percentage of organic sol-
vent in the mobile phase causes elution of the analytes. The gradient describes the rate of this
increased. As the percentage of organic solvent in the mobile phase is increased, analytes with
low hydrophobicity become more loosely bound to the stationary phase. They flow down the
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column, with further increases in organic solvent, analytes with greater hydrophobicity elute.
Sample can be visualised eluting off the column using in-line ultraviolet-visible spectroscopy
(UV-Vis). Sample can either be collected as a number of fractions or analysed continuously
as they elute by electrospray ionisation (ESI) coupled MS. If conditions are the same (ie sta-
tionary phase, mobile phase, column length, temperature and gradient) analytes will have
reproducible retention times.
More than one stationary phase can be used in series, if two types of separations are suffi-
ciently different they are said to be orthogonal. No two stationary phases are truly orthogonal,
but the term is still used if their separations are sufficiently different. For example, if a sample
is first separated on SCX, peptide eluting together from SCX should not elute together when
separated by RP. Different modes of separation can therefore be used one after the other to
increase separation.
2.2.2 Mass spectrometry
All MS’s consist of three components; an ion source, an analyser and a detector.
Ion Source The purpose of an ion source is to produce gas phase ions from analytes. Initial
hard ionisation techniques fragmented the analytes when producing ions. More recent soft
ionization techniques do little damage to the analytes during ionisation. The charges on ions
allow them to be electromagnetically manipulated within the mass analyser. There are two
basic soft ionisation techniques routinely used in proteomics: matrix assisted laser desorption
ionization (MALDI) and ESI. The 2002 Nobel prize in chemistry was awarded to Koichi Tanaka
and John B. Fenn for applying these techniques to macromolecular ionisation. thereby enabling
their use in biology.
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(a) (b)
Figure 2.2: (a) Matrix assisted laser desorption ionization.221 and (b) Electro-
spray ionisation.54
MALDI In MALDI analytes are deposited within an aromatic matrix. A laser is fired
at the matrix triggering ablation and desorption of the matrix. During desorption charges
are passed from the aromatic matrix to the analytes, ionising them. These ions are focuses
electromagnetically and then accelerated into the mass analyser (Figure 2.2). MALDI was first
coined by Karas et al. in 1985, while studying the ionisation of amino acids they discovered
an increased desorption of aromatic amino acids. In 1988 Tanaka et al. applied it to marco-
molecules making it amenable to biological work. Today organic matrices with nitrogen laser’s
are routinely used. MALDI works well for simple samples, such as peptide mass fingerprinting,
where a purified protein is enzymatically digested and spotted on a MALDI plate. The masses
of the peptides produced by digestion enables identification of the protein. MALDI can also be
combined with LC, with drop sized fractions mixed with matrix spotted onto a MALDI plate
for subsequent analysis. In addition MALDI is now being applied to tissue imaging, where
tissue slices are coated in matrix and different areas fired with a laser, thereby identifying
proteins occurring in those areas.
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Electrospray ionisation ESI was first reported in 1984237 and in 1989 John Bennet70
applied it to the study of macromolecules. ESI is a soft ionisation technique that produces
multiply charged ions. In ESI a sharp metal or metal coated emitter is coupled directly to the
end of a HPLC column. A charge ≈2kV is applied to the emitter producing a Tailor Cone.
Charged liquid droplets are sprayed towards the MS ion source which is heated (Figure 2.2).
As droplets approach the MS the solvent begins to evaporate and the droplets become smaller.
As the droplets shrink the coulomb repulsion forces of the like charges increase. The Rayleigh
limit is a point at which the coulomb repulsion forces exceed the surface tension of the droplet.
Two models have been proposed as to how gas phase ions are produced.
In 1968 Dole proposed the ion evaporation model, whereby the droplets become deformed
and burst into smaller droplets, thus increasing the surface area, called Coulomb fission. This
continues to happen until each droplet contains a single ion, from which the solvent then
evaporates resulting in gas phase ions
An alternative charge residue model was proposed by Iribarne and Thomson in 1976. As
the droplets decrease in size and the field strength increases, individual ions are pushed out of
the droplets directly into the gas phase. Both mechanisms are possible depending on the sizes
and properties of the analytes. There is still much debate in literature to the exact mechanism
in peptides.147
Mass Analyser Mass Analysers control the trajectory of ions in a vacuum using electromag-
netism. The ions reaction to the magnetic field is affected by their mass/charge ratio (m/z).
The simplest mass analyser measures the time of flight (TOF) of ions electromagnetically ac-
celerated through a vacuum. Ions with larger m/z fly slower than ions with smaller m/z. A
transmission quadrupole (quad) utilises electromagnetic radio frequency (RF) to direct the
flight of ions through parallel electromagnetic rods. RF changes to the charges on the rods
stabilised or destabilised the path of the ions. The quad allows a range of m/z’s through,
narrowing this range enables selection of specific ions. Ion traps utilise similar technology, ions
are trapped rather than transferred and can then be selectively ejected by altering the RF
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frequency. An orbitrap consists of an outer barrel like electrode and an inner spindle shaped
electrode. Ions are trapped around the spindle shaped electrode, the ions rotate around the
spindle and oscillate along the axis. The axial frequency is independent of energy and position
of the ions and can be used to deduce its m/z.101,132
Detectors Detectors record a charge from colliding or closely passing ions. The state of the
mass analyser when the charge was produced determines the m/z of the ions detected (i.e the
RF frequency that allowed the detected ions to pass through the quad). Typically the number
of ions colliding with a detector is small so the signals are increased using electron multipli-
ers. In an orbitrap the ions move close to the the detector, thus producing a charge. The
detected wave form signal is converted through fourier transform into a spectrum of m/z peaks.
Mass Spectrometers There are many different types of MSs, with different configurations
of ion sources, analysers and detectors. The different configurations enable a large range of
applications. The simplest is a MALDI-TOF, a MALDI source is placed upfront of a TOF mass
analyser, ions produced by laser ablation are drawn into and focussed by an electromagnet.
The ions are then accelerated and their time of flight measured from time of acceleration to
time of impact with the detector. This produces the first mass spectrum scan (ms1), a series
of m/z peaks for each ion. MALDI produces singly charged ions, so their time of flight is
directly proportional to their mass. A single mass is usually insufficient to definitively identify
an analyte. In order to increase their identifiability, analytes can be fragmented within the MS.
In a MALDI-TOF/TOF, two TOFs are connected in parallel. In ms1 mode parent masses are
detected and the most intense peaks selected for fragmentation. The selected ions are isolated
based on their time of flight and fragmented through collision with gas particles, called collision
induced dissociation (CID). In CID peptide amide bonds reproducibly fragment between amino
acids. Changing the fragmentation energy or conditions, changes the position of fragmentation
(Figure 2.3). The fragments detected in the second TOF make-up the tandem mass spectrum
(ms2). The parent ion mass from the ms1 scan can the be used in conjunction with the ms2
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scan to more definitively identify the detected analyte.
Figure 2.3: Collision induced dissociation176
Another common MS is a triple quad, where three quads are lined up in series: Q1, Q2
and Q3. A full scan produces ms1. The Q1 can then be used to isolate selected ions, Q2 as
a collision cell, and the Q3 to scan ms2. Hybrid MSs use combinations of mass analysers, A
Q-TOF combines a quad and a TOF. A Q-trap uses a quad and a ion trap. The LTQ orbi-
trap velosTM uses an ion trap and an orbitrap. The Thermo scientificTMQ ExactiveTMhybrid
quadrupole-orbitrap mass spectrometer (Q Exactive) uses a quad and an orbitrap. The Thermo
ScientificTMOrbitrap FusionTM TribridTMmass spectrometer uses a quad an ion trap and an
orbitrap and can do parallel detection
2.2.3 Discovery proteomics
The aim of proteomics is the detection and quantification of proteins and their post transla-
tional modifications. In top-down proteomics, proteins are detected directly by LC-MS. MS
mass accuracy is calculated as a percentage of the mass measured, so the larger the mass,
the greater the degree of error. Proteins are therefore poor candidates for analysis because
of their large masses. Large numbers of heavy carbon and nitrogen isotope containing amino
acids produce a broad isotopic mass range further complicating identification. In bottom-up
proteomics, proteins are enzymatically cleaved into peptides of 6 to 20 amino acids. These
peptides have small enough masses to enable high mass accuracy. Their small isotopic series
means the mono-isotopic peak can be detected, further increasing the accuracy. Peptides are
fragmented within the MS to give a fragmentation spectra from which the peptide sequence
can be deduced and the protein identity inferred.
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Human cells contain more than 10000 proteins each. Digesting these into short peptides
drastically increases the complexity of the samples to be analysed. Peptides in proteomic
samples are therefore always separated by LC upstream of MS.
Currently most MS operate in a serial fashion, only able to do one measurement at a time.
In discovery proteomics or data dependent acquisition (DDA), a top 10 or top 20 approach
is usually used. 10-20 ms2 scans are performed for every ms1 scan. During a ms2 scan only
one peptide is being analysed, all other ions entering the MS are lost. The retention time of
a peptide usually ranges from 10-60s. It would therefore need to be detected within this time
or it would be lost. In a complex sample there is usually not sufficient time to analyse all
the peptides present, therefore only the most intense peptides are selected for ms2 scans. Not
detecting a protein or peptide does not mean that is was not in the sample, only that the levels
were to low to see in the time available.
Figure 2.4: Components of the Thermo scientificTMQ ExactiveTMhybrid quadrupole-
orbitrap mass spectrometer (Q Exactive)92, Ions enter the ion source are focussed by
the stacked-ring ion guide (S lens) and then passed through a bent flatapole, eliminating
unchanged species. A select range of ions is allowed to pass through the quadrapole, they
are then collected in the curved linear ion trap (c-trap). The c-trap focusses the ions and
passes them either to the Orbitrap of detection m/z or it can pass them to the high-energy
collisional dissociation (HCD) cell for fragmentation, after which the ions are returned
to the c-trap and then passed to the orbitrap for detection
Q Exactive The Q Exactive used in this study, is a hybrid MS, with a quad, c-trap, high-
energy collisional dissociation (HCD) cell and an orbitrap
In a general top ten discovery experiment, peptide ions are continually injected into the
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ion source throughout the LC gradient. In ms1 mode the quad allows all ions within 300 m/z
to 1750 m/z into the c-trap. The c-trap collects ions for a defined fill time or until it reaches
a set automatic gain control (AGC) threshold. The AGC is determined by the number of
charges filling the c-trap. The c-trap focuses the ions which are then passed to the orbitrap
for detection. Ions spin around the spindle of the orbitrap oscillating from side to side, the
frequency of oscillation is measured. Using fourier transform an accurate m/z is determined for
the ions. The time of flight between the c-trap and the orbitrap is also taken into consideration
to increase accuracy. In ms1 mode the the Q Exactive is operated at a resolution of 70 000 full
width at half maximum (FWHM), at 200 m/z and takes 256ms for each scan166 (Figure 2.4).
Ten peptide ions with the greatest intensity are selected for a ms2 mode scan. Each of
the peptides is isolated and collected individually in the c-trap. This is achieved by reducing
the mass range of the quad to 2 Dalton (Da) on either side of the selected peptide m/z. The
AGC and fill time threshold on the c-trap is reduced, since with a narrow m/z range less ions
are required. The isolated peptide ions are collected, transferred to the HCD cell, where the
peptide ions are fragment through collision with nitrogen gas. The fragments are transferred
back to the c-trap and then to the orbitrap for detection.
Peptide ions fragmented in the Q Exactive HCD preferentially produce a b/y ion fragmen-
tation series (Figure 2.3). This fragmentation series is later used to generate an amino acid
sequence for the isolated peptide through peptide spectral matching (PSM). All ten selected
peptide ions are scanned one after the other and placed on a dynamic exclusion list. If the
dynamic exclusion time is set to 30s, these peptide ions will not be selected for ms2 for the
next 30 seconds. The scan resolution in ms2 mode is 35 000, resulting in a scan time of 64ms,
with an additional 10ms for transfer and HCD time. The top ten cycle time is therefore ap-
proximately 1 second. Once all ten ms2 scans are complete another ms1 scan is performed, the
ten peptide ions with the highest intensity not on the dynamic exclusion list are selected for
another round of ms2 scans.
Using upstream fractionation processes it is possible to increase peptide separation. With
less peptides being eluted simultaneously, a greater percentage of the total number eluting
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at any one time can be identified. It is therefore possible to dig deeper into the proteome.
Measuring time and cost is however increased. Measuring time and sample quantity are the
two main limiting factors on the depth of analysis.
2.2.4 Quantitative proteomics
DDA focuses on the detection of peptides and generates a qualitative list of proteins. Quanti-
tative analysis is more useful since it enables us to determine differential expression of proteins
within cells. In discovery proteomics greater than 3000 proteins can be routinely detected in a
single experiment with only 1D fractionation, and 80% of these can generally be quantitated.
Traditionally quantitation was only performed through metabolic or chemical labelling of
peptides. Despite labelled samples being multiplexed thereby reducing measuring time, the
high purity required for metabolic and chemical labels often makes their use prohibitively
expensive.
HPLC has increased LC resolution and retention time reproducibility. While mass accuracy
and speed have increased in modern MSs. These advances have enabled the development of
new algorithms for label free quantitation (LFQ). LFQ is becoming more and more prevalent.
LFQ does not require expensive labels, but does however require each sample to be run at least
once. Measuring time on MSs is expensive, and is often the limiting factor on the number of
samples run in an experiment.
Labelling
Metabolic Labelling Peptides can be labelled in a number of different ways, the most
robust form of labelling being metabolic labelling. Cells or whole organisms can be labelled.
Cells are grown in tissue culture medium containing either heavy or light isotopes of the amino
acids arginine and lysine. These amino acids contain isotopes of carbon or nitrogen with an
additional neutron, which increases their mass by one Da, but does not alter the chemistry
of heavy peptides. Heavy arginine and lysine are used because trypsin, the most common
used protease in proteomics, cleaves peptides after arginine or lysine. This ensures that every
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peptide always has a heavy labelled amino acid. Almost all protein’s in the heavy labelled
cells need to be replaced for full incorporation to occur. Five cell doublings, results in more
than 95% of all arginine and lysine amino acids being heavy labelled. Heavy and light labelled
cells are harvested counted and combined in equal ratios. All downstream processing is done
on this combined sample, so sample processing bias does not affect quantitation. Upon MS
analysis peptides from the heavy and light labelled cells, elute at the same retention times,
since they have the same chemical properties. The heavy labelled peptides masses have been
altered by the number of neutrons added to the heavy amino acid. This can range from 6-10
Da depending on the number of carbons and nitrogens in the amino acid. These mass shifts
are easily distinguished by modern MSs. The difference in intensity between the two peaks is
used to generate a measure of relative abundance for the peptides, which is later conferred to
the proteins.
Only one of the peptide peaks needs to be sequenced for identification. The MS detection
software be can programmed to ignore peaks of a specific mass shift. Stable isotope labeling
by amino acids in cell culture (SILAC) is generally used in 2 plex experiments but can also
be scaled up to 3 plex or more. This increase in complexity of the ms1 spectra can reduce the
depth of analysis.
Chemical Labelling Chemical labeling involves the addition of reporter groups onto pro-
teins or peptides. In order to achieve complete enzymatic peptide cleavage, or digestion, it
is important to first reduce disulphide bonds and block the cysteines with iodoacetamide.
This process was easily amenable to labelling, through the use of isotope coded affinity tag
(ICAT) used in place of iodoacetamide. Samples are combined after labelling and digested,
with trypsin. The tags contain biotin, which is used to enrich the peptides containing ICAT.
The tags fragment during ms2. The relative intensities of the reporter fragments are used to
deduce relative abundance of peptides and proteins from the respective samples. One of the
drawbacks of the ICAT process is the small number of cysteine residues in proteins, so only a
few peptides can be quantitated. However this is also an advantage since sample complexity
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was also reduced in the process. In theory as long as a protein contained a cystein it could be
quantitated.
The most commonly used forms of chemical labelling are isobaric tags for relative and
absolute quantitation (iTRAQ R©) or Thermo scientificTMtandem mass tag (TMT). Cells are
lysed, proteins extracted and peptides digested. Labels are then covalently bound to the amino
groups of the amino acids, either to the terminal amino group or other free amino groups.
The labels consist of a reported group and a balance group. The labels have been designed
to fragment between the reported group and the balance group during CID. The resultant
reported groups can then be found in the lower end of the spectrum, below the masses of any
amino acids. Each reporter group’s mass is separated by 1 Da. Their relative abundance is
determined from the ratio between their peaks in the ms2 spectrum and relates to the relative
abundances of proteins from the originating samples. iTRAQ R© comes in either four or eight
plex, while TMT has up to 12 labels. This multiplexing allows more samples to be compared
simultaneously than with SILAC. Sample processing bias however may be introduced into the
quantitation since the labelling only occurs after digestion. This variance can be measured by
duplicating one of the samples or a pool of the samples, and using the deviation within this
sample as a technical variance of the experiment, making any variance observed beyond this
level biological variance.28
Label Free Quantitation
In SILAC quantitation is done by comparing the integrated area under the curve of the light
vs heavy labelled peptides within the same ms1 scan. In a label free discovery experiment
a similar integration is done for every peptide and translated to an intensity value. These
intensities values for peptides are then compared across different LC/MS/MS runs. The ac-
curacy of LFQ quantitation is less than for labelled quantitation, due to increased variance
caused by the measurements being taken across different LC/MS/MS runs. Some of the vari-
ance is accounted for by normalisation with algorithms like MaxQuant label free quantification
algorithm (MaxLFQ).
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Here the assumption is made that most of the proteins within a cell state are responsible
for homoeostatic control and therefore do not vary greatly. Most peptides are then expected
to be expressed in a 1:1 manner. MaxLFQ compares individual peptides in a pairwise manner
and determines which peptides should have 1:1 ratios. It uses the offset in the ratios of these
peptides to normalise the remaining peptides. A more reasonable distribution with a mean
of zero is then achieved. This enables the peptides and proteins that are truly differentially
expressed to be more clearly discriminated.
Accuracy can be improved by technical replicates, multiple LC/MS/MS runs of the same
sample, which however increases measuring time and cost.
2.2.5 Targeted proteomics
If information about specific proteins is required, rather than acquiring all possible spectra,
as in a DDA. The MS can be programmed to scan for specific masses at specific retention
times, called targeted proteomics. Targeting peptides in this manner increases the sensitivity
of detection 5-10 fold.59 The accuracy of quantitation is also increased by ensuring that a
sufficient number of points across the integration curve are detected per peptide. A list of
m/z values for the peptides to be targeted is required. A fragmentation spectrum generated
on the same MS aids identification. The simplest form of targeted proteomics simply adds
an inclusion list to a DDA experiment. Ms1 scans are performed, if the specified peptides
m/z’s are detected by ms1 they are triggered for ms2. In this mode selected peptides are
given preference but other peptides not on the list can also be detected like in a discovery
experiment. Quantitation is based on the ms1 peaks.
Selected reaction monitoring (SRM) usually done in a triple-quad uses only ms2 fragments
ions called transitions. An isolation list of transitions is cycled through from top to bottom.
The 1st quad is set to select each peptide individually, the width of detection can be set between
0.5 and 4 Da on either side of the peptide. All ions making it through the Q1 are fragmented
in Q2. Q3 isolates then the specified transitions for detection. Downstream software is used
to determine if detected transitions originate from the proteins being targeted. Usually three
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peptides and three transitions per peptide are required for a protein identification. Integration
of ms2 transitions is used for quantitation. The cycle time is the sum of the time it takes for
each transition in the isolation list to be scanned. In order to achieve accurate quantitation, 3-
10 scans of each transition are required during its elution time, thus limiting the total number
of transitions that can be scanned per cycle.
In parallel reaction monitoring (PRM) using a Q Exactive, up to ten peptides are collected
in the c-trap before before fragmentation. All the fragments are analysed simultaneously thus
reducing cycle time and allowing more peptides to be targeted per run. ms2 transitions are
used for quantitation.
In SRMs and PRMs, if the elution time of a specific peptide is robust enough, an elution
time range can be set in the inclusion list. A peptide or its transitions will only be targeted
during this elution time range. This reduces the scan time in all other time ranges and allows
more peptides to be added to the inclusion list.
A high accuracy peptide mass together with a robust elution time is sufficient for ms1 only
identification. Peptides need to be identified in by ms2 fragments and then the elution time
shown to be robust. Peptides can then be identified without fragmentation. It speeds up
analysis, and improves quantitation accuracy.
2.3 Neural stem cell proteomic studies
Zizkova et al. 2015 wrote a review of the need and importance of proteomic research on neural
stem cell development and differentiation. In it they describe a number of fundamental studies
that have advanced the field, some of those are mentioned here.
Chaerkady and Kerr 2009 differentiated human ESCs (hESCs) into neural progenitors cells,
motor neurons and astrocytes. The digested peptides from each population was labelled with
iTRAQ R© and analysed by LC/MS/MS. Their work may have been the first comprehensive pro-
teomics analysis of human neural stem cells derived from ESC. 1185 proteins were quantifiable.
The pluripotent markers ALPL, abnormal cell lineage 28 (LIN28 ) as well as two transcription
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factors HMGA1 and SIN3A were shown to be down-regulated during differentiation. They
also identified a number of proteins that could be used as potential novel markers of neural
stem cell differentiation.
In subsequent work by Chaerkady et al. 2011, hESC were differentiated to neural progen-
itors, glial restricted precursors and oligodendrocyte precursors. The digested peptides were
labelled with iTRAQ R© and analysed by LC/MS/MS. They identified 2956 protein groups.
Their focus was the analysis of proteins showing differential expression during oligodendrocyte
differentiation. They were able to verify many of the genes already discovered by transcrip-
tomic analysis, highlighting CD44 as important in directing oligodendrocyte fate.
Maltman et al. 2011 use a top-down proteomics approach to study the peptidome. Im-
mortalised human neural progenitors were allowed to differentiate spontaneously by removing
the growth factors from the media. All cells stained positive for TUBB3 and GFAP indi-
cating a mixed population of neurons and astrocytes. Protein was extracted from lysates
using C8 columns and analysed by MALDI-TOF/TOF. A number of intermediate filaments
and cytoskeletal proteins were found up or down-regulated during differentiation indicating
re-arrangement of the cytoskeleton during differentiation, together with STMN1 a regulator
of the cytoskeleton.
Cao et al. 2012 analysed membrane proteins from immortalised mouse neural stem cells
differentiated into astroglial cells. The cells had been labelled with SILAC and were analysed
by LC/MS/MS on a LTQ-Orbitrap. They identified more than 700 proteins and found that
the differentiated cells membranes were far more complex that that of the neural stem cells.
They also observed an activation of oxidative metabolism and concluded that this may be a
signature of neural stem cell differentiation.
Abraham et al. 2013 analysed changes in neural stem cell using a mouse neurosphere assay.
Second passage neurospheres were compared to eighth passage neurospheres by LC/MS/MS.
Neurospheres loose their neurogenic potential with successive passages, so this would help
identify potential gliogenic markers. Candidates were then further assessed by immunohisto-
chemistry. They observed changes in high mobility group (HMG) proteins in neural progeni-
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tors over time and during differentiation. In particular HMGB2 was shown to decrease during
development and may be controlled by lethal-7 (let-7 ).
Singec et al. 2016 differentiated hESC to a pure population of neural stem cell using a small
molecule cocktail, to suppress non-neural differentiation. The neural stem cells produced were
tri-potent able to be differentiated in the neurons, astrocytes and oligodendrocytes, indicating
that were probably RG like cells. A phosphoproteomic comparison was made between the
hESC and neural stem cells. They found that suppression of WNT signalling and the up-
regulation of MDK was necessary for differentiation of hESC into neural stem cells.
A lot of research has been performed on neural stem cell development using proteomic
tools. The work in this Thesis is the first to be conduction on neural stem cells derived from
human foetal hindbrain and more particularly comparing hfNES cells to hfNS cells.
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Chapter 3
Bioinformatics
3.1 PSM identification
LC/MS/MS data comes as ms1 and ms2 scans. Both scans are associated with a retention time
(RT), the time the sample was eluted from the LC and detected by the MS. The ms2 scans are
associated with the m/z of the isolated ms1 precursor, called the parent ion. Each scan consists
of two data columns m/z values and intensities. The ms1 scans are used for quantitation
discussed in section 2.2.4, while the ms2 scans are used to identify the peptides sequences.
The software MaxQuant (MQ)49,52 was used in this work for identification and quantitation.
A protein sequence database was downloaded from the universal protein resource (Uniprot),24
with the search criteria taxonomy number 9606 for homo sapiens. This protein sequence fasta
file contains amino acids sequences for all known human proteins including their isoforms. It
is curated and constantly updated with new information.
MQ generates theoretical spectra through an in silico digest of the proteins sequences
within the fasta file. Trypsin is usually used because it produces the most appropriately sized
peptides. Only peptides between 6 and 20 amino acids in length are used for the database
search. Smaller peptides are two ambiguous to identify. Larger peptide suffer from mass
accuracy and sequencing problems. Trypsin cleaves polypeptides after arginine and lysine
residues unless the the next amino acid is a proline. Two missed cleavages are usually allowed
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since the enzymes are never perfectly efficient in vitro.
A theoretical spectrum is generated for each of the peptides, with peaks representing a b/y
ion fragmentation. MQ then uses the Andromeda search engine which is based on a similar
algorithm as Mascot,163 to match the detected ms2 scans to the theoretical peptides. Using
the isotopic mass shifts of the parent ion it’s charge is determined and thereby its detected
mass from the mass/charge ratio (m/z). Only theoretical spectra with masses matching that
of the ms2 scan’s parent ion mass are compared. The peaks of the acquired ms2 scans are
correlated to the peaks in the theoretical spectrum, and the match is scored.
Due to the large search space, the number of theoretical peptides in the database, compared
to the number of ms2 scans, there is a high likely hood of some spectra matching theoretical
spectra by random chance. To determine the number of random matches, a second round of
matching is done against a decoy database. The decoy databases is generated by reversing
the sequences of the original protein database. Any ms2 scan matching the theoretical spectra
from the decoy database is an incorrect match. A PSM match score cut-off is selected where
1% of matches originate from the decoy database. It is then surmised that up to 1% of the
experimental data may be false positives, called the false discovery rate (FDR). It is not
possible to determine which of the matches might be false positives. Only proteins identified
by more than one peptide are used, so a few incorrect matches should not affect the data
significantly.
In addition to the global FDR, a local FDR can be calculated on a peptide by peptide
basis. This calculation uses the percentage of decoy hits with the same score as the peptide
and is referred to as a posterior error probability (PEP). Global FDR is use when a list of
proteins in required for downstream functional analysis. PEP is used when a confidence score
is important for individual proteins identification.
MQ produces a table for every level of identification allowing users to track the steps
the software went through in identifying proteins. The tables are structured like a relational
database, with row numbers linking the various files. The MScan.txt and MSMScan.txt tables
contain the ms1 and ms2 scan information respectively. All PSM’s are in the evidence.txt table.
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The peptide.txt table contains single entries for identified peptides together with quantitation
information represented by a columns for each of the .raw files. The proteins identified need to
be inferred from the peptides identified. Often proteins will be identified that share peptides
with other proteins, especially if the database consists of many isoforms. When a protein or
isoform cannot be uniquely identified it forms part of a protein group in the proteinGroups.txt
table. Peptides shared by more than one protein are called razor peptides. Protein group
quantitation is collated across multiple .raw files, by assigning the an experiment name to
multiple .raw files. This can even be done across 2D fractionated samples.
3.2 Statistics
Once quantitative information is available for samples, the next step is to determine which of
the proteins is significantly differentially expressed. In this work ratios were generate between
conditions tested. The ratios were logarithm base 2 (log2) transformed. Plotting the log2
transformed data by histogram reveals a normal distribution, distributed evenly across zero.
A standard deviation (σ) was then calculated. The σ of the replicate data represents the
degree of technical variance in the data. According to the Empirical Rule, 95% of data points
fall within 2σ. This was selected as the extent of technical variance. Unfortunately only using
the mean log2 ratio is not sufficient to determine significant differential expression. In some
cases the variance between replicates is so great that their mean is misleading. In order to
test for significance the two-sided Student’s t test (t test) was used. The t test determines if
the means of two sets of data points are significantly different, while taking the variance into
account. Data with too great a variance are negatively scored. The t test returns a calculated
probability (p-value), below 0.05 is accepted as significantly differentially expressed.
3.2.1 Multiple testing correction
Using a p-value of 0.05 means that 5% of the tests done may be incorrect by random chance150.
The likelihood of getting false positives due to random chance is greatly increase by the number
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of tests being done. In order to counteract this multiple-testing correction is done. It takes
the number of tests being done into consideration and adjusts the p-value accordingly.
Bonferroni adjustment The Bonferroni adjustment is the most widely used and simplest
correction method, values remain significant if the p-value divided by the number of tests is
still significant.150 This minimises to the family-wise error, but it often too strict. Bonferroni
adjustment will often result in no data being significant, so less conservative approaches need
to be applied.
False discovery rate (FDR) FDR correction allows a percentage of positive results to be
false. This can be done by comparing real values against values randomly generated, or through
the use of the Benjamini-Hochberg (BH) procedure which uses the p-value distribution. The
p-values need to be uniform exponentially decaying distribution.150 The p-values are sorted in
ascending order and then divided by the percentile mark, to give the estimated FDR.150
In proteomics multiple-testing correction is often problematic due to a number of different
factors. Due to the high cost, the analysis power is often low. Often only a small percentage of
the data will show an effective, change and the effect size might be small.160 If the p-value value
distribution is exponentially decaying, this is usually a good sign that there is a measurable
change. Multiple-testing correction will often still however render all the resulting p-values not
significant. It is a blunt tool, but can still be used to reduce false positives if no downstream
targeted experiments are planned.
Removing some of values before performing t test can reduce some of the losses due to
multiple-testing correction. It is however important not to remove values that would inadver-
tently bias the t test.
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Chapter 4
Aim
Proliferating hfNES cells have a neuroepithelial cell like morphology and appear to differ-
entiate into an almost pure population of neurons. hfNS cells have a RG like morphology
and differentiate into a mixed population of neurons and glia. It is hypothesised that there
are specific control mechanisms responsible for producing this difference and that through
proteomic analysis it may be possible to identify these mechanisms. It is further hypothesised
that identifying the specific mechanisms responsible for maintaining hfNES cells cellular state,
may produce candidate molecules for the development or brain regenerative therapies.
The project is divided into two experimental phases.
Neural Stem Cell Proliferation Comparison Quantitative comparison of the proteomes
of hfNES cells and hfNS cells.
Neural Stem Cell Differentiation Analysis Quantitative assessment of the proteomic
changes occurring in hfNES cells and hfNS cells as they undergo differentiation.
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Part II
Methods
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Reagents
100µm fused silica capillary
fused silica capillary, 100 µm ID (Next advance CAP-100) 61
10cm TC dish
10cm TPP tissue culture dish (Sigma Z707686) 44, 45, 58
15ml falcon tube
15ml falcon tube 44
24 well TC plate
Corning R© Costar R© cell culture plate, 24 well, flat bottom (Sigma CLS3527) 64
30kDa MWCO filters
molecular weight cut off filters 47
5µm SCX beads
strong cation exchange bulk packing material (Phenomenex 04A-4398) 61
5µm luna C18 beads
5µm luna C18(2) bulk packing material (Phenomenex 04A-4398) 49, 61, 66
6 well TC plate
Corning R© Costar R© cell culture plate, 6 well, flat bottom (Sigma CLS3516) 58
6cm TC dish
6cm TPP tissue culture dish (Sigma Z707678) 58
96 well flat bottom plate
Greiner R© polystyrene 96 well plates, flat bottom (Sigma M3061) 46
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ABC
0.05M ammonium bicarbonate (Sigma A6141) 47
Alexa 448 (Green) anti-mouse IgG2A
goat anti-mouse IgG2A Alexa Fluor R© 488 65
Alexa 555 (Red) anti-mouse IgG1A
goat anti-mouse IgG1A Alexa Fluor R© 555 65
Alexa 555 (Red) anti-sheep
donkey anti-sheep IgG Alexa Fluor R© 555 65
ammonium acetate
ammonium acetate (Merck SAAR1122220EM) 61, 62
ammonium formate
ammonium formate 59
anti-GFAP
sheep anti-GFAP (R&D Systems, 1:50) 65, 81, 82, 92–95
anti-Nestin
mouse IgG1A anti-Nestin (R&D Systems, 1:200) 64, 65, 81, 82, 92–94
anti-TuJ-1
mouse IgG2A anti-β-III-Tubulin (R&D Systems, 1:200) 64, 65, 81, 82, 92–95
B
ACN 0.1% FA 49, 61, 62
BCA assay
Pierce bicinchoninic acid protein quantitation assay (Pierce 23227) 46, 59
Benzonaze R©
Benzonase R© Nuclease(Sigma E1014) 46
Bio-Rad R© microplate reader
Bio-Rad R© iMark R© microplate absorbance reader 46
blocking solution
0.3% Triton-X100 and 5% goat serum in PBS 64
44
C18
octadecyl hydrocarbon bonded silica stationary phase 47, 48, 59
C18 SPE tube
discovery R© DSC-18 SPE tube (Supelco 52606-U) 48
cryo vials
Corning R© cryogenic vials, external thread (Sigma CLS430661) 45
DAPI
4’,6-diamidino-2-phenylindole 64, 65, 93–95
Dionex
Dionex Ultimate 3000 UHPLC 49, 66
DMSO
dimethyl sulphoxide (Sigma D2650) 45, 58
DTT
dithiothreitol (MERCK 3869) 47
Dundee control SILAC
control SILAC DMEM-F12 R0K0 (Dundee cell products DMEF-38) 59
Dundee heavy SILAC
SILAC DMEM-F12 K6R6 media (Dundee cell products DMEF-39) 59
Easy-nLC
Thermo scientificTMEasy-nLC II 61
EGF
epidermal growth factor (Gibco PHG0311) 80, 92, 176
FAST READ 102
FAST READ 102 disposable haemocytometer (Davies diagnostic HYC-MISC-BVS100)
45
FCS
foetal calf serum (Sigma F7524) 44, 58
45
FGF
fibroblast growth factor (Gibco PHG0026) 80, 92, 176
gel loader tip
GT-10-6 gell-well pipette tip (Mettler toledo 17002380) 47
glass insert
glass insert shell 0.35ml (SUPELCO 24715) 48
HB1025
NS cell line 57, 59–62, 64, 85, 86, 95
HB901
NS cell line 57, 60, 61, 64, 85, 86, 95
heavy SILAC medium
neural stem cell medium, with the DMEM:F12 replaced by either Dundee heavy SILAC
or Thermo SILAC DMEM:F12 with K6 and R10 58, 59, 61
IAA
UA with 0.05M iodoacetamide 47
isopropanol
isopropanol (Sigma 34965) 45
K0
L-lysine-2HCl (Thermo scientific PI-89987) 61
K6
L-lysine-2HCl, 13C (Thermo scientific PI-89988) 61
laminin
laminin (Sigma L2020) 57, 64
Leica application suite advanced fluorescence
Leica application suite advanced fluorescence 65
46
Leica inverted fluorescent microscope
Leika inverted fluorescent microscope (Leica DMI 4000) 65
light SILAC medium
neural stem cell medium with the DMEM:F12 replaced by either Dundee control SILAC
or Thermo SILAC DMEM:F12 with K0 and R0 58, 59, 61
LTQ orbitrap velosTM
Thermo scientificTMLTQ orbitrap velosTM 27, 60, 61
modified RIPA buffer
modified radioimmunoprecipitation assay buffer (150mM NaCl, 50mM TEAB pH 8.5,
0.5% DOC, 1% SDS) 46, 59
Mr Frosty R©
freezing container, Nalgene R© Mr Frosty (C1562 Sigma) 45
neural stem cell differentiation medium
neural stem cell medium without FGF and EGF 64, 65
neural stem cell medium
DMEM:F12, 1x N2, 1x B27, 10ng/ml EGF, 10ng/ml FGF and PenStrep 57, 58, 64, 80
neuroblastoma freezing medium
DMEM, 20% FCS, 10% DMSO, PenStrep 45
neuroblastoma medium
DMEM, 10% FCS, 1x PenStrep 44, 69
PBS
phosphate saline buffer (Sigma D8537) 44, 45, 58, 64, 65
poly-L-ornithine
poly-L-ornithine (Sigma P3655) 57, 64
porous potassium silicate resin
Next advance frit kit 49
47
pressure injection cell
pressure injection cell (Next advance PC77) 49
protease inhibitor cocktail
protease inhibitor cocktail (Roche 11836170001) 45
R10
L-arginine-HCl 13C15N (Thermo scientific PI-89990) 61
retinoic acid
retinoic acid (Sigma R2625) 45, 69, 108
RO
L-arginine-HCl (Thermo scientific PI-8998) 61
Sai1
NES cell line 57, 59–61, 64, 85, 86, 95
Sai2
NES cell line 57, 60, 64, 86, 95
Sai3
NES cell line 57, 61, 64, 85, 86, 95
SDS
sodium dodecyl sulphate (Sigma 05030) 46
SH-SY5Y cell
SH-SY5Y neuroblastoma cell line 45
SH-SY5Y cell
SH-SY5Y neuroblastoma cell line 45, 49–52, 69–71, 74
SPE elution solution
80% ACN 0.1% TFA 48
SPE tube adapter
SPE tube adapter (Supelco 57020-U) 48
48
SPE wash solution
2% ACN, 0.1% TFA 48
T-150 flask
T-150 flask, canted neck, surface area 150 cm2 (Sigma CLS3291) 65
T-25 flask
T-25 flask, canted neck, surface area 25 cm2 (Sigma C6481) 64
T-75 flask
T-75 flask, canted neck, surface area 75 cm2 (Sigma CLS3290) 58, 64
Thermo SILAC DMEM:F12
DMEM:F12 (1:1) media for SILAC (Thermo) 61
triton
triton 64
trypan blue
Trypan blue (Sigma T8154) 45
TrypLE
TrypLETMexpress (Gibco 12605028) 57, 58
trypsin
sequencing grade modified trypsin (Promega PRV5111) 47
Trypsin-EDTA
Trypsin-EDTA (Sigma T4049) 44
UA
8M urea, 0.1M Tris/HCl pH 8.5 47
Waters acquity ultra performance LC
Waters acquity ultra performance LC 59
Waters nano acquity
Waters nano acquity 60
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Chapter 5
General methods
5.1 Tissue culture
5.1.1 Neuroblastoma
SH-SY5Y proliferation The SH-SY5Y cell line was kindly donated by the Wilkinson lab
(Wilkinson lab) at the University of Cape Town (UCT). The original cells received where
labelled passage 1, the actual passage number of the original cells in unknown. Cells were
expanded and stored in liquid nitrogen as the working stock. Cells for critical experiments
were always taken from this working stock, either passage 2 or 3.
1×106 SH-SY5Y cells were plated on a 10cm TC dish, at a density of 1.2×104 cells/cm2 in
neuroblastoma medium. The cells reached 80% confluency after five days.
Lifting Cells Cells were cultured in 10cm TC dishes until 80% confluent. Culture medium
was removed from the 10cm TC dish and cells were briefly washed with 3ml PBS. 1ml 0.05%
Trypsin-EDTA in PBS was added to the cells. They were incubated for 1 min at 37 ◦C
Cells were visually inspected to see if they had rounding up, insuring they had lifted. 3ml of
neuroblastoma medium was added, thereby inhibiting trypsin with FCS. The cells were washed
off of the dish and transferred to a sterile 15ml falcon tube. The 10cm TC dish was washed
again with neuroblastoma medium to ensure all cells were recovered. The cells were pelleted
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by 600g centrifugation and then re-suspended in 1ml PBS.
Counting Cells Cells were counted using the trypan blue method. 10µl of cells were added
to 10µl of trypan blue and placed in a FAST READ 102 disposable haemocytometer. Trypan
blue is actively pumped out of cells with intact cell membranes. Therefore, cells staining blue
are not viable and only clear cells are counted. An average of 1×107 SH-SY5Y cells were lifted
from a 10cm TC dish.
Plating, Freezing or Proteomic Analysing of Cells Cells to be re-plated were plated
1/10 on a new 10cm TC dish. Cells for freezing were re-suspended in neuroblastoma freezing
medium at 1×106 cells/ml in cryo vials. Cells were frozen to -80 ◦C in a Mr Frosty R© containing
isopropanol. Isopropanol reduced the cooling rate to 1 ◦C per minute, allowing the cells to
shrink slowly as water moved out of the pores created by DMSO, resulting in frozen dehydrated
cells. The cells were then place in liquid nitrogen, which turns their cytoplasm to glass, for long
term storage.71 Cells for proteomic analysis were washed twice with PBS, counted, pelleted
and flash frozen in liquid nitrogen, then stored at -80 ◦C until required.
5.1.2 SH-SY5Y differentiation experiment
1×106 SH-SY5Y cell were plated on six 10cm TC dishes. Cell were cultured to 80% confluency.
Three of the plates were lifted and the cell pellets flash frozen for MS analysis. The other three
cell plates were treated with retinoic acid for 6 days and then lifted for MS analysis.
5.2 Sample processing
5.2.1 Cell lysis
Sample were processed in parallel within individual experiments. Samples were individually
labelled, mixed up and treated randomly, to prevent processing bias. The frozen cell pellets
were re-suspended in 60µl PBS containing a protease inhibitor cocktail. The cells were tritu-
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rated vigorously to ensure a single cell suspension, thus giving greater access of the lysis buffer
to the cells. 60µl of the cell suspension were transferred to a new tube and 30µl of 3× modified
RIPA buffer was added to obtain a 1× modified RIPA buffer final concentration.
Samples were vortexed briefly to mix and then boiled at 95 ◦C for 5 minutes. Samples
were sonicated for 15 minutes, then cooled to 4 ◦C and 1µl Benzonaze R© was added. Samples
were incubate in Benzonaze R© for 1 hour at 4 ◦C , rotating by inversion. After the Benzonaze R©
incubation, samples were boiled at 95 ◦C for 5 minutes, to dissolve any precipitated SDS.
Sample were centrifuged at max speed (15 000g) for 5 minutes, no visible insoluble pellet
was generally present in any of the samples, if a pellet was observed, the vortexing, boiling
and sonication steps were repeated. If the pellets persisted, the concentration of protein was
thought to be too high, the volume of 1×modified RIPA buffer in all samples was incrementally
increased, until all the pellets had been dissolved. All alterations to the protocol were always
mirrored across all samples in the batch.
5.2.2 Protein quantitation
A bovine serum albumin (BSA) protein standard, 2mg/ml supplied as a stock in the BCA
assay kit, was used to generate a standard concentration curve. Initially 100ul of 1mg/ml BSA
in 1× modified RIPA buffer, was made-up to use for serial dilutions. 50µl of the following
concentrations were produced, 1, 0.5, 0.25, 0.125, 0.0625 mg/ml and 1× modified RIPA buffer
buffer as a blank.
Samples were diluted 5× and 10× with 1× modified RIPA buffer to fall within the range
of the quantitation assay. 10µl of each sample dilution and protein standard was added to
separate wells of a 96 well flat bottom plate. 200µl of BCA assay reagent was then added to
each well in quick succession using a multi-channel pipette. The 96 well flat bottom plate was
incubated for 30 min at room temperature. A visible colour change was observed and measured
by UV-Vis using a Bio-Rad R© microplate reader at 562nm. The Bio-Rad R© microplate reader
generated a standard curve, as well as output the concentration of sample in mg/ml. The total
quantity of sample and the yield per million cells was calculated.
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5.2.3 Tryptic digest
After protein quantitation, 200µg from each sample was transferred to a fresh tube and incu-
bated in 0.1M DTT for 30 minutes. The remaining protein sample was stored at -80 ◦C. 30kDa
MWCO filters were used for FASP. At each FASP step the filters were centrifuged at 14000g.
After each centrifugation filters were checked to ensure the liquid had been spun through to
the dead volume of 40µl, if not, additional centrifugation steps were added. UA, IAA and
ABC solutions for FASP were prepared fresh and used the same day.
The filters were first washed by adding 500µl UA and centrifuging them for 10 minutes. The
flow through was discarded. 200µg of DTT reduced protein samples was added to separately
labelled filters. 200µl of UA was then added and filters which were centrifuged for 15 minutes,
this was repeated twice. The flow through from the filters was discarded. 100µl of IAA was
added and the filters were vortex gently at 600 rpm for 1 min. Filters were incubated in the
dark for 20 minutes without mixing, followed by centrifugation for 10 minutes. 100µl of UA
was added and filters were centrifuged for 10 minutes, repeated 3 times. 100µl ABC was then
added, and centrifuged for 10 minutes, repeated twice.
The collection vial on the 30kDa MWCO filters was replaced with a fresh vial. Trypsin
was re-suspended at 1ug/µl in ABC and added at a protein to trypsin ratio of 50:1. The filters
were then vortexed gently at 600 rmp for 1 minute. The potential hydrogen (pH) of each
sample was tested by placing 1µl from each filter onto a pH strip, to ensure it was above a pH
of 7. The 30kDa MWCO filters we then place in a wet chamber at 37 ◦C . After 16 hours of
incubation with trypsin, the peptides were eluted from the filter using 50µl 0.1% trifluoroacetic
acid (TFA), centrifuged for 10 minutes, repeated three times. The pH of the eluted peptides
were tested, to ensure a pH below 3. Peptides were either desalted directly or stored at -20 ◦C.
5.2.4 Peptide desalting
Custom C18 solid phase extraction (SPE) micro columns were produced in-house from gel
loader tips. The last 5mm of a gel loader tip was crimped at 45◦ using a serrated forceps. The
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forceps was then rotated by 90◦. Holes were punched through the lids of 1.5ml polypropylene
centrifuge tubes (centrifuge tubes) so that the micro columns could be stored upright.
SPE elution solution was added to the micro columns in 50µl volumes and forced through
using air pressure. Air pressure was supplied by a 10ml syringe attached through a SPE tube
adapter to the micro column. Effective crimping produced back-pressure, but still allowed
solvent to pass through slowly.
A C18 SPE tube was broken open and the C18 beads added to a 1.5ml centrifuge tube.
A slurry was made by triturating the beads in 500ml of SPE elution solution. 20µl from the
bottom of the slurry equalled roughly 4mg of C18 beads. 20µl of C18 beads were added to the
SPE elution solution in the micro column. The beads slowly sank to the bottom of the micro
column. The beads were then tightly packed by applying air pressure. When the SPE elution
solution reached 2mm above the level of the beads, 50µl of SPE elution solution was added to
the column and it was re-pressurised, this was repeated three times. Throughout the process
the C18 beads were always kept wet.
The beads were then equilibrated by passing three 50µl volumes of SPE wash solution
over them. Peptide produced by FASP were centrifuged at 14000g for 10 minutes, to pellet
any particulates. The peptides were passed through the beads in 50µl volumes, as slowly as
possible. Peptides bound to the the beads were then washed with two 50µl volumes of SPE
wash solution. The micro column was transferred to a fresh centrifuge tube containing a 300µl
glass insert. The bound peptides were eluted from the micro columns using three 50µl volumes
of SPE elution solution and collected in the glass inserts.
Peptide were then dried down in a vacuum centrifuge, and stored dry at -80 ◦C
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5.3 Sample analysis
5.3.1 Liquid chromatography
5.3.2 Preparing columns
Nano Columns for the LC were produced in-house using a pressure injection cell. Fused silica
capillaries were cut to length and fritted on one end, using porous potassium silicate resin. 30µl
Kasil 1624, 10 µl Kasil 1 and 10µl formamide were mixed together. Fused silica columns were
dipped into the solution for 3s, allowing 2cm of the porous potassium silicate resin solution to
be draw up by capillary action. The columns were then baked for 8 hours at 150 ◦C . Frits were
trimmed to 1cm. Bulk packing material was suspended in 100% B and forced into columns at
1000psi using a pressure injection cell. Columns were prepared for use by running 80% B at
1µl/min for 1 hour. They were then trimmed to length.
5.3.3 Dionex
All SH-SY5Y cell samples were run on a Dionex with a 2cm 100µm trap column with 5µm luna
C18 beads and a 40cm 75µm analytical column with 5µm luna C18 beads. 300µg of sample
was injected. Sample loading was normalised to ensure an average total ion chromatogram
(TIC) peak height of 1×1010. Peptides were separated by 120 minute gradient from 5%B to
25%B. Nano ESI set a 2.1kV ionised the eluting peptides, for analysis by a Q Exactive.
5.3.4 QE
The Q Exactive was operated in full ms1 to data dependent ms2 mode. Peptide ms1s were
initially scanned between 300-1750 m/z at 70 000 resolution, with a c-trap AGC of 3×106.
Data dependent ms2 was triggered for ions with charges 2-4 and with intensity greater than
1.7×104 using an underfil ratio of 1%. The isolation width was set to 4 m/z. Selected ions
were collected until the AGC of 2×105 or maximum injection time of 120 ms. Peptide were
fragment with a normalised collision energy (NCE) of 25 and then scanned with a resolution
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Table 5.1: Q Exactive setting for SILAC mudpit samples
Run time 157 min
ms1 Resolution 70 000
ms1 AGC Target 3×106
Scan Range 300-1750 m/z
ms2 Resolution 17 500
ms2 AGC Target 2×105
Loop Count 10
Isolation Width 4 m/z
NCE 25
dd Underfil Ration 1%
dd Intensity threshold 1.7×104
Dynamic Exclusion 30s
of 17 500. Ten ms2s were collected for every ms1, with the dynamic exclusion duration set to
30s.
5.3.5 MaxQuant analysis
MQ version 1.3.0.5 was used to for the SH-SY5Y cell peptide spectral matching and quan-
titation. Thermo .raw files were searched against the human complete proteome database
downloaded from uniprot on 9th January 2014. Reverse sequences of this database were used
as the decoy database. Trypsin/P was set as the enzyme, and 2 missed cleavages were allowed.
Carbamidomethyl of cystein’s was set at a fixed modification. Acetylation of the protein N-
terminus and Oxidation of Methionine we set as variables modifications. All FDRs were set
to 1%. The match between runs and dependent peptides features were turned on.
56
Table 5.2: MQ settings for SH-SY5Y cells
Experiment SH
Version 1.5.0.0
Enzyme Trypsin/P
Max. missed cleavages 2
Min. peptide Length 7
Min. peptides 1
Min. ratio count 2
Min. razor peptides 1
Min. unique peptides 0
Peptides used for protein quantification Razor
Fixed modifications Carbamidomethyl (C)
Variable modifications Acetyl (Protein N-term);Oxidation (M)
PSM FDR 0.01
Protein FDR 0.01
Site FDR 0.01
Match between runs False
Re-quantify False
Labels 0
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5.4 Bioinformatics
5.4.1 Statistics
All statistical and data manipulation was done in R171: a language and environment for
statistical computing (R), using a graphical user interface program written in-house using
shiny45 called CRUNCH. CRUNCH can be used to view the data and the plots generated from
the data at https://www.shaungarnett.co.za/thesis.html. MQ data was first prepared by
removing all protein groups that were reverse hits or contaminants marked by MQ. The FDR
was set at 1% on the peptide and protein level. No imputation of missing data was done. Where
there were no intensity values for proteins, the zero values were converted to not available (NA).
Missing values were then ignored in the statistical calculations in R. MQ protein groups were
collapsed down to the the first protein in the protein group, to enable ease of comparison
between different experiments and downstream meta-analysis. The Uniprot protein accession
numbers were further converted to human genome organisation gene nomenclature committee
(HUGO/HGNC)1 gene symbols (gene symbols).
Label free quantitation statistics
In the SH-SY5Y cells pairwise LFQ experiment samples were divided into two groups: control
and treated. Ratios were generated between the replicates (control vs control and treated
vs treated) and the comparisons (control vs treated), providing information of technical and
biological variance respectively. The mean values of each protein replicate ratios was log2
transformed. Histograms of the log2 ratios generally showed normal distributions with a mean
of 0. These log2 ratios were then used to calculate the σ. 2σ was taken to represent the extent
of the technical variance within the experiment. The t test was applied to the comparisons,
LFQ intensity values per protein, producing a p-value indicating the degree of significance.
Due to the large number of t test performed multiple-testing correction needed to be applied.
The multiple-testing correction test BH was applied to all proteins.. All proteins with a log2
mean comparison ratio greater than the technical variance 2σ and a BH p-value less than
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0.05 were accepted as being significantly differentially expressed. The lists of proteins which
were significantly differentially expressed were then used in gene ontology (GO) and Kyoto
encyclopedia of genes and genomes (KEGG) enrichment.
5.4.2 Plotting
Boxplots In an attempt to visualise all the data for individual proteins boxplots were gener-
ated using ggplot2233 in R. For the binary comparison experiments data points are represented
as a boxplot. The p-values for each experiment were displayed below the boxplot. For the
timecourse data the ratio points were plotted in boxplots, together with the mean line and
p-values calculated by one-way analysis of variance (ANOVA). The boxplots were filled with
either red or green, if the data were significantly up- or down-regulated (Figure 9.32).
Histograms and Density Plots To generate a histogram data is ordered, then a number
of bins are created across the data range of log2 ratios, plotted on the x axis. A frequency
is then determined for the number of data points falling within each bin plotted along the y
axis. Histograms are barplot of these frequencies (Figure 6.6 (a)). Density plots use the same
principle but are viewed as a continuous line, thus enabling multiple datasets to be overlaid
(Figure 6.5 (a)).
FDR Plot Once p-values had been generated either by t test or after multiple-testing cor-
rection. The distribution of the p-value values was plotted by histogram. A mean frequency
of p-values between 0.8 and 1 was calculated. Using this frequency the number of p-values
occurring by random chance was determined. This number was divided by the total number
of p-values below 0.05 to give an estimated FDR (Figure 6.6 (a)).
Heatmaps Proteins were plotted as a heatmap using the base heatmap plot R, which per-
forms hierarchical clustering on the protein ratios. Colours were set to green as negative and
red as positive. The R heatmap function is only able to generate heatmaps on complete data.
Every protein would require a intensity value in every sample. This was not feasible so missing
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ratio values were changed to zero, indicating no change or not detected, represented as black
on the plot. The hierarchical clustering performed by the heatmap provided a means of de-
termining if there were any large batch effects within the data. Using the tile plot in ggplot2
heatmaps were also generated to show significantly differentially expressed (SDE) of multiple
proteins at the same time, thereby condensing the display of data. Red and green were used
to show up- or down-regulation respectively (Figure 9.14).
5.4.3 Functional Analysis
topGO
The topGO14: enrichment analysis for gene ontology package in R (topGO) was used to for
GO enrichment of cellular component (CC), molecular function (MF), and biological process
(BP). First, all detected proteins were mapped to GO terms using the STRINGdb73 package
in R (STRINGdb). A list of either the up- or down-regulated differentially expressed proteins
were then compared to the full list of proteins detected in that experiment. Performing the en-
richment against only those detected reduces detection bias, introduced by the sample analysis
technique used.
Each of the three GOs, CC, MF, and BP forms a hierarchical network. There is a high
degree of relatedness between the terms within each network. Sibling terms contain a subset
of proteins from their parent terms. Terms higher up the hierarchy are often more signifi-
cantly enriched than the lower, more descriptive terms. Multiple-testing correction further
compounds this problem since it cannot take the relatedness of the terms into account. The
topGO algorithm accounts for this bias using algorithms that either eliminate the higher
terms or negatively weights them. Using the weight01 algorithm in the topGO package13 in R
(weight01), if any of the proteins within the term are detected in significantly enriched child
terms, the parent terms are negatively weighted. The weighting only works vertically and does
not affect sibling terms.15 Multiple-testing correction is applied during the generating of the
weighted p-values
60
The STRINGdb package in R is also able to do enrichment calculations.210 Unlike topGO
it does not use weighting, the STRINGdb get enrichment was used to calculate enrichment
p-values using the Fisher exact test adjusted by the Bonferroni correction. Enrichment was
performed separately on the lists of SDE proteins showing up- or down-regulation.
The resultant corrected enrichment p-values from topGO and STRINGdb were logarithm
base 10 (log10) transformed to return negative values. The enrichment scores from the up-
regulated proteins were then inverted to positive values. These enrichment scores were then
plotted on horizontal barplots. All the experiments in this study were all collated together
into one plot. This highlighted the differences in enrichment between those showing up- or
down-regulation, within experiments and across them. Blue horizontal lines represent the a
p-value threshold of 0.01 (Figure 12.1).
5.4.4 STRINGdb
Each enriched GO term consists of a list of proteins. The proteins for a significantly enriched
term, found to be significantly differentially expressed were extracted. This protein list was
then plotted as a STRINGdb network using the STRINGdb210 package in R. A STRINGdb
network is comprised of nodes and edges. Nodes are individual proteins, which are visualised
as orbs containing their crystal structures. Coloured halo’s around the nodes indicate up or
down regulation. Edges are the connections between the nodes. The edges are coloured and
represent the information used to determine the connection between the nodes (Figure 5.1).
Edge information can range from high to low confidence. High confidence interactions are
known interactions, extracted from curated databases. Less confident interactions are deduced
from protein homology and text mining. A combined score of 400 from STRINGdb version
10 was used and takes all of these evidences into account. Hubs are proteins with many
connections within a network, while a clique is a number of highly connected proteins (Figure
12.7).
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Figure 5.1: Colour codes on STRINGdb network, from string-db. org
5.4.5 AnimalTFBD
Lists of transcription factor (TF), transcription co-factors and chromatin remodelling factors
were downloaded from the AnimalTFDB.241 The TFs were identified by Hidden Markov Model
of DNA-binding domains. They defined transcription factors as having ”a sequence specific
DNA-binding domain and regulating target gene expression”.241 These list were compared to
the SDE genes and proteins in this study, enrichment analysis was performed using the Fisher
exact test corrected by BH.
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Chapter 6
Human foetal neural stem cells
6.0.1 SILAC proliferation study
6.0.2 Neural stem cells
Cell lines
Table 6.1: Human foetal neural stem cell cell lines
key Cell Line Cell Type
S1 Sai1 hfNES cells
S2 Sai2 hfNES cells
S3 Sai3 hfNES cells
H9 HB901 hfNS cells
H98 HB985 hfNS cells
H10 HB1025 hfNS cells
Proliferation
Three hfNES cells (Sai1, Sai2, Sai3) as well as two hfNS cells, (HB901 and HB1025) were kindly
donated by the Smith lab. These cells were cultured on tissue culture (TC) plates coated with
100µg/ml poly-L-ornithine for 20-30min at 37 ◦C and 2µg/ml laminin for 4-12h at 37 ◦C. hfNES
cells and hfNS cells were plated at high density 4×104 cell/cm2 in neural stem cell medium.
Continuous contact between the cells is necessary to maintain stable cultures. Neural stem
cell medium was changed daily. Cells were passaged every three days using TrypLE, which
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does not require FCS for inhibition. The old medium was first removed. The cells were then
washed with PBS and incubated with 1ml TrypLE for three minutes at 37 ◦C. The TrypLE
was then diluted 3× with neural stem cell medium. Cells were pelleted, counted and re-plated
1/3 thereby maintaining a high cell density. For long term storage cells were frozen in neural
stem cell medium with 10% DMSO.
Quantitative labelling
SILAC Labelling hfNES cells and hfNS cells were each plated in a single well of a 6 well
TC plate in either light SILAC medium or heavy SILAC medium respectively. The cells were
expanded to a 6cm TC dish and then a 10cm TC dish in either light SILAC medium or heavy
SILAC medium. This expansion comprised more than five cell doublings. This resulted in full
incorporation of light arginine and lysine in one set of cells and heavy arginine and lysine in
the other. The cells were referred to as light of heavy from this point on. Each 10cm TC dish
was split and 1/3 cryo-preserved,
1/3 tested for incorporation and
1/3 re-plated.
Heavy amino acid incorporation was tested on a sample of all cells cultured in heavy SILAC
medium. Peptides from the heavy cells were analysed by MS. The spectra were processed using
MQ with variable modifications for heavy arginine, lysine and proline. The total number of
heavy arginine and lysine containing peptides were compared to the total number of light argi-
nine and lysine containing peptides. Using formula 6.1 the incorporation rate was determined.
An incorporation rate greater than 95% was required for full incorporation. Peptides contain-
ing heavy and light prolines were analysed in the same manner to determine the conversion
rate of heavy arginine to heavy proline,
Incorporation rate (%) = (1− # light Peptides
# light Peptides + # heavy Peptides
) ∗ 100 (6.1)
The re-plated cells were further expanded to a T-75 flask. The cells were then lifted, flash
frozen in liquid nitrogen and stored until required.
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SILAC labelled cells are usually combined based on cell number. Due to the difference
in cell morphology and size between, hfNES cells and hfNS cells they were combined based
on protein quantity rather than cell number. Cells were thawed and resuspended in modified
RIPA buffer. Proteins were quantitated using the BCA assay. 100µg heavy SILAC hfNS cells
protein was combined with 100µg light SILAC hfNES cells proteins. The SILAC labelling
was reversed in some cases, light hfNS cells combined with heavy hfNES cells, to account for
labelling bias,
In order to test the accuracy of mixing MA plots, with M (log ratios) and A (Intensity)
were generated, showing a distribution over zero across all intensity values
6.0.3 SILAC experiments
SILAC was done in three separate experiments, the exact sample compositions can be seen in
table 8.4
SILAC experiment 1 (SILAC 1) The initial pilot SILAC experiment 1 (SILAC 1) was
done in the Smith lab where Sai1 and HB1025 where grown in Dundee control SILAC as K0R0
light SILAC medium and Dundee heavy SILAC as K6R6 heavy SILAC medium. Incorporation
was tested on the heavy HB1025 cells. In order to test technical variance, 25µg of heavy and
light HB1025 were combined, processed by FASP and compared to each other using a single
LC/MS/MS run.
High pH reverse phase In the comparison experiment 100µg of light Sai1 and 100µg of
heavy HB1025 were combined and processed with FASP. Desalted peptides from FASP were
dried down and resuspended in 20mM ammonium formate (pH 10). The entire sample was
loaded onto a Waters acquity ultra performance LC. Peptides were separated on a C18 column
compatible with high pH, using 20mM ammonium formate in water as Solvent A and 20mM
ammonium formate in 80% acetonitrile (ACN) as Solvent B. The gradient started at 0% B
for 10 minutes followed by a 50 minute linear ramp up to 70% B. The column was washed at
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100%B for 7 minutes before coming down to 0%B. Peptide elution was detected and plotted
using an inline ultraviolet (UV) detector. Fractions were taken every 2 minutes from minute 12
to 42, using a automated fraction collector. Fractions from 32-36 minutes and 36-42 minutes
were pooled.
Figure 6.1: High pH reverse phase UV chromatogram and fractionation times
Each fraction was desalted, dried down and resuspended in 0.1% TFA. The 13 peptide
fractions were separated on a Waters nano acquity. The gradient ramped from 5-40%B in 100
minutes. The column was washed at 85%B for 5 minutes and then equilibrated for 15 minutes
at 5%B.
Eluted peptides were analysed by a LTQ orbitrap velosTM at the Cambridge centre for
proteomics (CCP) using the settings in table 6.2
SILAC experiment 2 Sai1, Sai2, HB901 and HB1025 for SILAC experiment 2 (SILAC 2)
were cultured in the Smith lab in heavy and light SILAC medium as described in SILAC 1.
The frozen cells were then brought back to the Blackburn lab, IDM, University of Cape Town
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Table 6.2: LTQ orbitrap velosTM settings for SILAC experiment 1
Run time 120 min
Mass Range 380-1500 m/z
Minimal Signal Required 500
Isolation width 2 m/z
Normalised Collision Energy 30
Dynamic Exclusion Repeat Duration 20 s
Dynamic Exclusion Duration 300 s
(Blackburn lab) for processing and analysis. Heavy HB901, HB1025 and Sai1 peptides were
tested for incorporation. Sai1 and HB901 were used to test technical variance. One reverse
label comparison was done to account for labelling bias.
SILAC experiment 3 In SILAC experiment 3 (SILAC 3), Sai3 and HB1025 cells were
cultured in duplicate in either Thermo SILAC DMEM:F12 with K0 and RO as light SILAC
medium or Thermo SILAC DMEM:F12 with K6 and R10 as heavy SILAC medium in the
Blackburn lab. When combined the labels were reversed in one of the duplicates. All heavy
labelled cells were tested for incorporation. Heavy and light HB1025 was combined to test the
technical variance.
Mudpit SILAC 2 and SILAC 3 peptides generated by FASP were desalted and then fraction-
ated in-line by multidimensional protein identification technology (MudPIT) in the Blackburn
lab. A MudPIT column was produced in-house using a 100µm fused silica capillary. The
capillary was fritted and packed with 2cm 5µm luna C18 beads, 3cm 5µm SCX beads and
3cm 5µm luna C18 beads. The MudPIT column was used instead of a trap column on an
Easy-nLC in the two-column configuration. The analytical column used was a 20cm 75µm
with 5µm luna C18 beads.
1ug of sample was loaded onto the MudPIT column in 2% ACN. Peptides bound to the
first 3cm of 5µm luna C18 beads. A 70 minute gradient from 2 to 35% B, separated all
peptides unable to bind SCX. Peptide bound to the SCX were eluted in fractions by a series
of ammonium acetate injections, called salt plugs. The salt plug series consisted of increasing
concentrations of ammonium acetate 25, 50, 75, 200, 400 and 500mM, in 5% B. An additional
67
two fractions increased the percentage of B to 13.5% and 22% while keeping the ammonium
acetate concentration at 500mM. Peptides eluted by the salt plugs from the MudPIT column
were separated on the analytical column by a 70 minute gradient from 2% to 35%B and
analysed by a Q Exactive
Analysis on the Q Exactive was done using the settings in the table 6.3
Table 6.3: Q Exactive acquisition settings for SILAC experiment 2 and SILAC
experiment 3
Run time 100 min
ms1 Resolution 70 000
ms1 AGC Target 3e6
Scan Range 300-1750 m/z
ms2 Resolution 17 500
ms2 AGC Target 2e5
Loop Count 10
Isolation Width 4 m/z
NCE 25
dd Underfil Ration 1%
dd Intensity threshold 1.7e4
Dynamic Exclusion 30s
Combined data
The SILAC experiment for the comparison of proliferating NS
NES
(SILAC NS
NES
experiment) con-
sists of multiple samples from three separate experiments, that were processed and analysed
independently. The SILAC experiments were individually processed in MQ using the setting in
Table 6.5. Data from the three MQ proteinGroups.txt files was collated into a single dataset.
Rows were combined using the first protein accession in the protein group converted to gene
symbol. The SILAC normalised heavy/light (H/L) ratio for each sample was log2 transformed.
The reverse comparison ratios were inverted were so that all ratios were hfNS cells/hfNES cells.
Using the SILAC technical replicates, (i.e Heavy HB1025 vs light HB1025), a σ of 0.29 was
calculated for the replicate samples (see Table 8.4), from this the assumption is made that any
difference greater than 2σ or 0.58 is a biological change and therefore constitutes differential
expression. Using a t test all SILAC NS
NES
experiment comparison H/L ratios were compared
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against a mean of 0. BH multiple-testing correction from R was then applied against all
proteins present in at least 2 samples.
The final list of significant proteins is generated from samples with a mean ratio greater
than 2σ (0.58) with a BH p-value of less than 0.05 and only if the protein is detected in at
least 2 samples
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6.0.4 Differentiation experiment
Differentiation
HfNS cells and HfNES cells differentiate spontaneously in neural stem cell differentiation
medium on plates coated in laminin and poly-L-ornithine. Neural stem cell differentiation
medium was only replaced every three days. Upon media change cells stopped proliferating.
Many cells died, became rounded and lifted off of the plate. The surviving cells began extend-
ing processes. During media change the dead cells were washed off the plate as carefully as
possible, by swirling PBS over the cells twice before applying fresh medium. After 6 days few
cells were still dying and at this time most cells had developed extensive processes. In one
trial hfNES cells were cultured for 8 weeks, illustrating the potential of long term culture of
these cells.
In the neural stem cell differentiation experiment five cell lines were cultured three hfNES
cells (Sai1, Sai2 and Sai3) and two hfNS cells (HB901, HB1025). Cells were thawed from liquid
nitrogen stocks and plated on T-25 flasks, then expanded to three T-75 flask, two of which were
frozen for long term storage. The remaining plate was expanded for immunohistochemistry
and proteomic analysis.
Immunohistochemistry A single T-75 flask was split to fill all wells of two 24 well TC
plates. Cells were then allowed to proliferate in neural stem cell medium for a day, to let them
settle. Each plate was differentiated by changing to neural stem cell differentiation medium
and fixed on days 2, 4, 8 or 12 of differentiation for immunohistochemistry.
For cell fixing, media was removed from each of the wells and the cells washed with PBS.
The cells were fixed with 4% paraformaldehyde for 10 minutes and then washed with PBS.
The wells were blocked for 1 hour with blocking solution at room temperature, then washed
with PBS. The fixed cells were incubated with primary antibodies in 0.1% triton and 1% BSA
for 12 hours. Wells were washed three times with PBS before applying secondary antibodies,
including DAPI, for 1 hour.
The primary antibodies used were anti-Nestin an early neuronal stem cell marker, anti-
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TuJ-1 a neuronal marker and anti-GFAP a glial marker. Primary antibodies were visualised
by secondary antibodies conjugated to fluorophores Alexa 448 (Green) anti-mouse IgG2A for
anti-TuJ-1, Alexa 555 (Red) anti-mouse IgG1A for anti-GFAP and Alexa 555 (Red) anti-sheep
for anti-Nestin. DAPI was used to stain the nuclei blue. Images were taken on a Leica inverted
fluorescent microscope and processed with the Leica application suite advanced fluorescence
software.
Figure 6.2: Neural stem cell differentiation experiment design
Proteomics analysis Cell culture was scaled up to nine T-150 flasks per cell line, Each
T-150 flask was expanded until 80% confluent. The first time-point Day 0 was taken by lifting
one of the plates for each cell line. The remaining cells were differentiated by changing media
to neural stem cell differentiation medium. One T-150 flask was lifted per cell line on days
1,2,4,8 and 12. Lifted cells were spun down and washed twice with PBS before being flash
frozen on dry ice and then stored at -80 ◦C, until all samples could be collected and processed
in parallel.
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Cell pellets were thawed, lysed and quantitated. 200µg from each sample was processed
by FASP, as described previously. Peptides were desalted and 1µg separated by Dionex, using
2cm 5µm luna C18 beads trap and 40cm 5µm luna C18 beads analytical column. The gradient
separated peptides for 120 minutes from 2%B to 35%B. Each sample was analysed in three
separate injections on a Q Exactive using the settings in table 6.4. All the differentiation
samples were analysed as one run in MQ using the settings in column ”Diff” of Table 6.5.
Table 6.4: Q Exactive setting for LFQ Samples
Run time 190 min
ms1 Resolution 70 000
ms1 AGC Target 3e6
Scan Range 300-1750 m/z
ms2 Resolution 17 500
ms2 AGC Target 5e4
Loop Count 20
Isolation Width 1.6 m/z
NCE 28
dd Underfil Ration 5%
dd Intensity threshold 4.3e4
Dynamic Exclusion 45s
6.0.5 Differentiation ratios
The data was ordered from Day 0 to Day 12. The data was then transformed into log2 ratio
by dividing all values in the dataset by the first detected sample in a protein row. This
first measurement was then zero and all other measurement positive or negative, indicating
whether the change was upwards or downward. The data was then separated into groups based
on differentiation days and an ANOVA in R base applied. To account for multiple testing, the
ANOVA p-values were corrected by BH. The slope of the linear regression used in the ANOVA
was used to determine if the change was up or down regulation. All proteins with corrected
p-values of less than 0.05 and a positive slope was assumed to be upregulated. These up and
down regulated lists were then used to do GO, KEGG enrichment as described before. The list
of differentially expressed proteins was always compared to the entire list of protein detected
in the entire differentiation experiment. An alternative approach may have been to use only
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Table 6.5: MQ settings across all experiments
Experiment Diff SH SIL1 SIL2 SIL3
Version 1.5.2.8 1.5.0.0 1.3.0.3 1.3.0.5 1.3.0.5
Protease Trypsin/P Trypsin/P Trypsin Trypsin/P Trypsin/P
Max. missed cleavages 2 2 2 2 2
Min. peptide Length 7 7 7 7 7
Min. peptides 1 1 1 1 1
Min. ratio count 2 2 2 2 2
Min. razor peptides 1 1 1 1 1
Min. unique peptides 0 0 1 1 1
Peptides used for protein quantification Razor Razor Unique Unique Razor
Fixed modifications Carbamidomethyl (C) Carbamidomethyl (C) Carbamidomethyl (C) Carbamidomethyl (C) Carbamidomethyl (C)
Variable modifications
Acetyl (Protein N-
term);Oxidation (M)
Acetyl (Protein N-
term);Oxidation (M)
Oxidation (M);Acetyl
(Protein N-term)
Oxidation (M);Acetyl
(Protein N-term)
Oxidation (M);Acetyl
(Protein N-term)
PSM FDR 0.01 0.01
Peptide FDR 0.01 0.01 0.01
Protein FDR 0.01 0.01 0.01 0.01 0.01
Site FDR 0.01 0.01 0.01 0.01 0.01
Dependent peptide FDR 0.01
Dependent peptide FDR 0.01
Match between runs True False False False False
Matching time window [min] 0.7
Alignment time window [min] 20
Re-quantify False False True True True
Labels0
Labels1 Arg6;Lys6 Arg6;Lys6 Arg10;Lys6
those detected in the cell type, but using a more inclusive list was more stringent.
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Part III
Results
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6.1 SH-SY5Y cell differentiation results
Proliferating SH-SY5Y cells were compared to SH-SY5Y cells differentiated through treatment
with retinoic acid. Cells displayed distinct differences in morphology: proliferating cells have a
bi- or tripolar morphology, while the differentiated cells extended distinct neuronal processes
(Figure 6.3). The cells were lifted, their protein content was extracted, digested, and analysed
by LC/MS/MS. The data were analysed using MaxLFQ. Intensity values were processed and
statistically validated using CRUNCH. A total of 22701 peptides were detected, with approxi-
mately 12000 peptides per sample, resulting in over 2000 proteins per sample (Figure 6.4) and
a total of 3700 proteins.
(a) (b)
Figure 6.3: Bright-field microscope images of SH-SY5Y cells. (a) SH-SY5Y cells
cultured in neuroblastoma medium. (b) SH-SY5Y cells treated with retinoic acid
for 6 days and BDNF for 4 days.
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Table 6.6: Overview of the number of mass spectra detected and peptides iden-
tified per sample in the SH-SY5Y cells differentiation experiment (SH-SY5Y cells
differentiation experiment)
Samples MS MS/MS MS/MS Id Peptide Id
Peptide
Sequences
Identified
Percentage
MS/MS Id
Percentage
Repeated
SH7 10-01 6332 29352 14306 12238 12238 48.74 23.27
SH7 10-02 6125 30191 14964 12543 12543 49.56 24.39
SH7 10-03 6301 30000 15518 13359 13359 51.73 25.10
SH7 R-01 6717 27735 14075 12265 12265 50.75 22.62
SH7 R-02 7106 25529 11120 9918 9918 43.56 21.92
SH7 R-03 6505 28754 15043 12951 12951 52.32 22.93
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Figure 6.4: Protein numbers for the SH-SY5Y cells differentiation experiment
samples.
There were a total of 20.55% missed cleavages. Log2 ratios were generated for replicates of
proliferating or differentiating SH-SY5Y cells, and for comparisons between proliferating and
differentiating SH-SY5Y cells. Density plots for the replicate and comparison ratios showed
that comparisons between replicating and differentiating cells displayed a broader distribu-
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tion than comparison between replicates (Figure 6.5(a)). The σ was between 0.27 and 0.46
for replicates, while it was between 0.62 and 0.71 for comparisons between proliferating and
differentiating cells (Figure 6.5(b)). This indicates a distinct difference between the two con-
ditions. The maximum σ for replicates was 0.46 and 2σ (0.92, fold change of 1.9) was selected
as the threshold for substantial differential expression.
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Figure 6.5: (a) A density plot of the frequency of log2 ratios for proteins from
replicates and comparisons, for the SH-SY5Y cells differentiation experiment sam-
ples. The vertical lines indicate 2σ for replicates. (b) Boxplot of σ for SH-SY5Y
cell replicates and comparisons.
An expression change threshold is not sufficient to determine differential expression, so the
intensities were further evaluated by t test. From the t test results, the FDR was determined
by dividing the total number of proteins with a p-value less than 0.05 by those randomly
generated. The frequency of p-values randomly generated is assumed to be the same as the
average number of proteins with a p-value between 0.8 and 1. The FDR plot revealed, a FDR
of 7.14% (Figure 6.6(a)). After multiple-testing correction by BH there remained 10 proteins
up-regulated and 38 proteins down-regulated.
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Figure 6.6: (a) FDR plot for the t test p-values. The mean frequency between
0.8 and 1 was extrapolated to represent p-values generated by random chance (blue
line). The FDR is the percentage of all proteins with a p-value smaller than 0.05
(red line) and those with a p-value smaller than 0.05 generated by random chance.
(b) The volcano plot plots the log2 mean ratio of the comparison vs the -log10 of the
p-value. The vertical blue lines depict the 2σ of the replicates (0.92). The horizontal
red line marks a p-value of 0.05. All values above the red line and outside of the
blue line represent significantly differentially expressed (SDE) proteins
There were few enough proteins SDE in the SH-SY5Y cells differentiation experiment, that
they could all be displayed as a STRINGdb network (Figure 6.7). The down-regulated proteins
formed three clusters. The cluster with MCM4 as a hub, contained proteins involved in the
DNA replication and cell proliferation. The cluster with EGFR as a hub, forms part of CC
focal adhesion , the basolateral plasma membrane , and the nuclear membrane . The
third cluster containing NUP50 , NUP37 and, NUP153 forms part of the CC nuclear pore .
The up-regulated proteins did not form any distinct clusters. There was an up-regulation of
the histones HIST1H4A and H1F0 , a replication independent histone, this indicating a change
in chromatin compaction with cessation of proliferation, discussed in section 13.2.2.
There were not sufficient number of proteins SDE in this work for GO of KEGG enrichment
analysis to return details results on the mechanism at play here. The analysis would need to
be on protein by proteins basis, but appears to indicate as expected a move from proliferation
to differentiation.
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proteins: 48
interactions: 41
expected interactions: 23 (p−value: 0.000880132232651487)
Figure 6.7: STRINGdb network of the SDE proteins in the SH-SY5Y cells dif-
ferentiation experiment. Red and green halos indicate up- and down-regulation re-
spectively.
6.1.1 Gene ontology
Despite the low number of SDE proteins GO enrichment p-values were calculated for all SDE
proteins using the weight01. Up- and down-regulated proteins were enriched independently
and then combined in boxplots to illustrate the differences between the two conditions (Figure
6.8).
Only three CCs terms were significantly enriched by the weight01 algorithm from topGO,
condesin complex , focal adhesion , and basolateral plasma membrane . All three
79
were enriched in the proteins that were down-regulated during differentiation and indicate a
reduction in proliferation and cell-cell contact interactions.
MF terms enriched in proteins downregulated during differentiation of SH-SY5Y cells in-
clude the ribonucleoside-diphosphate reductase activity term proteins which are respon-
sible for conversion of ribonucleotides to deoxyribonucleotide and are important for deoxyri-
bonucleic acid (DNA) synthesis during cell replication. Proteins from histone demethylase
activity (H4-K20 specific) cause de-methylation of histones may affect chromatin during
differentiation.
The enriched BPs include terms that would indicate a reduction in proliferation and changes
in chromatin structure.
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Figure 6.8: GO for the SH-SY5Y cells differentiation experiment. Enrichment
p-values were log10 transformed. Down-regulated genes and proteins have negative
log10(p-values) while up-regulated genes and proteins have positive log10(p-values),
so that they can be plotted together to illustrate the differences in enrichment. Ver-
tical blue lines represent the p-value cutoff of log10(0.01), positive and negative.
KEGG enrichment
KEGG enrichment indicated changes in metabolism and p53 signalling, both expected during
differentiation of a cancer cell line (Figure 6.9).
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Figure 6.9: KEGG enrichment for the SH-SY5Y cells differentiation experiment.
Enrichment p-values were log10 transformed. Down-regulated genes and proteins
have negative log10(p-values) while up-regulated genes and proteins have positive
log10(p-values), so that they can be plotted together to illustrate the differences in
enrichment. Vertical blue lines represent the p-value cutoff of log10(0.01), positive
and negative.
Due to the low number of proteins SDE in the SH-SY5Y cells differentiation experiment, not
much useful information was gained from this experiment. The low number of SDE proteins
could be due to a large degree of variability in the cells, especially the differentiating cells.
Additional cell replicates together with a longer timecourse differentiation protocol, could
yield better results.
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Chapter 7
Results for Human ESC cells / derived
NES cells
Huang et al. 2016 102 published Affymetrix HG-U133 Plus 2.0 Genechip microarray data, com-
paring proliferating hESC cultured on mouse fibroblast feeder cells to neuroepithelial like stem
cells derived from hESC cells in vitro (dNES cell). They found involvement of TGF-β and
WNT/β-catenin signalling as well as DNA methylation and histone modification begin in-
volved in the differentiation of neuroepithelial stem cells. Since this data focused on a detailed
analysis of differentiation to neuroepithelial like stem cells it was incorporated into this study
to put the hfNES cell and hfNS cell cell data into perspective.
7.0.1 Statistical re-evaluation
The data were made available by uploading it to a public repository. Upon request, the authors
also provided a spreadsheet with the normalised expression values for the experiment. These
data were incorporated into this study and are referred to as the dNES
hESC
experiment by Huang
et al. 2016 102 (Huang dNES
hESC
experiment). Adding data from ESC to hfNES cell fills an important
gap in understanding the subsequent neural stem cell data. In this work the authors used three
timepoints; hESC, differentiation at day six as an intermediate timepoint and differentiation
at day ten as complete dNES cell differentiation. Huang et al. used ANOVA without multiple-
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testing correction.102 To make the data more comparable, using CRUNCH, the data were
statistically re-evaluated using the same statistical approach that was used as with all other
data in this study. Due to the increased stringency applied here, far fewer genes were SDE
than in the study by Huang et al..
The dataset was divided into two groups: three hESC replicates and three replicates from
the ten day dNES cell timepoints, as these are the most relevant timepoints for comparison
to this work. The σ was determined at the probe level, as described before, from log2 dNES
cell/hESC ratios. The σ values for this dataset were twice as high as for the Illumina bead chip
microarrays, gene expression data comparing proliferating NS
NES
(GE NS
NES
experiment), described
later and σ for comparison ratios was only marginally greater than for replicate ratios. This
indicates a greater degree of experimental variation, but also a smaller difference between cell
types than was observed in the GE NS
NES
experiment. A 2σ cutoff of 0.3 (fold change of 1.2) was
selected as a threshold for differential expression.
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Figure 7.1: (a) A density plot of the frequency of log2 ratios for genes from repli-
cates and comparisons, for the Huang dNES
hESC
experiment samples. The vertical lines
indicate 2σ for replicates. (b) Boxplot of σ for Huang dNES
hESC
experiment replicates
and comparisons.
Affymetrix probe ID’s were converted to gene symbols. There is a many-to-one ratio
between the probes and the gene symbols. Using a t test all probe values for hESC, and
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dNES cell were compared for each gene symbol. From the p-values, the FDR was calculated
as 51.17%, further supporting the notion that there was a large degree of variability in this
data. Using BH corrected p-values smaller than 0.05 and mean log2 ratios greater than 0.3
(fold change 1.2), 214 genes were considered SDE. Of these 129 and 85 genes were down- and
up-regulated, respectively during the transition from hESC to dNES cells. These lists were
used for KEGG and GO enrichment, mapped to STRINGdb networks, and compared to the
other data in this work.
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Figure 7.2: (a) FDR plot for the Huang dNES
hESC
experiment t test p-values. The
mean frequency between 0.8 and 1 was extrapolated to represent p-values generated
by random chance (blue line). The FDR is the percentage of all proteins with a
p-value smaller than 0.05 (red line) and those with a p-value smaller than 0.05
generated by random chance. (b) The volcano plot plots the log2 mean ratio of the
comparison vs the -log10 of the p-value. The vertical blue lines depict the 2σ of the
replicate (0.3). The horizontal red line marks a p-value of 0.05. All values above the
red line and outside of the green lines represent significantly differentially expressed
(SDE) genes
Although the dataset differer, most significantly in the variances within the datasets, it
appears that there is less difference between the hESC and dNES cells than between the
hfNES cells and hfNS cells.
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Chapter 8
Neural stem cell results
8.1 Proliferating hfNES cells vs Proliferating hfNS cells
8.1.1 Microscope images
HfNES cells were compared to hfNS cells visually. Both cell lines were cultured in neural stem
cell medium containing EGF and FGF. The cells were plated on flat-bottomed cell culture
dishes and visualised using bright-field microscopy and fluorescent microscopy. hfNES cells
have an epithelial like morphology with neural tube characteristic rosettes (Figure 8.1). The
hfNS cells have a RG-like appearance with prominent cellular processes (Figure 8.3). hfNES
cells express TUBB3 and NES , but not GFAP , (Figure 8.2). hfNS cells express TUBB3 and
GFAP , and some NES (Figure 8.4). The immunohistochemical staining for NES does not
appear to be homogeneous, a sub-population of cells stain positive for NES . This may indicate
heterogeneity in the cell populations.
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Figure 8.1: Brigh-field image of proliferating hfNES cells
(a) (b)
Figure 8.2: Proliferating hfNES cells stain positive for anti-TuJ-1 in green (a and
b), negative for anti-GFAP in red (a), Some cells stain positive for anti-Nestin in
red (b)
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Figure 8.3: Brigh-field image of proliferating hfNS cells
(a) (b)
Figure 8.4: Proliferating hfNS cells stain positive for anti-TuJ-1 in green (a and
b). Positive for anti-GFAP in red (a). Some cells stain positive for anti-Nestin in
red (b).
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8.1.2 Gene expression data
GE NS
NES
experiment were provided by the Smith lab, as previously described by Tailor et al.
2013. Within this dataset, only the hfNES cell and hfNS cell samples were used. Ratios were
generated for replicates (hfNScells/
hfNScells
and hfNEScells/
hfNEScells
), and for the comparisons
hfNScells/
hfNEScells
. The log2 ratios were plotted using a density plot. Replicates had a narrow
distribution and small σ compared to the comparisons (Figure 8.5 (a)), indicating a greater
difference between comparisons than replicates. When σ’s were calculated separately between
the log2 ratios for the replicates, they had a maximum σ of 0.06 and 0.05 respectively (Figure
8.5 (b)). Comparison ratios yielded a maximum σ of 0.11. From this data a 2σ technical
variance of 0.12, which is equal to a fold change of 1.087, was used as a measure of differential
expression for the comparison of samples hfNScells/
hfNEScells
.
(a)
0
5
10
−0.25 0.00 0.25
log2(ratio)
de
ns
ity
(b)
l
ll
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
ll
l
l
l
l
l
l
l
l
0.02
0.04
0.06
0.08
0.10
sample
st
an
da
rd
 d
ev
ia
tio
n
sample
l
l
l
NES
NS
NS / NES
Figure 8.5: (a) A density plot indicating the frequency of log2 ratios. Blue curves
represent the replicates, which have a tighter distribution than the more broad com-
parisons ratios in red. Green and orange horizontal lines indicate 2σ for the repli-
cates and comparisons, respectively. (b) A boxplot of the σ for replicates and com-
parisons.
A t test was applied comparing hfNES cells expression values to hfNS cells expression values.
A histogram of p-value shows an exponentially decaying distribution. FDR for t test p-values
was calculated as 4.63% (Figure 8.6 (a)). The p-values were corrected using BH multiple-
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testing correction. Comparison log2 mean ratios and -log10 p-values were plotted on a volcano
plot to illustrate the spread of datapoints (Figure 8.6 (b)). After applying a 2σ threshold of
0.12 (fold change 1.087) to the mean log2 ratios together with BH-corrected p-values of less
than 0.05, 1817 genes were SDE, with 1024 upregulated, or more highly expressed in hfNS cells
and 793 downregulated, or more highly expressed in hfNES cells
(a)
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Figure 8.6: t test FDR and volcano plots for the GE. (a) Histogram of
the t test p-values for all GE NS
NES
experiment log2 ratios. (b) Volcano plot, log2
NS/NES ratios on x axis vs -log10(p-values) on the y axis. The green horizontal
lines indicate the technical replicate 2σ, while the blue horizontal lines indicate the
comparison 2σ. The red line indicates a p-value of 0.05. All values above the red
line and outside of the green lines were considered SDE.
8.1.3 SILAC experiment
MaxQuant summary SILAC labelling was done in three separate experiments: SILAC 1,
SILAC 2, and SILAC 3. (Table 8.2). In each experiment, SILAC incorporations were tested
and technical replicates were analysed to determine the experimental variance. The exact
sample compositions of all experiments can be seen in Table 8.4. The Q Exactive generated
raw files were processed via MQ using the parameters listed in Table 6.5. FDR was set to
0.1% at all levels (PSM, peptide, and protein). Less than 1.2% contaminants were identified
and there were fewer than 30% missed cleavages in all samples (Table 8.2). SILAC heavy label
90
incorporation was shown to be greater than 95% in all cases. (Table 8.3).
Table 8.1: Summay of the mass spectra collected in the SILAC NS
NES
experiment
Raw file MS MS/MS MS/MS Identified
MS/MS
Identified
[%]
Peptide
Se-
quences
Identified
Isotope
Patterns
Repeat-
edly Se-
quenced
[%]
SILAC 1 98856 158198 65191 38.03 32870 5.99
SILAC 2 331531 810618 241308 24.04 22448 15.4
SILAC 3 651028 1143790 336942 22.2 24411 17.6
Table 8.2: SILAC NS
NES
experiment experimental overview table
Experiment Peptides Proteins FDR Contaminants Missed Cleavages
SILAC 1 replicates 6085 921 0.9% 1.1% 6.96%
SILAC 1 32870 4406 1.2% 0.5% 7.75%
SILAC 2 replicates 5138 115 1.0% 1.2% 24.38
SILAC 2 22150 3406 1.1% 0.8% 29.36%
SILAC 3 replicates 10017 1658 1.1% 0.4% 16.75%
SILAC 3 24146 3524 1.1% 0.4% 16.74%
Table 8.3: SILAC heavy label incorporation test results
Experiment Sample # light Peptides # heavy Peptides Incorporation rate
SILAC 1 HB1025 51 1170 95.8%
SILAC 2 HB901 41 4582 99.1%
SILAC 2 HB1025 108 4582 97.7%
SILAC 2 Sai1 58 4183 98.6%
SILAC 3 HB901 1 84 3351 99.6%
SILAC 3 HB901 2 68 3326 98.0%
SILAC 3 Sai3 1 49 2746 97.2%
SILAC 3 Sai3 2 68 3039 97.8%
Samples from all experiments were combined and statistically assessed as a single experi-
ment. A total of 4391 proteins were detected from sample SILAC 1 S2L H10H in SILAC 1,
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Table 8.4: SILAC : Full protein number of all samples
Sampe Name Experiment type light heavy # proteins
SILAC 1 H10 SILAC 1 technical replicate HB1025 HB1025 926
SILAC 1 S2L H10H SILAC 1 comparison Sai2 HB1025 4391
SILAC 2 HS1.LH9 SILAC 2 reverse comparison Sai1 HB901 1696
SILAC 2 LH9 HH9 SILAC 2 technical replicate HB901 HB901 397
SILAC 2 LS1 HH10 SILAC 2 comparison Sai1 HB1025 1811
SILAC 2 LS1.HH9 07 SILAC 2 comparison Sai1 HB901 1728
SILAC 2 LS1 HS1 SILAC 2 technical replicate Sai1 Sai1 593
SILAC 2 LS2 HH10 SILAC 2 comparison Sai2 HB1025 1506
SILAC 2 LS2.HH9 SILAC 2 comparison Sai2 HB901 1563
SILAC 3 S3L1H1 SILAC 3 technical replicate Sai3 Sai3 561
SILAC 3 S3L2H2 SILAC 3 technical replicate Sai3 Sai3 516
SILAC 3 S3L1.H9H1 06 SILAC 3 comparison Sai3 HB901 1807
SILAC 3 S3L2.H9H2 03 SILAC 3 comparison Sai3 HB901 1542
SILAC 3 S3H1.H9L1 06 SILAC 3 reverse comparison HB901 Sai3 2070
while fewer than 2000 were detected in all other samples. This is a result of high pH RP frac-
tionation being applied in SILAC 1 while MudPIT was used in SILAC 2 and SILAC 3, (Figure
8.7). There is however a high degree of overlap across the samples. A total of 1571 quantitated
protein were unique to SILAC 1 S2L H10H and 2901 and 2370 protein groups were detected
in at least 2 and 3 samples, respectively.
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Figure 8.7: Barplot of the number of proteins identified in the SILAC NS
NES
exper-
iment.
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Quality control SILAC comparison samples comprised 100 µg of heavy hfNS cells and 100 µg
of light hfNES cells samples combined. After analysis, quantitation was reflected as H/L ratios.
In order to asses the accuracy of mixing, MA plots were generated for each of the comparison
samples. PSM, peptide, and proteins intensities were compared to their H/L ratios. Accurate
mixing resulted in the H/L ratios being distributed across zero at all intensities. In Figure
8.8, reverse labelled samples from SILAC 3 were compared. MA plots from these samples are
mirror images of each other, indicating there is no sample labelling bias.
(a) (b)
Figure 8.8: MA plot of two oppositely labelled SILAC samples from SILAC 3 (a)
S3L1 H9H1 SILAC 3 and (b) S3H1 H9L1 SILAC 3. The x-axis is the H/L ratio,
while the y-axis is the log10 of the intensity data. Black dots represent PSMs, blue
represent peptides, and red represent proteins
In addition to MA plots, the log2 ratios were plotted on density plots (Figure 8.9a). Like
the GE NS
NES
experiment, there was less variance amongst the replicates than the comparisons.
Two of the comparison samples, SILAC 2 LS1 HH10 and SILAC 2 LS1.HH9 07 did not show
as much variance as the other samples, but they were still substantially different from the
replicates, so these were included. The technical replicates have a maximum σ of 0.29, thus
a 2σ of 0.58 (fold change of 1.49) was used as threshold for substantial differential expression
(Figure 8.9b).
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Figure 8.9: (a) Density plot for the SILAC NS
NES
experiment. Blue and red curves
represent the replicates and comparisons respectively. The green horizontal line
indicates the 2σ of the replicates. (b) Boxplot of the σ for replicates and comparisons
Upon hierarchical clustering (Figure 8.10), data from different experiments, were evenly
distributed across clusters. Samples where labels were reversed, clustered with the normal
samples after the log2 ratios had been inverted, another indication that there was minimal
labelling bias (Figure 8.10).
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Figure 8.10: SILAC NS
NES
experiment samples clustered by hierarchical clustering
Statistics T tests were applied to all comparison H/L log2 ratios against a mean of zero for
all proteins detected in two or more samples. The resultant FDR was 3.19% (Figure 8.11).
The p-values were corrected using BH multiple-testing correction. The H/L ratios and BH-
corrected p-value were plotted on a volcano plot (Figure 8.11). After selection of proteins with
a BH-corrected p-value of smaller than 0.05 and mean log2 ratio greater than the replicate
2σ threshold of 0.61, 473 proteins were considered SDE. A total of 177 and 296 proteins were
down or up-regulated respectively.
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Figure 8.11: (a) FDR plot for BH-corrected p-values. The mean of frequency
between 0.8 and 1 was extrapolated to represent p-values generated by random chance
(blue line). The FDR is a percentage of the number of p-values below 0.05 (red line)
and those with a p-value below 0.05 generated by random chance. (b) The volcano
plot, shows the log2 mean ratio of the comparison vs the -log10 of the p-value. The
horizontal green and blue lines depict the 2σ of the replicate (0.92) or comparisons
(1.32), respectively. The vertical red line marks a p-value of 0.05. All values above
the red line and outside of the green line were considered SDE.
8.1.4 Collating GE NS
NES
experiment and SILAC NS
NES
experiment data
Of the 473 proteins significantly differentially expressed in the SILAC NS
NES
experiment, 166
showed similar SDE to genes in the GE NS
NES
experiment. Furthermore, 307 proteins were SDE
in the the SILAC NS
NES
experiment but not in the GE NS
NES
experiment. An additional 1651
genes were differentially expressed in the GE NS
NES
experiment (Figure 8.12). Approximately
one third of the proteins SDE in the SILAC NS
NES
experiment were also SDE in the GE NS
NES
experiment. There were not conflicts between in SDE between the datasets. Those not showing
overlapping SDE were either dysregulated but did not pass the criteria for SDE or there are
post-translational regulation mechanisms at play here.
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Figure 8.12: Venn diagram comparing proteins and genes SDE in the SILAC NS
NES
experiment and GE NS
NES
experiment.
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8.2 NSC differentiation experiment
8.2.1 Immunohistochemistry
Human foetal derived neural stem cells are differentiated by removing the growth factors
EGF and FGF from their culture medium. The cells spontaneously differentiate, hfNES cells
differentiate into an almost pure population of neurons,211 whereas hfNS cells differentiate
into a mixed population of neurons and astrocytes and have the potential to differentiate into
oligodendrocytes.206 Immunohistochemical staining showed all the cells staining positive for
TUBB3 by anti-TuJ-1. TUBB3 was up-regulated in the SILAC NS
NES
experiment (Figure 9.35).
The hfNES cells and hfNS cell stained positive for anti-Nestin. NES was not SDE in the SILAC
NS
NES
experiment (Figure 9.25). The hfNS cell stained more positive for anti-GFAP (Figure 8.14),
confirmed by the SILAC NS
NES
experiment (Figure 9.26).
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(a) (b)
(c) (d)
Figure 8.13: Immunohistochemistry of differentiating human foetal neural stem
cells. (a) hfNES cells stained with anti-Nestin (red), (b) hfNS cells stained with
anti-Nestin (red), (c) hfNES cells stained with anti-GFAP (red), and (d) hfNS cells
stained with anti-GFAP (red). All cells were stained with anti-TuJ-1 (green) and
nuclei stained with DAPI (blue).
Upon differentiation the hfNES cells still stained positive for anti-Nestin, despite it being
down-regulated in the MaxLFQ hfNES cell differentiation timecourse experiment (hfNES cell
differentiation experiment) (Figure 9.25). The cells took on a neuronal morphology forming
interconnected networks (Figure 8.14 (a)). The hfNS cells were drawn together forming high
density tracts, leaving other areas virtually empty. These cell tracts become more defined
as differentiation progressed. This may have been due to glial cell attachment creating more
complex tissue like structures (Figure 8.14 (b)). Upon differentiation TUBB3 was up-regulated
and NES was down-regulated in the hfNES cells, while GFAP was upregulated in the hfNS
cells (Figure 8.14).
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(a) (b)
(c) (d)
Figure 8.14: Immunohistochemistry of differentiating human foetal neural stem
cells. (a) hfNES cells stained with anti-Nestin (red), and (b) hfNS cells stained with
anti-Nestin (red), (c) hfNES cells stained with anti-GFAP (red), and (d) hfNS cells
stained with anti-GFAP (red), All cells were stained with anti-TuJ-1 (green) and
nuclei stained with DAPI (blue).
In areas where hfNES cells were cultured at high density the nuclei group together form-
ing a concentrated cluster out of which neuronal tracks extended into the surrounding cells
(Figure 8.15 (a)). In areas where the hfNS cells were sparsely cultured, individual cells formed
astrocytes that stained strongly for anti-GFAP (Figure 8.15 (b)).
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(a) (b)
Figure 8.15: Immunohistochemistry of differentiating human foetal neural stem
cells. (a) hfNES cells stained with anti-GFAP (red), and (b) hfNS cells stained with
anti-GFAP (red). All cells were stained with anti-TuJ-1 (green) and nuclei stained
with DAPI (blue).
In the neural stem cell differentiation experiment, six timepoints day 0,1,2,4,8, and 12 were
taken across five cell lines, (three hfNES cell and two hfNS cell lines). No cell culture technical
replicates were generated but the cell lines serve as biological replicates, since they have unique
biological origins. Each of the samples was analysed in triplicate by a Q Exactive, and these
mass spectrometery (MS) technical replicates were combined as a single sample during MQ
analysis. The samples are labelled cell line (S1, S2, and S3) for the three hfNES cell lines,
Sai1, Sai2 and Sai3, respectively. The two hfNS cell lines were labelled H9 and H10 for HB901
and HB1025 cell lines, respectively. A total of 5022 proteins were detected with an average of
2631 proteins per sample. Of the 5022 proteins, 872 were found in only one sample while 1036
were detected across all samples (Figure 8.16). Due to low TIC intensities, some samples were
excluded from the experiment. There was variability in the total number of detected proteins
per sample, probably due to variation in sample preparation.
Ratios were generated by dividing all LFQ intensities by the first measurement made for
that protein. The resulting ratios showed clear upwards or downwards trends as differentiation
progressed. Density plots showed increased spreading with successive days of differentiation
(Figure 8.17). Indicating greater degrees of change as differentiation progressed.
An ANOVA was performed on a per-protein basis. The histogram of the ANOVA p-values
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for the hfNES cells and hfNS cells showed exponentially decaying distributions for both datasets.
Their respective FDRs were 16.71% and 14.12%, for hfNES cells and hfNS cells, respectively
(Figure 8.18). Histograms of the linear regression slope from the ANOVA data showed normal
distributions for both datasets and volcano plots indicated clear separation of slopes with
decreasing BH-corrected p-values (Figure 8.19). After statistical analysis of the data, there
were 243 hfNES cells proteins with a BH-corrected p-values smaller than 0.05. Of these, 134
were downregulated and 109 were upregulated. In the hfNS cells, 177 hfNS cells proteins had a
BH-corrected p-values smaller than 0.05, with 69 of these upregulated and 108 downregulated.
Table 8.5: Summary of the number of mass spectra detected in the
Raw file MS MS/MS MS/MS Identified
MS/MS
Identified
[%]
Peptide
Se-
quences
Identified
Isotope
Patterns
Repeat-
edly Se-
quenced
[%]
Total 784195 3458467 1322619 32.14 48371 25.25
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Figure 8.16: Protein numbers for the (a) hfNES cell differentiation experiment
and (b) the MaxLFQ hfNS cell differentiation timecource experiment (hfNS cell dif-
ferentiation experiment).
(a)
0.0
0.5
1.0
1.5
−2 0 2
log2(ratio)
de
ns
ity
condition
0
1
2
4
8
12
(b)
0
1
2
3
−2 0 2
log2(ratio)
de
ns
ity
condition
0
1
2
4
8
12
0
1
2
3
−2 0 2
log2(ratio)
de
ns
ity
condition
0
1
2
4
8
12
Figure 8.17: Density plots for the the (a) hfNES cell differentiation experiment
and (b) the hfNS cell differentiation experiment. The density plot plots become more
spread out as the cells differentiate, indicating a greater difference in the cells as
differentiation progresses.
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Figure 8.18: FDR plots for the the (a) hfNES cell differentiation experiment and
(b) the hfNS cell differentiation experiment
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Figure 8.19: Volcano plots for the (a) hfNES cell differentiation experiment and
(b) the hfNS cell differentiation experiment
Using the R base heatmap function, samples were hierarchically clustered. The hfNS cells
cluster separately from the hfNES cells. Within these two clusters, the more differentiated sam-
ples cluster separately from the early proliferation and early differentiated samples. However,
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this distinction is not so clear in the hfNES cells.
Figure 8.20: Heirarchical clustering of the MaxLFQ intensity values for the NSC
differentiation experiment using the heatmap function in R.
8.3 Combining of Experiments
The data from the Huang dNES
hESC
, GE NS
NES
, and SILAC NS
NES
experiments and the hfNES and hfNS
cell differentiation experiments were all analysed together in an attempt to generate a uni-
fying description of the differences between the hfNES cells and hfNS cells. The Huang
dNES
hESC
experiment was used to determine the trajectory the hfNES cells were on before differentiating
into hfNS cells. Most of the GO and KEGG enrichment analysis was based on the GE
NS
NES
experiment due to the more complete nature of transcriptome analysis. The SILAC NS
NES
ex-
periment served to extend and confirm the conclusions derived from the GE NS
NES
experiment.
The differentiation data was used to further validate observed trajectories of the hfNES cells
and hfNS cells.
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Part IV
Analysis
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Chapter 9
Markers of cellular identity
Cell markers are molecules, used as monograms to identify cells. These can be proteins, lipids,
or cell surface carbohydrates. They are expressed either by specific cells, or in a specific
cellular context. Antibodies are readily available from many suppliers, allowing identification
of cells using immunohistochemistry. Abcam3 provides a list of antibodies specifically for
the identification of different types of neural cells (Figure 9.1). This list is accompanied by
references for the markers.5 Transcription factors and proteins produced through the activation
of specific signalling pathways can also be used to identify cells. This discussion will focus on
proteins, as they can be detected by proteomics.
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Neural lineage markers at a glance
To find out more, please visit abcam.com/neuralmarkers
Copyright © 2016 Abcam, All rights reserved
Neuroepithelial
cells
– Nestin
– SOX2
– Notch1
– HES1
– HES3
– Occludin
– E-cadherin
– SOX10
Schwann cell
precursor
– SOX10
– GAP43
– BLBP
– MPZ
– Dhh
– P75NTR
Myelinating
Schwann cell
– SOX10
– S100
– EGR2
– MBP
– MPZ
Non myelinating
Schwann cell
– SOX10
– S100
– GAP43
– NCAM
– P75NTR
Astrocytes
– GFAP
– EAAT1/GLAST
– EAAT2/GLT-1
– Glutamine
   synthetase
– S100 beta
– ALDH1L1
Microglia
– CD11b
– CD45
– Iba1
– F4/80
– CD68
– CD40
Oligodendrocytes
– Olig1
– Olig2
– Olig3
– OSP
– MBP
– MOG
– SOX10
Oligodendrocyte
precursor cell
– PDGFRA
– NG2
Radial glia
– Vimentin
– PAX6
– HES1
– HES5
– GFAP
– EAAT1/GLAST
– BLBP
– TN-C
– N-cadherin
– Nestin
– SOX2
Intermediate
progenitors
– TBR2
– MASH1
Glutamatergic
neurons
– vGluT1
– VGluT2
– NMDAR1
– NMDAR2B
– Glutaminase
– Glutamine 
   synthetase
GABAergic
neurons
– GAT1
– GABAB 
   receptor 1
– GABAB 
   receptor 2
– GAD65
– GAD67
Dopaminergic
neurons
– TH
– DAT
– FOXA2
– GIRK2
– Nurr1
– LMX1B
Serotonergic
neurons
– TPH
– Serotonin 
   transporter
– Pet1
Cholinergic 
neurons
– ChAT
– VAChT
– Acetylcho-
   linesterase
Immature
neurons
– Doublecortin
– NeuroD1
– TBR1
– Beta III tubulin
– Stathmin 1
Mature neurons
– NeuN
– MAP2
– 160 kDa Neurofilament Medium
– 200 kDa Neurofilament Heavy
– Synaptophysin
– PSD95
Figure 9.1: Abcam3 list of antibodies available for markers of nervous system
cells.
9.1 Pluripotency factors
Many pluripotent and proliferation markers are up-regulated in the hfNES cells.
KL4, POU5F1, and NANOG The pluripotency markers KLF4 , POU5F1 , and NANOG
are known to be highly expressed in ESCs. Together with SOX2 , they are commonly used to
transform adult somatic cells into iPSCs. In vivo, their downregulation would coincide with
differentiation from ESCs into neuroepithelial cells. NANOG and KLF4 were down-regulated
in the Huang dNES
hESC
experiment, although not statistically significantly, probably because of the
large variance in the data (Figure 9.2).
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Figure 9.2: Boxplots comparing the log2 ratios for KLF4 and NANOG. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
Expression of POU5F1 is known to be restricted to pluripotent and germ line cells, and
it was down-regulated in the Huang dNES
hESC
experiment (Figure 9.3). SALL4 , an antagonist of
POU5F1 , was down-regulated in the GE NS
NES
experiment, thereby possibly mitigating any effect
POU5F1 may have been inducing in the hfNES cells. POU5F1 is likely not necessary once
differentiation progresses to the hfNS cell stage. The SILAC 1 sample S2L H10H supported
the GE NS
NES
experiment evidence for the down-regulation of SALL4 (Figure 9.3).
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Figure 9.3: Boxplots comparing the log2 ratios for POU5F1 and SALL4. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
9.1.1 SOX2
The sex determining region Y box (SOX) family of transcription factors play critical roles
in development, influencing the formation of tissues and organs. They form heterodimers,
thereby allowing them to have different functions in different cellular contexts. SOX2 is
responsible for maintaining pluripotency during neural stem cell self-renewal by regulating
genes involved in stem cell maintenance and neural differentiation.149,181In vivo its expression,
during gastrulation, is confined to the neural plate and its expression is extinguished in most
adult tissues.212 In ESC, it forms a heterodimer with POU5F1 , enforcing ESC pluripotency.
In neural stem cells, SOX2 forms a heterodimer with POU3F2 , thereby conferring neural
identity.129 SOX2 expression was down-regulated in the SILAC NS
NES
experiment (Figure 9.4).
POU5F1 was down-regulated in the Huang dNES
hESC
experiment (Figure 9.3). POU3F2 showed an
upwards trend in the Huang dNES
hESC
experiment and a downwards trend in the GE NS
NES
and SILAC
NS
NES
experiments, although neither was statistically significant (Figure 9.5). This fits well with
what has been previously observed in literature. Up-regulation of SOX2 and POU3F2 in
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dNES cells would confer neural identity to the hfNES cells and then their down-regulation in
hfNS cells would allow further differentiation. Furthermore, SOX2 appears to have decreased
steadily in the hfNES cell differentiation experiment. However because of a lack of sufficient
numbers of data points, the change was not statistically significant. There are a number
of additional SOX transcription factors that were SDE in this study, some of which will be
discussed in section 14.2 (Figure 14.4)
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Figure 9.4: Boxplots comparing the log2 ratios for SOX2. Each experiment has its
own scale and the horizontal blue lines indicate the 2 standard deviation (σ) thresh-
olds for the respective experiment. Red and green filled boxplots indicate significant
up- or down-regulation respectively. The p-values are included on the bottom of the
plots.
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Figure 9.5: Boxplots comparing the log2 ratios for POU3F2. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
9.1.2 LIN28
LIN28 maintains stemness by binding and blocking the processing of let-7 microRNA, which
antagonises proliferation and self-renewal of stem cells.238 LIN28A and LIN28B showed no
difference in the Huang dNES
hESC
experiment but were significantly down-regulated in the GE NS
NES
experiment. LIN28A was also significantly down-regulated in the SILAC NS
NES
experiment and
hfNES cells differentiation experiment. LIN28B showed similar but non-significant trends
(Figure 9.6 and 9.7). LIN28 is discussed further in section 13.2.3.
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Figure 9.6: Boxplots comparing the log2 ratios for LIN28A. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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Figure 9.7: Boxplots comparing the log2 ratios for LIN28B. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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9.1.3 ZFP42
ZFP42 , a transcription factor marker of ESCs, is known to be down-regulated when ESCs are
treated with retinoic acid to induce differentiation,248 although its molecular function remains
uncertain. It was down-regulated in the Huang dNES
hESC
experiment, but not detected in the other
experiments (Figure 9.8).
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Figure 9.8: Boxplots comparing the log2 ratios for ZFP42. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
9.2 Proliferation markers
9.2.1 MYC
The MYC proteins induce cell proliferation and cell growth. MYC and MYCN have comple-
mentary expression patterns, with MYCN expressed in early development particularly, in the
neuroepithelium. MYC is expressed in all adult proliferative cells.232 Differing expression pat-
terns indicate the possibility of functional differences despite similar biochemical properties.232
In MYC -deficient mice, MYCN can replace MYC with few developmental deficiencies.232 The
endogenous expression of either MYC or MYCN is essential for maintaining pluripotency.
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MYCN was down-regulated in the GE NS
NES
experiment (Figure 9.9). However, no statistically
significant change was observed in MYC expression.
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Figure 9.9: Boxplots comparing the log2 ratios for MYC and MYCN. Each ex-
periment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
9.2.2 MKI67 and PCNA
The proliferation markers MKI67 and PCNA were both down-regulated in the SILAC NS
NES
ex-
periment but not in the GE NS
NES
experiment. They were also both down-regulated in the hfNES
and hfNS cell differentiation experiments (Figure 9.10 and 9.11). MKI67 covers chromosomes
and disperses them by forming a steric and electrostatic charge barrier, thus preventing the
chromosomes from collapsing and thereby enabling them to disperse. PCNA is essential for
DNA replication. It serves as a DNA clamp and localises to pre-replication sites227 where
it encircles the DNA, forming a sliding clamp.165 It then recruits proteins involved in DNA
replication and facilitates their progress along the DNA.
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Figure 9.10: Boxplots comparing the log2 ratios for MKI67. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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Figure 9.11: Boxplots comparing the log2 ratios for PCNA. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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9.2.3 MCM2
MCM2 is a proliferation marker often used as a marker of neural stem cell proliferation. It
forms part of the minichromosome maintenance protein complex (MCM complex), which is
critical for replisome assembly. It is significantly down-regulated in both the GE NS
NES
and
SILAC NS
NES
experiments. It is also significantly down-regulated in the hfNS cell differentiation
experiment (Figure 9.12). The MCM complex is discussed in more detail in section 12.1.1.
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Figure 9.12: Boxplots comparing the log2 ratios for MCM2. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
9.2.4 HMGA2
The HMG protein HMGA2 binds DNA and changes its conformation, and then induces tran-
scription through interaction with other transcription factors.248 It does not have its own
transcriptional activation capacity. It increases the cell cycle progression through interaction
with CCNA2 , thereby promoting stem cell self renewal. HMGA2 was down-regulated in the
GE NS
NES
and SILAC NS
NES
experiments. CCNA2 shows a non significant downward trend in the
GE NS
NES
and SILAC NS
NES
experiments, indicating some degree of co-expression in the hfNES cells
(Figure 9.13). There are additional HMG proteins, SDE in this work (Figure 9.14).
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Figure 9.13: Boxplots comparing the log2 ratios for CCNA2 and HMGA2. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
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Figure 9.14: Heatmap of HMG proteins significantly differentially expressed
(SDE). Red and green indicates up- and down-regulation respectively.
9.2.5 PDGFRB
PDGFRB is a tyrosine kinase cell surface receptor, that binds PDGFD and PDGFB homod-
imers or PDGFA and PDGFB heterodimers. None of these ligands were SDE (Figure 9.16).
Activation of the receptor results in auto-phosphorylation and phosphorylation of intracellular
proteins. Activation usually triggers proliferation and migration, as has been shown in neu-
roepithelial cells in vitro.72 In vivo, its expression in up-regulated in response to traumatic
brain injury (TBI), triggering cell proliferation and formation of a glial scar. Its inhibition
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disrupts the formation of this glial scar.161 It was down-regulated in the GE NS
NES
experiment
(Figure 9.15) and may be promoting proliferation of the hfNES cells.
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Figure 9.15: Boxplots comparing the log2 ratios for PDGFRA and PDGFRB.
Each experiment has its own scale and the horizontal blue lines indicate the 2
standard deviation (σ) thresholds for the respective experiment. Red and green
filled boxplots indicate significant up- or down-regulation respectively. The p-values
are included on the bottom of the plots.
l
ll
l
ll
ll
ll
ll
ll
l
ll
l
0.727
lll
l
lllll
lllll
ll
lll
l
lll
l
0.232
ESC_dNES GE SILAC
−0.6
−0.3
0.0
0.3
0.6
−0.10
−0.05
0.00
0.05
0.10
−0.3
0.0
0.3
lo
g2
(ra
tio
)
Significantly
up−regulated
down−regulated
PDGFA
l
l
llll
ll
llllll
lllllll
llll
ll
1
ll
llll
llll
lll
llll
lllll
ll
llll
llll
lll
llllll
lll
l
ll
l
0.0471
ESC_dNES GE SILAC
−0.6
−0.3
0.0
0.3
0.6
−0.1
0.0
0.1
−0.2
0.0
0.2
lo
g2
(ra
tio
)
Significantly
up−regulated
down−regulated
PDGFB
l
ll
ll
ll
ll
llll
lll
ll
0.845
ll
ll
llll
llll
lllll
llll
ll
l
0.000534
ESC_dNES GE SILAC
−0.6
−0.3
0.0
0.3
0.6
−0.1
0.0
0.1
−0.6
−0.3
0.0
0.3
0.6
lo
g2
(ra
tio
)
Significantly
up−regulated
down−regulated
PDGFC
l
l
l
ll
ll
ll
lll
ll
lll
ll
l
1
l
lll
ll
ll
llll
llllllll
llll
llllll
l
lll
llllll
llll
llll
0.00492
ESC_dNES GE SILAC
−0.6
−0.3
0.0
0.3
0.6
−0.1
0.0
0.1
−0.2
0.0
0.2
lo
g2
(ra
tio
)
Significantly
up−regulated
down−regulated
PDGFD
Figure 9.16: Boxplots comparing the log2 ratios for PDGFA, PDGFB, PDGFC
and PDGFD. Each experiment has its own scale and the horizontal blue lines indi-
cate the 2 standard deviation (σ) thresholds for the respective experiment. Red and
green filled boxplots indicate significant up- or down-regulation respectively. The
p-values are included on the bottom of the plots.
9.2.6 TERF1 and ALPL
Enzymes can also be used as markers: TERF1 , a common ESC marker, was down-regulated in
the Huang dNES
hESC
experiment (Figure 9.17). It negatively regulates telomerase and protects chro-
mosome ends. ALPL, an alkaline phosphatase isozyme, is widely used as an ESC pluripotency
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marker, and was down-regulated in the GE NS
NES
experiment, but showed too much variance in
the Huang dNES
hESC
experiment to deduce any trend (Figure 9.17).
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Figure 9.17: Boxplots comparing the log2 ratios for ALPL and TERF1. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
9.3 Neural stem cell markers
9.3.1 Paired box transcripion factors
Zhang and Jiao (2015) published a review on markers of embryonic and adult neurogenesis.
Key amongst these is the paired box transcription factor PAX6 , which plays a pivotal role initi-
ating the neural cell fate. PAX6 cooperates with SOX2 in gene regulation during neurogenesis.
It activates neuronal genes while repressing those that promote non-neuronal lineages.220 It
was up-regulated in the Huang dNES
hESC
experiment (Figure 9.18) and may be partially responsible
for conferring neural tissue properties upon dNES cells.
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Figure 9.18: Boxplots comparing the log2 ratios for PAX3 and PAX6. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
PAX3 promotes neural stem cell survival229 and stemness127 and is down-regulated during
neural stem cell differentiation into neurons42 or astrocytes.127 PAX3 is known to be involved in
neural tube development, its hypermethylation may play a role in neural tube defects.124 PAX3
was up-regulated in the GE NS
NES
experiment (Figure 9.18) and may be helping to maintain the
stemness of the hfNS cells. None of the other paired box (PAX) genes were SDE (Figure 9.19).
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Figure 9.19: Heatmap for the expression of all PAX genes or proteins across all
experiments. Red and green indicates up- and down-regulation respectively.
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9.3.2 Nuclear hormone receptors
The nuclear hormone receptors NR2F1 and NR2F2 are key regulators in neural stem cell
temporal specification. They were both up-regulated in the Huang dNES
hESC
experiment. NR2F1
was down-regulated in the GE NS
NES
experiment (Figures 9.20 and 9.21). They are discussed in
further in the transcription factor section 14.4.2.
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Figure 9.20: Boxplots comparing the log2 ratios for NR2F1. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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Figure 9.21: Boxplots comparing the log2 ratios for NR2F2. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
9.3.3 EGR2
EGR2 is a transcription regulatory factor important in hind-brain development. Deletion of
this gene in mice results in hind-brain defects and an inability to survive after birth.212 It was
down-regulated in the GE NS
NES
experiment (Figure 9.22), indicating that it is possibly only
crucial during the neuroepithelial phase of hind-brain development.
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Figure 9.22: Boxplots comparing the log2 ratios for ASCL1 and EGR2. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
9.3.4 ASCL1
ASCL1 , a pro-neural basic helix-loop-helix (bHLH) specific transcription factor, is often used
as a RG marker, together with NEUROD2 and NEUROG2 . It has been shown to be essential
for maintaining neural stem cell neurogenesis potential, in late developmental stages, beyond
Carnegie Stage 18.148,223 When it is knocked down in murine neural stem cells that differen-
tiate into neurons, they become glial cells instead.164 It is induced by BMP-SMAD signalling
and is usually expressed after PAX6 , with NEUROG2 but before NEUROD2 and MYT1L.
ASCL1 was up-regulated in the GE NS
NES
experiment but not detected in the SILAC NS
NES
exper-
iment (Figure 9.22). NEUROG2 , NEUROD2 , and MYT1L were not SDE in the Huang dNES
hESC
experiment or detected in the other experiments.
9.3.5 Hairy and enhancer of split transcription factors
The hairy and enhancer of split (HES) family of bHLH transcription factors suppresses tran-
scription, particularly that of pro-neural genes. HES1 , a common neuroepithelial marker,
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showed an non-significant upwards trend in the Huang dNES
hESC
experiment (Figure 9.23). HES3
was not present in this dataset. HES4 and HES5 showed non-significant upwards trends in
the Huang dNES
hESC
experiment and were up-regulated in the GE NS
NES
experiment (Figure 9.23 and
9.24). They may be responsible for conferring increased gliogenic potential onto the hfNS cells.
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Figure 9.23: Boxplots comparing the log2 ratios for HES1, HES2, HES3 and
HES4. Each experiment has its own scale and the horizontal blue lines indicate the
2 standard deviation (σ) thresholds for the respective experiment. Red and green
filled boxplots indicate significant up- or down-regulation respectively. The p-values
are included on the bottom of the plots.
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Figure 9.24: Boxplots comparing the log2 ratios for HES5, HES6 and HES7. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
9.3.6 Intermediate filaments
NES an intermediate filament used as a marker for neural stem cells, it is expressed in neural
stem cells and its expression vanishes upon differentiation, so it is absent from nearly all
mature CNS cells. In this study, there appeared to be no difference in expression of NES in
the proliferating cells. Its expression then decreased during differentiation, significantly so in
the hfNES cells (Figure 9.25).
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Figure 9.25: Boxplots comparing the log2 ratios for NES. Each experiment has its
own scale and the horizontal blue lines indicate the 2 standard deviation (σ) thresh-
olds for the respective experiment. Red and green filled boxplots indicate significant
up- or down-regulation respectively. The p-values are included on the bottom of the
plots.
The hfNS cells express many RG markers, such as the intermediate filaments VIM and
GFAP . VIM is used as a RG marker in the embryo, and vanishes at the termination of
gestation, when it is replaced by GFAP , which provides mechanical strength to astrocytes.
GFAP -positive progenitors have been shown to produce all three types of neural cells. GFAP
and VIM were up-regulated in the SILAC NS
NES
experiment and then GFAP was further up-
regulated during hfNS cell differentiation (Figure 9.26 and 9.27). Multiple isoforms were de-
tected for GFAP , P14136 was most abundantly detected and showed the greatest change in
expression.
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Figure 9.26: Boxplots comparing the log2 ratios for GFAP. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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Figure 9.27: Boxplots comparing the log2 ratios for VIM. Each experiment has its
own scale and the horizontal blue lines indicate the 2 standard deviation (σ) thresh-
olds for the respective experiment. Red and green filled boxplots indicate significant
up- or down-regulation respectively. The p-values are included on the bottom of the
plots.
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9.3.7 FABP7
FABP7 , another common RG marker, is required for the glial fibre system. This is a network
of astrocytes across which neurons migrate. By similarity, FABP7 has been identified as a
fatty acid transporter, but its ligand is as yet unknown. In vivo its expression is regulated
by PAX6 . It is not expressed in the neuroepithelium and its expression coincides with RG
differentiation.17 Its expression is maintained in astrocytes. It was up-regulated in the GE NS
NES
and SILAC NS
NES
experiments. (Figure 9.28).
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Figure 9.28: Boxplots comparing the log2 ratios for FABP7. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
9.3.8 Glutamate transporters
The glutamate transporters SLC1A1 , SLC1A2 , and SLC1A3 have specific expression in dif-
ferent cells and areas of the CNS.178 SLC1A3 , commonly known as GLAST-1, was the only
glutamate transporter SDE in this study. It is an astrocyte-specific transporter of glutamate
and aspartate. It removes glutamate from the synaptic cleft, terminating post-synaptic action.
It is highly expressed in Bergmann glia but is also found in neurons.178 Together with GFAP ,
FABP7 is used as a marker to determine the transition from neuroepithelial cells to RG.5
128
Here, it was up-regulated in the GE NS
NES
and SILAC NS
NES
experiments (Figure 9.29). There
were many solute carriers SDE in this study (Figure 9.30), and their differential expression
across these cells may make them useful as potentially novel markers.
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Figure 9.29: Boxplots comparing the log2 ratios for SLC1A3. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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Figure 9.30: Heatmap of all solute carriers significantly differentially expressed
(SDE) across all experiments. Red and green indicates up- and down-regulation
respectively.
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9.3.9 MBP
The myelin basic protein (MBP) forms and stabilises the myelin membrane structure. It was
up-regulated in the GE NS
NES
experiment and its expression in hfNS cells indicates the potential
for these cells to differentiate into oligodendrocytes.
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Figure 9.31: Boxplots comparing the log2 ratios for MBP and RBFOX3. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
9.4 Neuronal markers
9.4.1 DCX
DCX is a microtubule-associated protein that facilitates microtubule polymerisation. It is
known to become down-regulated as the neurons mature and is replaced by RBFOX3 . DCX
was up-regulated in the Huang dNES
hESC
experiment and down-regulated in the GE NS
NES
experiment.
The increased expression of DCX in both differentiating hfNES cells and hfNS cells indicates
that the study terminated while the neurons were still immature (Figure 9.32). RBFOX3
showed a downwards trend in the Huang dNES
hESC
experiment (Figure 9.31).
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Figure 9.32: Boxplots comparing the log2 ratios for DCX. Each experiment has its
own scale and the horizontal blue lines indicate the 2 standard deviation (σ) thresh-
olds for the respective experiment. Red and green filled boxplots indicate significant
up- or down-regulation respectively. The p-values are included on the bottom of the
plots.
9.4.2 MAP2
MAP2 is a cytoskeletal protein involved in stabilising microtubules by crosslinking them to
other microtubules or to intermediate filaments. It is often used as marker for mature neurons.
Interestingly, it was down-regulated in the GE NS
NES
experiment. The two isoforms detected in
the SILAC NS
NES
experiment also show downwards trends. MAP2 was up-regulated in both
the hfNES cell differentiation experiment and the hfNS cell differentiation experiments. Two
isoforms were detected, the P11137-3 isoform was the most abundant and showed the greatest
increase in expression during differentiation (Figure 9.33).
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Figure 9.33: Boxplots comparing the log2 ratios for MAP2. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
9.4.3 CALB1
CALB1 , a calcium buffer and sensor that is important in regulating pre-synaptic calcium,
is down-regulated in the Huang dNES
hESC
and SILAC NS
NES
experiments (Figure 9.34). This might
indicate that it is playing additional roles in calcium signalling in pluripotent cells.
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Figure 9.34: Boxplots comparing the log2 ratios for CALB1. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
9.4.4 Tubulins
Tubulins are major constituents of microtubules, their expression is accurately controlled in
different neural tissue cells. TUBB3 is thought to be a neuron-specific marker and is important
for proper axon maintenance and guidance. It is more dynamic than other tubulins which is a
necessity for the rapid changes that occur during neurite outgrowth. Here it’s expression was
detected by immunohistochemistry in hfNES cells and hfNS cells, and it was up-regulated in
the SILAC NS
NES
experiment and hfNES cells differentiation experiment (Figure 9.35). It may
become up-regulated in hfNS cells to produce their processes. Its expression did not appear
to change much as the hfNS cells differentiated, but it was up-regulated as the hfNES cells
differentiated. There are a number of additional tubulins SDE in this work (Figure 9.36).
They may each play specific roles in each of the different cellular contexts.
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Figure 9.35: Boxplots comparing the log2 ratios for TUBB3. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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Figure 9.36: Tubulins significantly differentially expressed (SDE).
9.4.5 Neurofilaments
Neurofilaments are intermediate filaments that provide structural support for neuronal pro-
cesses, in particular maintaining the diameter of the axon. NEFL and NEFM are replaced
by NEFH as neurons mature. NEFL was up-regulated in the SILAC NS
NES
experiment (Figure
9.37). NEFM was down-regulated during hfNS cell differentiation (Figure 9.38). Strangely,
NEFH was down-regulated in the Huang dNES
hESC
experiment (Figure 9.39), indicating that it
was more highly expressed in human ESC lines (hESC cells) than dNES cells, although its
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expression should only increase upon neuronal maturation.
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Figure 9.37: Boxplots comparing the log2 ratios for NEFL. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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Figure 9.38: Boxplots comparing the log2 ratios for NEFM. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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Figure 9.39: Boxplots comparing the log2 ratios for NEFH. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
9.4.6 NCAM1
NCAM1 is a cell adhesion molecule that creates like-like interactions between neurons. It
plays vital roles in neurite outgrowth, synaptic plasticity, memory, and learning. It directs
neurite outgrowth through phosphatidylinositol and calcium signalling, and is often used as
a neuronal marker. Here, it was up-regulated in the SILAC NS
NES
experiment and also during
differentiation of both hfNES cells and hfNS cells (Figure 9.40).
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Figure 9.40: Boxplots comparing the log2 ratios for NCAM1. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
9.4.7 GAP43
GAP43 , commonly called neuromodulin, is a cytoplasmic protein that plays a prominent role
in brain and particularly cerebellum development. It performs important roles in neurite
formation and plasticity. It is expressed at high levels in neuronal growth cones during devel-
opment. It forms a heterodimer with calmodulin, thereby affecting local calcium signalling. Its
influence on calcium signalling may be important for directing growth cone formation. Here, it
was up-regulated in the GE NS
NES
and SILAC NS
NES
experiments, and the hfNES cell differentiation
experiment (Figure 9.41) and may be partly responsible for the more complex morphology of
the hfNS cells, as they extend processes that may be immature neurite buds. GAP43 was
up-regulated as the hfNES cells differentiate, but it may be expressed at sufficiently high levels
in hfNS cells, for further up-regulation not to be necessary.
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Figure 9.41: Boxplots comparing the log2 ratios for GAP43. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
9.5 Gliogenic markers
9.5.1 CD44
CD44 is a cell surface glycoprotein receptor for hyaluronic acid (HA), the chief component
of extracellular matrix (ECM). It is also a receptor for SPP1 , membrane metalloproteases
(MMPs), and collagens. CD44 is involved in cell-cell and cell-matrix adhesion, thereby pro-
moting cell aggregation and migration. Here, it was up-regulated in the GE NS
NES
and SILAC
NS
NES
experiments (Figure 9.42). Interestingly, SPP1 was also up-regulated in the GE NS
NES
ex-
periment, which was also corroborated by the SILAC 1 sample (Figure 9.43). SPP1 may be
important for the proliferation and survival of neural stem cells and may even increase neuro-
genic potential.172 Its effect appears to be mediated through CXCR4 , which was up-regulated
in the Huang dNES
hESC
and GE NS
NES
experiments (Figure 9.43). These interactions explain the im-
portance of the up-regulation of CD44 in hfNS cells. Many collagens were also SDE in this
study, but no MMPs were SDE (Figure 9.44). Information about the differential expression of
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collagens may be useful to further optimise cell culture conditions for neural stem cells.
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Figure 9.42: Boxplots comparing the log2 ratios for CD44. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
lll
llllllllllll
llllll
llllllllllll
lllllllllllllll
llllllllllll
llllll
lll
lllllllll
lll
0.00658
llllll
llllllllllll
llllllllllllllll
llllllllllllllll
llllllllllll
llllllllll
llllllll
llllllllllllllll
0.00343
ESC_dNES GE SILAC
−1.0
−0.5
0.0
0.5
1.0
−0.4
−0.2
0.0
0.2
0.4
−0.4
0.0
0.4
lo
g2
(ra
tio
)
Significantly
up−regulated
down−regulated
CXCR4
ll
lll
lll
l
0.852
llllllll
llllllllllllllllllllllllll
llllllllllllllllllllllllllll
ll
llllllll
llllllll
llllllll
llllllll
3.85e−08
l
ESC_dNES GE SILAC
−1
0
1
−0.5
0.0
0.5
−0.4
0.0
0.4
lo
g2
(ra
tio
)
Significantly
up−regulated
down−regulated
SPP1
Figure 9.43: Boxplots comparing the log2 ratios for CXCR4 and SPP1. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
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Figure 9.44: A heatmap of all the collagen molecules significantly differentially
expressed (SDE) in all experiment in this work. Red and green indicate up- and
down regulation respectively. Red and green indicates up- and down-regulation re-
spectively.
9.5.2 Cadherins
Epithelial cadherin, CDH1 , is listed by Abcam3 as a neuroepithelial cell marker. It showed a
non-significant downwards trend in the Huang dNES
hESC
experiment and an upwards trend in the GE
NS
NES
experiment (Figure 9.45). It was not present in high enough amounts to be detected in any
of the proteomic experiments. Neural cadherin, CDH2 , is a calcium-dependent cell adhesion
protein. It plays important roles in cell attachment and positioning during development. In
neural tissue, it is responsible for maintaining attachment between the pre-synaptic and post-
synaptic neurons. Here, it showed a gradual upwards trend in all experiments, although it is
not SDE in any of these (Figure 9.45). Additional cadherins that are SDE in this work are
not discussed (Figure 9.46).
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Figure 9.45: Boxplots comparing the log2 ratios for CDH1 and CDH2. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
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Figure 9.46: Heatmap of significantly differentially expressed (SDE) cadherin
proteins across all experiments, Red and green indicates up- and down-regulation
respectively.
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9.5.3 Dihydropyrimidinase-related proteins
During the maturation of the nervous system, members of the dihydropyrimidinase-related pro-
tein (DPYSL) family are developmentally regulated.217 They play roles in neurite outgrowth,
axonal guidance, and cell differentiation.217 DPYSL2 and DPYSL3 have been found to be
overexpressed in neural stem cells.249 Interestingly, all the DPYSLs are SDE in this work, and
may be useful to characterise the development of neural stem cells. DPYSL2 has previously
been shown to be up-regulated in neural stem cells vs ESC.249 Here, however, DPYSL2 only
showed a marginal upwards trend in the Huang dNES
hESC
experiment, and did not show any sig-
nificant changes between proliferating hfNES cells and hfNS cells. DPYSL2 was up-regulated
in the hfNES cell differentiation experiment and the hfNS cell differentiation experiment, in-
dicating that it may play important roles in differentiated neural tissue cells. DPYSL3 was
up-regulated in the GE NS
NES
experiment and in the hfNES cell differentiation experiment. In
neuroblastoma cells, its expression was shown to be inhibited by MYCN ,217 while here they
had inverse expressions patterns. DPYSL4 was down-regulated in the GE NS
NES
experiment and
SILAC NS
NES
experiment, but became up-regulated during differentiation of both cells types.
DPYSL5 was down-regulated in the SILAC NS
NES
experiment and up-regulated in the hfNS cell
differentiation experiment (Figure 9.48).
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Figure 9.47: Boxplots comparing the log2 ratios for DPYSL2. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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Figure 9.48: Heatmap of all significantly differentially expressed (SDE) DPSYL
proteins across all experiments. Red and green indicates up- and down-regulation
respectively.
9.5.4 Integrins
ITGB4 is a receptor for laminins. Integrins mediate cell-to-cell and cell-to-matrix adhesion.
They also transduce signals into cells. ITGB4 has been shown to be involved in foetal astroglial
migration in vitro.230 Here it was up-regulated in the GE NS
NES
and SILAC NS
NES
experiments.
There are a number of integrins SDE in these data, almost all were up-regulated in the GE
NS
NES
and SILAC NS
NES
experiments (Figure 9.49).
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Figure 9.49: Heatmap of all integrins significantly differentially expressed (SDE)
across all experiment in this work
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Chapter 10
Cell and tissue enrichment
10.1 Tissues
Tissue enrichment analysis was performed using the STRINGdb. The SDE genes and proteins
from each experiment were enriched relative to that of all genes or proteins detected in that
experiment. The p-values were corrected via Bonferroni correction.
146
(a)
Neural crest
Notochord
Neuroepithelium
Neural tube
Neural plate
Mesoderm
Ectoderm
Endoderm
−20 −10 0 10 20
log10(p value)
ESC_dNES
GE
SILAC
LFQ_NES
LFQ_NS
(b)
Adult
0 50
log10(p value)
SILAC
LFQ_NES
LFQ_NS
Figure 10.1: STRINGdb73 package in R enrichment of (a) germline, embryonic
neural tissues and (b) adult tissue. The adult tissues are highly enriched and plot-
ted on a different scale. ESC dNES (red) refers to the Huang dNES
hESC
experiment, GE
(orange) refers to the GE NS
NES
experiment, SILAC (yellow) refers to the SILAC NS
NES
experiment, LFQ NES (green) refers to the hfNES cell differentiation experiment,
and LFQ NS (blue) refers to the hfNS cell differentiation experiment. Enrichment
p-values were log10 transformed. Down-regulated genes and proteins have negative
log10(p-values) while up-regulated genes and proteins have positive log10(p-values),
so that they can be plotted together to illustrate the differences in enrichment. Ver-
tical blue lines represent the p-value cutoff of log10(0.01), positive and negative.
Tissue enrichment for the Huang dNES
hESC
experiment revealed the up-regulation of genes as-
sociated with the mesoderm , ectoderm , neural plate , neural tube , neuroepithelium ,
notocord , and neural crest (Figure 10.1 (a)). This is in concordance with hESCs differen-
tiating into dNES cells. In vivo, neuroepithelial cells would be a part of all of these tissues. In
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the remaining experiment, the cells down-regulate genes from these tissues as they differentiate
into RG and terminally differentiate into neurons and glia. (Figure 10.1 (a)). Interestingly,
adult tissue was highly enriched in all the proteomic experiments, but not in the transcriptomic
experiments (Figure 10.1 (b)).
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10.2 Cells
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Figure 10.2: STRINGdb enrichment of stem cells and neural tissue cells.
ESC dNES (red) refers to the Huang dNES
hESC
experiment, GE (orange) refers to the GE
NS
NES
experiment, SILAC (yellow) refers to the SILAC NS
NES
experiment, LFQ NES
(green) refers to the hfNES cell differentiation experiment, and LFQ NS (blue)
refers to the hfNS cell differentiation experiment. Enrichment p-values were log10
transformed. Down-regulated genes and proteins have negative log10(p-values) while
up-regulated genes and proteins have positive log10(p-values), so that they can be
plotted together to illustrate the differences in enrichment. Vertical blue lines rep-
resent the p-value cutoff of log10(0.01), positive and negative.
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Similarly, the genes enriched across cells largely corroborate the cell model (Figure 10.2). Em-
bryonic stem cells were down-regulated during differentiation. Neuroepithelial proteins,
paradoxically were up-regulated during differentiation. Neural stem cells were enriched both
ways, except in the Huang dNES
hESC
experiment. Adult stem cell genes were strongly enriched in
all cells except those of the Huang dNES
hESC
experiments. Glial cells were more highly enriched
in hfNS cells than hfNES cells. Interestingly, Bergmanns glia found in the cerebellum were
only enriched in the SILAC NS
NES
experiment hfNS cells. Neurons were also enriched in all
differentiating cells, but more so in the hfNS cells and differentiating hfNES cell. Paradoxically,
there was no neuron enrichment observed in the GE NS
NES
experiment (Figure 10.2).
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Chapter 11
KEGG pathway enrichment
KEGG enrichment analysis was generated using the STRINGdb. The SDE genes or proteins
were enriched relative to that of all genes or proteins detected in the experiment. The p-values
were corrected via Bonferroni correction.
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11.1 KEGG pathways down-regulated in NES
Pathways in cancer
Ribosome biogenesis in eukaryotes
Glycine, serine and threonine metabolism
Base excision repair
Ubiquitin mediated proteolysis
RNA transport
Spliceosome
Metabolic pathways
Mismatch repair
Cell cycle
DNA replication
0 20 40
log10(p value)
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LFQ_NES
LFQ_NS
Figure 11.1: Kyoto encyclopedia of genes and genomes enrichments for SILAC
NS
NES
experiment down-regulated proteins. All other experiment relative enrichment
are overlayed on this plot to illustrate potential differences. ESC dNES (red) refers
to the Huang dNES
hESC
experiment, GE (orange) refers to the GE NS
NES
experiment,
SILAC (yellow) refers to the SILAC NS
NES
experiment, LFQ NES (green) refers to
the hfNES cell differentiation experiment, and LFQ NS (blue) refers to the hfNS cell
differentiation experiment. Enrichment p-values were log10 transformed. Down-
regulated genes and proteins have negative log10(p-values) while up-regulated genes
and proteins have positive log10(p-values), so that they can be plotted together to
illustrate the differences in enrichment. Vertical blue lines represent the p-value
cutoff of log10(0.01), positive and negative.
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The pathways downregulated in the SILAC NS
NES
experiment are mainly involved in supporting
the cell cycle. Several metabolic pathways were also enriched, and these may also play a role
in supporting the cell cycle.
11.1.1 Cell cycle
Figure 11.2: Cell cycle.56
During the progression of stem cells towards lineage restricted progenitors there is a reduction
in the rate of the cell cycle. The first growth phase of the cell cycle (G1) phase increases in
length allowing cells to be influence more strongly by extracellular signals, and thereby accu-
mulating fate specifying transcription factors.88,164,180 The cell cycle has a number of different
stages (Figure 11.2) controlled by the cycling of the cyclin and their dependent kinases.The
cyclin-dependent kinases (CDKs) and cyclins (CCNs) are responsible for progression of the
cells cycle, whereas cyclin-dependent kinase inhibitor (CDKN) restrict the cell cycle. The
higher expression of CDK1 and CDK2 in hfNES cells would push these cells through the
growth phases of the cell cycle, thereby facilitating rapid proliferation. Interestingly greater
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difference were observed in CDK proteins in the proteomics data than in the genomic data,
whereas greater differences were observed for the CCNs in the transcriptomics data than the
proteomics data. Most importantly down-regulation of CCND2 , CCNJ , and CCNB1 and up-
regulation of CCNA1 and CCND1 (Figure 11.3). During differentiation CDK1 , CDK2 , and
CDK6 were down-regulated, this would most likely halt the cell cycle.
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Figure 11.3: Heatmaps of CDKs and CCNs across all experiments. Red and green
indicates up- and down-regulation respectively.
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proteins: 12
interactions: 38
expected interactions: 6 (p−value: 1.11022302462516e−16)
Figure 11.4: STRINGdb network of KEGG Cell cycle proteins SDE in the
SILAC NS
NES
experiment. Red and green halos indicate up- and down-regulation
respectively.
The KEGG term cell cycle was highly enriched in hfNES cells and therefore down-
regulated in the GE NS
NES
and SILAC NS
NES
experiments and down-regulated in both the hfNES
and hfNS cell differentiation experiments. There were many more genes SDE in the GE
NS
NES
experiment than in the SILAC NS
NES
experiment. Most of those found to be SDE in the SILAC
NS
NES
experiment were however not SDE in the GE NS
NES
experiment (Figure 11.5). Despite
the poor overlap, there were no contradictions between the genes and proteins found to be
SDE. This indicates the potential post-transcriptional regulation of these proteins. The down-
regulated proteins in the SILAC NS
NES
experiment mainly form part of the CC MCM complex
(see Figure 11.4 and section 12.1.1). Members of the MCM complex and PCNA and were
down-regulated across all proteomic experiments (Figure 11.5).
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Figure 11.5: A heatmap of SDE genes and proteins across all experiments that
form part of the KEGG cell cycle pathway. Red and green indicates up- and
down-regulation respectively.
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11.1.2 DNA replication
proteins: 34
interactions: 357
expected interactions: 14 (p−value: 0)
GE down
GE down & SILAC down
GE up
SILAC down
Figure 11.6: STRINGdb network for the KEGG pathway DNA replication for
the GE NS
NES
and SILAC NS
NES
experiments. The halo colours indicate the overlaps
in SDE between experiments, as per the legend, molecules without halos were not
SDE.
KEGG DNA replication was enriched in the down-regulated genes and proteins from all
experiments except the Huang dNES
hESC
experiment. In the GE NS
NES
experiment, there was a dif-
ference between DNA polymerases expressed in hfNES cells and hfNS cells. POLD1 , POLD3 ,
POLE , and POLE2 were down-regulated whereas POLD4 and POLE4 was up-regulated (Fig-
ure 11.7). POLD1 , POLD3 , and POLE showed similar trends in the SILAC NS
NES
experiment
despite not having sufficient replicates to be SDE (Figure 11.8). These DNA polymerase
delta and epsilon, are responsible for extending the leading and lagging strands during DNA
replication. Interestingly, POLQ , for which there is little information in the literature, is
down-regulated in the GE NS
NES
experiment. It is involved in the double-stranded break repair
pathway alternative end-joining pathway, reviewed in Black et al. 2016.
PCNA was downregulated in the SILAC NS
NES
experiment and the hfNES and hfNS cell differ-
entiation experiments, and it is instrumental in DNA replication. It localises to pre-replication
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sites before replication begins. It is a DNA clamp, that forms a homodimer encircling the DNA
and acts as a scaffold. It tethers the replication complex to the DNA strand. This sliding plat-
form is necessary to increase the processivity of DNA polymerases. PCNA is involved in DNA
replication, DNA repair and chromatin remodelling. It interacts with LIG1 , FEN1 , DNMT1 ,
CHAF1B , and MSH6 , which were all down-regulated in the SILAC NS
NES
experiment.
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Figure 11.7: Heatmap for the KEGG pathway DNA replication for the GE
NS
NES
and SILAC NS
NES
experiments. Red and green indicates up- and down-regulation
respectively.
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Figure 11.8: Boxplots comparing the log2 ratios for POLD1, POLD3, POLE and
POLQ. Each experiment has its own scale and the horizontal blue lines indicate the
2 standard deviation (σ) thresholds for the respective experiment. Red and green
filled boxplots indicate significant up- or down-regulation respectively. The p-values
are included on the bottom of the plots.
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11.1.3 Mismatch repair
(a)
proteins: 8
interactions: 23
expected interactions: 0 (p−value: 1.11022302462516e−16)
(b)
proteins: 5
interactions: 9
expected interactions: 1 (p−value: 1.93496514748451e−06)
(c)
proteins: 26
interactions: 184
expected interactions: 7 (p−value: 0)
GE down
GE down & LFQ_NS down & SILAC down
GE down & SILAC down
GE up
LFQ_NES down & LFQ_NS down & SILAC down
SILAC down
Figure 11.9: STRINGdb network of KEGG Mismatch repair for SDE genes
and proteins from the (a) the GE NS
NES
experiment, (b) the SILAC NS
NES
experiment,
and (c) a combined plot. In plots (a) and (b), red and green halos indicate up- and
down-regulation respectively.. In (c) the halo colours indicate the overlaps in SDE
between experiments, as per the legend, molecules without halos were not SDE.
The KEGG term Mismatch repair is enriched in down-regulated genes and proteins from
the GE NS
NES
and SILAC NS
NES
experiments. Even in cells not exposed to mutagens, DNA damage
occurs at a rate of approximately 10000 hits/cell.165 Mismatch repair recognises erroneously in-
serted or deleted nucleotides on the newly synthesised daughter DNA strand and repairs them.
It is strand-specific, as errors are most likely on the daughter strand. Mismatches are recognised
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by the two heterodimers MutS-alpha (MSH2 and MSH3 ) and MutS-beta (MSH2 and MSH3 ).
MSH2 and MSH6 were upregulated in the SILAC NS
NES
experiment. These heterodimers recruit
the heterodimer MutL-alpha (MLH1 and PMS2 ). PMS2 nicks the DNA spanning the mis-
match, and EXO1 then removes the incorrect DNA fragment. The single-stranded gap is filled
by POLD1 and its cofactors PCNA and replication factor C. The remaining nick is sealed by
LIG1 . This pathways is expressed during active cell proliferation.
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Figure 11.10: Heatmap of KEGG Mismatch repair for SDE genes and proteins.
Red and green indicates up- and down-regulation respectively.
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11.1.4 RNA transport
(a)
proteins: 16
interactions: 28
expected interactions: 2 (p−value: 0)
(b)
proteins: 6
interactions: 3
expected interactions: 0 (p−value: 0.0475584865343171)
(c)
proteins: 25
interactions: 51
expected interactions: 6 (p−value: 0)
GE down
GE down & SILAC down
LFQ_NES down
LFQ_NS down
LFQ_NS up
SILAC down
Figure 11.11: STRINGdb network of KEGG RNA transport for SDE genes
and proteins from (a) the GE NS
NES
experiment, (b) the SILAC NS
NES
experiment, and
(c) a combined plot. In plot (a) and (b) red and green halos indicate up- and down-
regulation respectively. In (c) the halo colours indicate the overlaps in SDE between
experiments, as per the legend
The KEGG term RNA transport refers the transport of ribonucleic acid (RNA) from the
nucleus to the cytoplasm. This process is fundamental to gene expression. Karyopherin-beta
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proteins are involved in the transport of transport RNAs (tRNAs), ribosomal RNAs (rRNAs),
and small nuclear RNAs (snRNAs), whereas mRNAs are transported through the nucleopore.
NUP35 and NUP153 , which were down-regulated in the SILAC NS
NES
experiment, and are
components of the nucleopore. A number of additional nucleopore proteins were also down-
regulated in the GE NS
NES
experiment (see Figure 11.11 and 11.14), together with GEMIN4 ,
which is involved in the maturation of snRNAs.
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Figure 11.12: Boxplots comparing the log2 ratios for PNN. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
The apoptosis and splicing–associated protein complex (ASAP complex) is composed of
SAP18 , RNPS1 and ACIN1 , none of which were SDE in these experiments (Figure 11.13).
PNN localises to the desmosome plaque, where it enhances epithelial cell attachment.100 It
is also found in the nuclear speckles, where it replaces ACIN1 in the ASAP complex to form
the Pinin containing ASAP complex (PSAP complex), which is involved in recruiting the
exon junction complex (EJC) to splice sites on mRNA. PNN , which was downregulated in the
SILAC NS
NES
experiment (Figure 11.12). MAGOH , MAGOHB and WIBG , components of the
EJC were down-regulated in the GE NS
NES
experiment. During development, the expression of
PNN varies in different tissues and it is highly expressed in the neuroepithelium.100
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Figure 11.13: Boxplots comparing the log2 ratios for ACIN1, RNPS1 and SAP18.
Each experiment has its own scale and the horizontal blue lines indicate the 2 stan-
dard deviation (σ) thresholds for the respective experiment. Red and green filled
boxplots indicate significant up- or down-regulation respectively. The p-values are
included on the bottom of the plots.
PNN shows a higher affinity for the complex than ACIN1 , which is unable to displace
it. These complexes regulate transcription and splicing. Replacing ACIN1 with PNN would
affect splice site selection and thereby potentially affect the identity of cells. PNN is also
thought to connect the chromatin to splicing events. Splicing is known to take place during
transcription and can therefore be affected by the chromatin state. If it is knocked down in
the corneal epithelium, it may cause a loss of cell-cell adhesion and changes in cell shape and
movement out of the epithelium.12 Overexpression of PNN in HEK293 cells results in more
epithelial-like phenotypes.100 In a pull-down experiment PNN was found to associate with
SRSF2 and MAGOH 108 both were SDE here.
XPO5 , which was downregulated in the SILAC NS
NES
experiment (Figure 11.14), mediates
the transport of proteins containing double-stranded RNA-binding domains and their cargos.
These can take the form of short hairpin interfering RNA. Its overexpression can enhance RNA-
mediated gene silencing. It requires Ras-related nuclear protein (Ran)-GTP for transport.
XPO5 is responsible for let-7 export out of the nucleus. Its overexpression would enhance the
LIN28 let-7 pathways, discussed in section 13.2.3.
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Figure 11.14: Heatmap of KEGG RNA transport for SDE genes and proteins.
Red and green indicates up- and down-regulation respectively.
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11.2 KEGG pathways up-regulated in NS
Fatty acid degradation
PI3K−Akt signaling pathway
Fatty acid elongation
Carbon metabolism
Endocytosis
PPAR signaling pathway
Glycolysis / Gluconeogenesis
Amino sugar and nucleotide sugar metabolism
Valine, leucine and isoleucine degradation
Cytokine−cytokine receptor interaction
ECM−receptor interaction
Calcium signaling pathway
Antigen processing and presentation
Proteoglycans in cancer
Phagosome
Lysosome
Cell adhesion molecules (CAMs)
Regulation of actin cytoskeleton
Focal adhesion
Metabolic pathways
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log10(p value)
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Figure 11.15: Top twenty KEGG terms enriched in the up-regulated genes and
proteins across all experiments. ESC dNES (red) refers to the Huang dNES
hESC
experi-
ment, GE (orange) refers to the GE NS
NES
experiment, SILAC (yellow) refers to the
SILAC NS
NES
experiment, LFQ NES (green) refers to the hfNES cell differentiation
experiment, and LFQ NS (blue) refers to the hfNS cell differentiation experiment.
Enrichment p-values were log10 transformed. Down-regulated genes and proteins
have negative log10(p-values) while up-regulated genes and proteins have positive
log10(p-values), so that they can be plotted together to illustrate the differences in
enrichment. Vertical blue lines represent the p-value cutoff of log10(0.01), positive
and negative.
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11.2.1 ECM-receptor interaction
(a)
proteins: 21
interactions: 100
expected interactions: 2 (p−value: 0)
˜
(b)
proteins: 9
interactions: 24
expected interactions: 0 (p−value: 0)
(c)
proteins: 27
interactions: 192
expected interactions: 5 (p−value: 0)
ESC_dNES down
ESC_dNES down & GE up & SILAC up
ESC_dNES up & GE down & LFQ_NES down
ESC_dNES up & GE down & SILAC down
GE down
GE up
GE up & LFQ_NS down & SILAC up
GE up & SILAC up
LFQ_NES down & LFQ_NS down
LFQ_NS down
SILAC up
Figure 11.16: STRINGdb network for KEGG ECM-receptor interaction (a)
the GE NS
NES
experiment and (b) the SILAC NS
NES
experiment, and (c) all the ex-
periments combined. In (a) and (b) red and green halos indicate up- and down-
regulation respectively. In (c) the halo colours indicate the overlaps in SDE between
experiments, as per the legend
The KEGG term ECM-receptor interaction was enriched in up-regulated genes and pro-
teins of the GE NS
NES
and SILAC NS
NES
experiments and in the down-regulated proteins in the
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hfNS cell differentiation experiment (Figure 11.15). Upon hfNES cells differentiation into hfNS
cells, the protein PNN , which plays a vital role in epithelial adherence is down-regulated. This
may lead to the up-regulation of ECM receptor proteins such as CD44 , COL6A1 , the integrins
(ITGAV , ITGB4 , ITGB5 , ITGB8 ), LAMB2 , and TNC (Figure 11.18).
CD44 is a receptor for hyaluronic acid, one of the chief components of the ECM. CD44
senses stimuli from the environment and regulates migration and proliferation. It is also
involved in cell-cell and cell-substrate adhesion. CD44 is expressed as a number of different
isoforms. The standard isoform is expressed ubiquitously, but some isoforms are selectively
expressed in epithelial tissues at specific stages of development. CD44 also binds SPP1 ,
collagens, and MMPs. SPP1 and certain collagens are up-regulated in hfNS cells, but not
MMPs. Overexpression of CD44 is known to attenuate the Hippo pathway.128
The integrins ITGAV , ITGB4 , ITGB5 , and ITGB8 were also up-regulated. The integrins
form heterodimers, usually with one alpha and one beta subunit. Different heterodimers play
different roles. They sense the ECM, and are necessary for the proliferation of neural stem
cells, particularly ITGAV and ITGB3 . ITGB3 , was not SDE but did show some degree of
up-regulation in hfNS cells (Figure 11.17).
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Figure 11.17: Boxplots comparing the log2 ratios for ITGB3. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
In the GE NS
NES
experiment, laminins LAMA1 and LAMC3 were down-regulated while
LAMA4 , LAMA5 ,LAMB2 were up-regulated. Laminins form part of the ECM basal mem-
brane.
ECM-receptor interaction was enriched in hfNS cells and in the down-regulated proteins
of the hfNS cell differentiation experiment. This indicates that the interaction with the ECM
is more important in hfNS cells than hfNES cells and is also more important in their stem cell
phase than after differentiation.
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Figure 11.18: Heatmap of KEGGs ECM-receptor interaction. Red and green
indicates up- and down-regulation respectively.
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11.2.2 Focal adhesion
(a)
proteins: 23
interactions: 124
expected interactions: 15 (p−value: 0)
(b)
proteins: 12
interactions: 14
expected interactions: 2 (p−value: 1.42157846938495e−07)
(c)
proteins: 9
interactions: 15
expected interactions: 1 (p−value: 4.45721237696262e−12)
Figure 11.19: STRINGdb network for KEGG Focal adhesion for (a) the SILAC
NS
NES
experiment, the (b) hfNES cell differentiation experiment and (c) hfNS cell
differentiation experiment. Red and green halos indicate up- and down-regulation
respectively.
Focal adhesion is an adhesive contact between the cell and the ECM, through a large
dynamic protein complex. Contact to the ECM is mainly mediated by integrins. Integrins
bind laminins, fibronectins, and vibronectins. Scaffold and intercellular signalling molecules,
PXN , SRC TLN1 , VCL, and ZYX bind integrins, thereby transferring signalling from the
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ECM into the cell, or from the cell to the ECM.112 Focal adhesion plays a role in cell migration.
Index
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Cell adhesion molecules (CAMs)
Figure 11.20: Overlap of the genes and proteins up-regulated in the GE NS
NES
and SILAC NS
NES
experiments that form part of the KEGG enriched terms for cell
adhesion and response to ECM interaction
Many of the proteins forming part of KEGG ECM-receptor interaction also form part
of KEGG Focal adhesion (Figure 11.20). This term was enriched in both hfNES cells and
hfNS cells in the GE
NS
NES
experiment, with p-value, of 0.0012 and 8.76×10−19, respectively
(Figure 11.15). It was far more highly enriched in hfNS cells, in agreement with enrichment
in hfNS cells in the SILAC
NS
NES
experiment. Focal adhesion is also enriched in the down-
regulated proteins in both the hfNES and hfNS cell differentiation experiments, thus indicating
that it is important in the pluripotent stages of neural stem cells, more so in hfNS cells, but
becomes less important after differentiation.
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Figure 11.21: Heatmap of all SDE genes and proteins for KEGG Focal ad-
hesion across all experiments. Red and green indicates up- and down-regulation
respectively.
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11.2.3 Cell adhesion molecules
proteins: 34
interactions: 51
expected interactions: 4 (p−value: 0)
ESC_dNES down
ESC_dNES down & GE up
ESC_dNES up
ESC_dNES up & GE up & SILAC up
GE down
GE up
GE up & SILAC up
LFQ_NES up & LFQ_NS up & SILAC up
LFQ_NS down
SILAC up
Figure 11.22: STRINGdb network for KEGG cell adhesion molecules for all
experiments. The halo colours indicate the overlaps in SDE between experiments,
as per the legend
Interestingly, the KEGG term Focal adhesion shares many molecules up-regulated in the
GE NS
NES
and SILAC NS
NES
experiments with the terms ECM-receptor interaction and Regu-
lation of actin cytoskeleton , although there were many more cell adhesion molecules SDE
in hfNS cell not included in Focal adhesion (Figure 11.20).
Cell adhesion molecules are molecules on the cell surface that allow the cell to bind the
ECM or other cells. Cell adhesion is an important part of development as it regulates the
structure and formation of the tissues. CADM1 was upregulated in the Huang dNES
hESC
, GE NS
NES
,
and SILAC NS
NES
experiments (Figure 11.23). It is critical to neural development and plays
many roles in the attachment of neuronal structures, axons, dendritic spines, and synapses.
It may also be involved in neuronal migration and axon growth. NCAM1 was upregulated in
the SILAC NS
NES
experiment, and the hfNES and hfNS cell differentiation experiments (Figure
11.23). It is a neural-specific adhesion protein often used as a neuronal marker, involved in
nervous system development and neuron-neuron adhesion.
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Figure 11.23: Heatmap of the genes and proteins SDE in all experiments that
form part of KEGG Cell adhesion molecules. Red and green indicates up- and
down-regulation respectively.
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11.2.4 Lysosome
proteins: 33
interactions: 39
expected interactions: 1 (p−value: 0)
GE down
GE up
GE up & SILAC up
SILAC up
Figure 11.24: STRINGdb network for KEGG Lysosome for the GE NS
NES
and
SILAC NS
NES
experiments. The halo colours indicate the overlaps in SDE between
experiments, as per the legend
The KEGG term Lysosome was enriched in up-regulated genes and proteins from the GE
NS
NES
and SILAC NS
NES
experiments and the hfNS cell differentiation experiment. The lysosome
is known to play a role in differentiation by targeting the degradation of signalling molecules,
thereby allowing the development of a specific fate. The lysosome may therefore be upregulated
in hfNS cells as a means to stabilise their fate determination both as hfNS cells and during hfNS
cell differentiation.
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Figure 11.25: Heatmap for SDE genes and proteins of KEGG Lysosome. Red
and green indicates up- and down-regulation respectively.
11.3 Signalling pathways
Most of the KEGG signalling pathways significantly enriched in this study are from the up-
regulated genes and proteins in the GE NS
NES
and SILAC NS
NES
experiments (Figure 11.26). This
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indicates an increase in complexity of the hfNS cells ability to respond to its environment.
Thereby enabling these cells to integrate into the developing neuronal tissue and respond to
changes as development progresses.
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Figure 11.26: The twenty most highly enriched KEGG Signalling pathways across
all the experiments. ESC dNES (red) refers to the Huang dNES
hESC
experiment, GE (or-
ange) refers to the GE NS
NES
experiment, SILAC (yellow) refers to the SILAC NS
NES
experiment, LFQ NES (green) refers to the hfNES cell differentiation experiment,
and LFQ NS (blue) refers to the hfNS cell differentiation experiment. Enrichment
p-values were log10 transformed. Down-regulated genes and proteins have negative
log10(p-values) while up-regulated genes and proteins have positive log10(p-values),
so that they can be plotted together to illustrate the differences in enrichment. Ver-
tical blue lines represent the p-value cutoff of log10(0.01), positive and negative.
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11.3.1 Neural induction
BMP signalling
Repression of BMP signalling is instrumental in the formation of the neural plate. The BMP
inhibitors CHRD , FST NOG and CER1 prevent the dorsal ectoderm from becoming epider-
mis, and induce formation of the neural plate. None of the BMP inhibitors were SDE and none
of the BMPs proteins were detected. However BMP1 , BMP2 , and GDF10 were up-regulated
in GE NS
NES
experiment whereas BMP3 , GDF10 /BMPB3, and BMP5 were down-regulated in
GE NS
NES
experiment (Figure 11.27).
The BMPs interact with transmembrane serine/threonine kinase receptors, which transduce
the signals into the cells by phosphorylating receptor SMADs (R-SMADs). BMP and their
serine/threonine kinase receptors (STKR) are expressed throughout the brain at all stages
of development, reviewed in Hegarty et al. 2013. No proteins for BMPs, their receptors or
R-SMADs were detected in the SILAC NS
NES
experiment. BMPR2 and TGFBR2 were up-
regulated in the GE NS
NES
experiment. None of the SMAD proteins were detected, and none
were differentially expressed in the Huang dNES
hESC
and GE NS
NES
experiments.
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Figure 11.27: Heatmap of BMP proteins and their receptors SDE across alll
experiments. Red and green indicates up- and down-regulation respectively.
The SMAD interacting protein ZEB2 was up-regulated in Huang dNES
hESC
experiment and
down-regulated in GE NS
NES
experiment. It has been shown to induce neural fate by suppressing
BMP signalling.94 In chick embryos ZEB2 expression is induced by CHURC1 and induction
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of ZEB2 expression is able to recover phenotype after knock-down of CHURC1 .184 CHURC1
is a downstream effector of FGF signalling and down-regulates early mesodermal genes, while
upregulating early neural genes.119
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Figure 11.28: Boxplots comparing the log2 ratios for CHURC1, INHBB and
ZEB2. Each experiment has its own scale and the horizontal blue lines indicate the
2 standard deviation (σ) thresholds for the respective experiment. Red and green
filled boxplots indicate significant up- or down-regulation respectively. The p-values
are included on the bottom of the plots.
CHURC1 showed little change in the ESCs but was up-regulated in the GE NS
NES
experiment.
The inverse expression of ZEB2 and CHURC1 in the GE NS
NES
experiment indicates it may be
controlled by means other than CHURC1 induction in human embryos. CHURC1 ’s role
in human embryos may be more important in the hfNS cells than the hfNES cells. ZEB2
does not bind DNA and is therefore hypothesised to mediate this effect through other protein-
interactions.117 Studying its interactors within this cell model may yield interesting information
as to its role in foetal brain development.
TGFBR3 was down-regulated in the GE NS
NES
experiment and is known to antagonises
BMPs,226 in conjunction with inhibins. The inhibin beta subunit INHBB which forms the
homodimer activin was up-regulated in the GE NS
NES
experiment. Activins are known to have
neuroprotective effects in the CNS. In the olfactory bulb they have been show to affect ASCL1
positive progenitors. Activin inhibits proliferation of intermediate neural progenitors, and
favours glial over neuronal fate. Both ASCL1 and INHBB were upregulated in the GE NS
NES
experiment so they may be playing a similar roles in hfNS cells.
85
181
WNT pathway
proteins: 26
interactions: 86
expected interactions: 20 (p−value: 0)
GE down
GE up
SILAC down
SILAC up
Figure 11.29: STRINGdb network of KEGG WNT pathway genes and proteins
SDE in the GE NS
NES
and SILAC NS
NES
experimentss. the halo colours indicate the
overlaps in SDE between experiments, as per the legend
The proliferating hfNES cells and hfNS cells were under stimulus of FGF and EGF while
proliferating. Upon removal of FGF and EGF stimulation they spontaneously differentiated.
There are virtually no FGFs or FGF receptors SDE in this work. The FGF pathway is
know to stimulate the wingless-type MMTV integration site family (WNT) pathway. Which
was enriched in the down-regulated genes of the GE NS
NES
experiment (Figure 11.26), thus
potentially more active in the hfNES cells. The WNT pathway is known to be involved in
cell fate specification, proliferation and migration. SFRP2 modulates WNT signalling and
is involved in many of the pathways and processes enriched in in the hfNES cells. It was
upregulated in the Huang dNES
hESC
experiment and down-regulated in the GE NS
NES
experiment
(Figure 11.31).
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Figure 11.30: Heatmap of KEGG WNT pathway genes and proteins SDE in the
GE NS
NES
and SILAC NS
NES
experimentss. Red and green indicates up- and down-
regulation respectively.
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Figure 11.31: Boxplots comparing the log2 ratios for SFRP2. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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Figure 11.32: STRINGdb network of KEGG Hippo pathway genes and proteins
SDE across all experiments. the halo colours indicate the overlaps in SDE between
experiments, as per the legend
The only other pathway enriched in the down-regulated genes from the GE NS
NES
experiment is
the Hippo signalling pathway. Interestingly it contains many of the effectors molecules that
overlap with the WNT pathway and the BMP pathway. It is known to control organ size in an-
imals by regulating the proliferation rate of stem cells during development.22 The downstream
effector of the Hippo pathway is YAP1 , which is known to be highly expressed in ESCs121
and neural stem cells.236,243 Knock-down of YAP1 in mice results in death before neural dif-
ferentiation.243 It is up-regulated by SOX2 182 and controls organ size through regulating the
proliferation of progenitors. It does this by increasing the expression of CCND1.236 In this
study, CCND1 and YAP1 have inverse expression patterns. YAP1 inhibts the WNT pathway,
thereby maintaining stemness,182 suggesting that the WNT pathways and Hippo pathways are
working in opposition in the hfNES cells, the antagonism of the WNT pathway potentially
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becomes lifted in the hfNS cells allowing WNT to become more influential (Figure 11.26).
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Figure 11.33: Heatmap of KEGG Hippo pathway genes and proteins SDE across
all experiments. Red and green indicates up- and down-regulation respectively.
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Figure 11.34: Boxplots comparing the log2 ratios for CCND1. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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Figure 11.35: Boxplots comparing the log2 ratios for YAP1. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
187
11.4 Metabolism
(a)
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Figure 11.36: The twenty mostly highly enriched KEGG metabolic pathways for
the (a) down-regulated or (b) up-regulated genes and proteins in the GE NS
NES
and
SILAC NS
NES
experiments. Enrichment p-values were log10 transformed. Down-
regulated genes and proteins have negative log10(p-values) while up-regulated genes
and proteins have positive log10(p-values), so that they can be plotted together to
illustrate the differences in enrichment. Vertical blue lines represent the p-value
cutoff of log10(0.01), positive and negative.
There were significant changes in the enriched metabolic pathways between the genes and
protein SDE in the GE NS
NES
and SILAC NS
NES
experiments (Figure 11.36). The hfNES cells
were more highly enriched for pathways involved in the anabolic processes pyrimidine and
purine metabolism and biosynthesis of amino acids . This indicates that the cells
may be producing the building blocks required for cell division and proliferation. The hfNS
cells were more highly enriched for catabolic process, perhaps in preparation for cells that are
establishing and playing defined roles within the developing neural tissue.
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Chapter 12
Gene ontology enrichment
All SDE genes and proteins from the experiments, Huang dNES
hESC
, GE NS
NES
, and SILAC NS
NES
exper-
iments and the hfNES and hfNS cell differentiation experiments were enriched using topGO.
The SDE genes and proteins from each experiment was enriched relative to that of all the genes
or proteins detected in that experiment, and the p-values were corrected by the weight01. A
p-value theshold of 0.01 was used for all enriched terms. Although traditional enrichment
multiple-testing correction of GO enrichment removes some of the GO terms enriched. the
weight01 algorithm highlights deeper levels of enrichment, by removing the terms higher up
in the hierarchy. The deeper levels are more descriptive and the corresponding STRINGdb
networks are smaller and therefore easily visualised and annotated.
In the Huang dNES
hESC
experiment, down- and up-regulated genes represent the hESCs, and
dNES cells respectively, while in the GE NS
NES
and SILAC NS
NES
experiments the down- and
up-regulated genes and proteins represent the hfNES cells and hfNS cells, respectively. The
enrichment p-values have been transformed by log10, down-regulated genes have negative
log10(p-value) enrichment scores, whereas up-regulated genes have positive log10(p-values).
189
12.1 Cellular component
The CCs enriched in hfNES cells were mostly components of the nucleus , whereas those
enriched in hfNS cells included components on the periphery of the cell (Figure 12.1).
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Figure 12.1: The top twenty most highly enriched cellular component terms en-
richments for all experiments. ESC dNES (red) refers to the Huang dNES
hESC
experi-
ment, GE (orange) refers to the GE NS
NES
experiment, SILAC (yellow) refers to the
SILAC NS
NES
experiment, LFQ NES (green) refers to the hfNES cell differentiation
experiment, and LFQ NS (blue) refers to the hfNS cell differentiation experiment.
Enrichment p-values were log10 transformed. Down-regulated genes and proteins
have negative log10(p-values) while up-regulated genes and proteins have positive
log10(p-values), so that they can be plotted together to illustrate the differences in
enrichment. Vertical blue lines represent the p-value cutoff of log10(0.01), positive
and negative.
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12.1.1 Cellular components enriched in NES cells
exon−exon junction complex
nuclear chromatin
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Figure 12.2: The top twenty most highly enriched CCs terms in the down-regulated
genes and proteins in the GE NS
NES
and SILAC NS
NES
experiments. ESC dNES (red)
refers to the Huang dNES
hESC
experiment, GE (orange) refers to the GE NS
NES
experiment,
SILAC (yellow) refers to the SILAC NS
NES
experiment, LFQ NES (green) refers to
the hfNES cell differentiation experiment, and LFQ NS (blue) refers to the hfNS cell
differentiation experiment. Enrichment p-values were log10 transformed. Down-
regulated genes and proteins have negative log10(p-values) while up-regulated genes
and proteins have positive log10(p-values), so that they can be plotted together to
illustrate the differences in enrichment. Vertical blue lines represent the p-value
cutoff of log10(0.01), positive and negative.
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Many of the proteins down-regulated in the SILAC NS
NES
experiment were parts of the nucleus.
The CC terms chromosome , chromatin nucleolus , and the nucleoplasm were all en-
riched in the down-regulated proteins from the SILAC NS
NES
experiment (Figure 12.2).
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Figure 12.3: Overlapping proteins down-regulated in the SILAC NS
NES
experiment
from enriched components of the nucleus
Nucleoplasm
The nucleoplasm, which is the cytoplasm of the nucleus, was enriched in down-regulated genes
and proteins in the GE NS
NES
and SILAC NS
NES
experiments, with 179 genes and 100 proteins SDE
with p-values of 1.4×10−5 and 2.7×10−17 respectively. The STRINGdb network for nucle-
oplasm was too large to generate a meaningful plots. Most of proteins from the remaining
enriched terms formed part of the nucleoplasm .
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Nucleolus
proteins: 46
interactions: 83
expected interactions: 39 (p−value: 1.29973787288407e−09)
Figure 12.4: CC Nucleolus proteins SDE in the SILAC NS
NES
experiment, Red
and green halos indicate up- and down-regulation respectively.
The nucleolus was enriched in down-regulated genes and proteins in the GE NS
NES
and SILAC
NS
NES
experiments, with 56 genes and 28 proteins respectively. The nucleolus is the site of
ribosome biosynthesis. In studies of human embryos,154 cells close to the ventricular surface
were shown to have a larger number of nucleoli. A second increase in nucleoli occurred in
the SVZ, the second germinal layer. The enrichment of nucleolar proteins within hfNES cells
corresponds well with the increased numbers of nucleoli observed in vivo.
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Chromosome
The chromatin condenses to form chromosomes during cell replication. The down-regulated
proteins from the SILAC NS
NES
experiment are enriched for CCs chromatin and chromo-
somes . These components are all essential in advancing the cell cycle and allowing rapid
proliferation of these cells.
MCM complex
proteins: 8
interactions: 28
expected interactions: 1 (p−value: 0)
GE down & SILAC down
SILAC down
Figure 12.5: STRINGdb network of the CC MCM complex for the GE NS
NES
and
SILAC NS
NES
experiments. The halo colours indicate the overlaps in SDE between
experiments, as per the legend, molecules without halos were not SDE.
The MCM complex is a set of eight DNA helicase proteins, required for DNA replication. Six
of the eight CC MCM complex proteins were down-regulated in the SILAC NS
NES
experiment
(Figure 12.5). The down-regulated protein enrichment p-value for the SILAC NS
NES
experiment
was 2.2×10−8. The complex forms a STRINGdb network clique, with all the proteins being
connected to each other (Figure 12.5). In vivo, they form a ring structure, which is a component
of the pre-replication complex. MCM2 and MCM6 were down-regulated in the GE NS
NES
and
SILAC NS
NES
experiments. The other three MCM complex proteins were only down-regulated
in the SILAC NS
NES
experiment, indicating possible post-transcriptional regulation. The MCM
complex is down-regulated as the cells differentiate, and is no longer required when the cells
stop proliferating (Figure 12.2 and 12.6).
195
MCM7
MCM6
MCM5
MCM4
MCM3
MCM2
GE SILAC LFQ_NES LFQ_NS
Experiments
G
en
e 
Sy
m
bo
ls
Significantly
up−regulated
down−regulated
Figure 12.6: Heatmap of the CC MCM complex for all the experiments. Red
and green indicates up- and down-regulation respectively.
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SWI/SNF superfamily type complex
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expected interactions: 4 (p−value: 0)
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proteins: 14
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proteins: 13
interactions: 63
expected interactions: 3 (p−value: 0)
Figure 12.7: STRINGdb networks for the all genes and proteins from the CC (a)
SWI/SNF complex, (b) nBAF, and (c) npBAF. The halo colours indicate the
overlaps in SDE between experiments, as per the legend, molecules without halos
were not SDE.
The GO terms CC SWI/SNF complex , npBAF complex , and nBAF are significantly
enriched in down-regulated proteins of the SILAC NS
NES
experiment, with p-values of 0.00088,
0.0006, and 0.00025, respectively (Figure 12.2). npBAF and nBAF share the same enriched
SDE proteins, besides DPF3 , which was not present in nBAF (Figure 12.7). As described
below, these proteins also form part of the embryonic stem cell BAF (esBAF), for which there
is currently no GO annotation. The proteins enriched in the npBAF complex are involved
in the BPs of chromatin-mediated maintenance of transcription , nucleosome dis-
assembly , and neural retinal development . They have MFs related to transcription
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co-activation .
The SWI/SNF complex consists of a number of switching/sucrose non-fermenting sub-
class of TrxG proteins (SWI/SNF) proteins, also called BRG/BRM-associated factors (BAF)
proteins that form a diverse array of complexes. They are ATPase chromatin-remodelling com-
plexes that increase nucleosome mobility by altering DNA-nucleosome contacts via adenosine
triphosphate (ATP) hydrolysis, thereby changing the accessibility of DNA to transcription fac-
tors. The composition of the complexes specifies the effects on chromatin remodelling. BAF
complexes bind close to the transcription start sites (TSSs) of most highly expressed genes.98
In yeast, the effect is gene activation, but in vertebrates BAF can also repress genes. In higher
mammals, BAF has become specialised to control the chromatin state during neurogenesis. In
vivo, there is a transition from esBAF to neural progenitor BAF (npBAF) and finally neuron
BAF (nBAF) during neuronal development.97 Some of the critical subunits play non-redundant
and dosage-sensitive roles in each of these complexes.120
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(a)
proteins: 16
interactions: 93
expected interactions: 3 (p−value: 0)
GE down & SILAC down
GE up
LFQ_NES up
SILAC down
(b)
proteins: 6
interactions: 14
expected interactions: 0 (p−value: 1.04360964314765e−13)
(c)
proteins: 5
interactions: 10
exp cted interactions: 0 (p−value: 1.52100554373647e−14)
(d)
proteins: 4
interactions: 3
exp cted interactions: 0 (p−value: 3.90673731621993e−05)
Figure 12.8: STRINGdb network of BAF genes and proteins characterising spe-
cific BAF complexes. (a) All BAF complex molecules, molecules characterising (b)
esBAF molecules, (c) nBAF, and (d) npBAF. The halo colours indicate the over-
laps in SDE between experiments, as per the legend, molecules without halos were
not SDE.
SMARCA4 and SMARCA2 are used interchangeably with ten other subunits that usually
make up a BAF complex. BAF subunits are tightly associated and are not displaced in vitro.120
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Figure 12.9: Boxplots comparing the log2 ratios for SMARCA2 and SMARCA4.
Each experiment has its own scale and the horizontal blue lines indicate the 2 stan-
dard deviation (σ) thresholds for the respective experiment. Red and green filled
boxplots indicate significant up- or down-regulation respectively. The p-values are
included on the bottom of the plots.
The specific set of subunits SMARCA4 , ARID1A, SMARCC1 , and SMARCD2 were pre-
viously shown to be expressed in pluripotent cells as part of the esBAF. They are vital to
maintaining pluripotency,97 and showed little difference during differentiation from ESC to
dNES cells in the Huang dNES
hESC
experiment. They were however down-regulated in the GE NS
NES
and SILAC NS
NES
experiments (Figure 12.9 and 12.10).
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Figure 12.10: Boxplots comparing the log2 ratios for ARID1A, SMARCC1 and
SMARCD2. Each experiment has its own scale and the horizontal blue lines indicate
the 2 standard deviation (σ) thresholds for the respective experiment. Red and green
filled boxplots indicate significant up- or down-regulation respectively. The p-values
are included on the bottom of the plots.
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esBAF is also characterised by the absence of SMARCA2 , ARID1B , SMARCC2 , and
SMARCD3 .97 Of the proteins absent in esBAF, SMARCA2 was the only one showing up-
regulation in the GE NS
NES
and SILAC NS
NES
experiments, although this was not statistically
significant (Figure 12.9). The SILAC NS
NES
experiment corroborates the GE NS
NES
experiment
trend .
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Figure 12.11: Boxplots comparing the log2 ratios for ARID1B, SMARCC2 and
SMARCD3. Each experiment has its own scale and the horizontal blue lines indicate
the 2 standard deviation (σ) thresholds for the respective experiment. Red and green
filled boxplots indicate significant up- or down-regulation respectively. The p-values
are included on the bottom of the plots.
As pluripotent cells differentiate into neural stem cells in vitro, SMARCA2 , ARID1B ,
SMARCD3 , and DPF3 first appear as npBAF subunits. Here, DPF3 was significantly up-
regulated in the GE NS
NES
experiment (Figure 12.12), while SMARCA2 showed a non-significant
upwards trend (Figure 12.9).
In vivo, SMARCC1 in esBAF is replaced by SMARCC2 in npBAF.199 There were no
significant changes in any of the proliferating datasets for SMARCC2 , even in the Huang dNES
hESC
experiment where SMARCC2 should be virtually absent.97 SMARCC1 was down-regulated
in the GE NS
NES
and SILAC NS
NES
experiments (Figure 12.10). This decrease in SMARCC1 could
result in more npBAF relative to esBAF in hfNS cells. npBAF also contains DPF1 and DPF2 ,
neither of which were SDE in this work.97 In addition, SMARCD1 , which is present in esBAF
but absent in npBAF, is down-regulated in the SILAC NS
NES
experiment (Figure 12.12).
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Figure 12.12: Boxplots comparing the log2 ratios for DPF3 and SMARCD1. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
In vivo, there is a rapid and specific switch from npBAF to nBAF during the neural
progenitor’s last mitotic cycle. This occurs through a sudden reduction in ACTL6A, PHF10 ,
and SS18 , and production of ACTL6B , DPF1 , DPF3 , and SS18L1 .120,193,198,199 The npBAF
proteins are switched off and the neuronal daughter cells express the nBAF proteins. Here,
ACTL6A and PHF10 which are both known to be part of esBAF and npBAF showed no
significant downwards trends in the GE NS
NES
and SILAC NS
NES
experiments, but were either not
detected or unchanged during differentiation (Figure 12.13). DPF3 which is known to first
appear in npBAF was up-regulated in the GE NS
NES
experiment (Figure 12.12).
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Figure 12.13: Boxplots comparing the log2 ratios for ACTL6A, ACTL6B and
PHF10. Each experiment has its own scale and the horizontal blue lines indicate
the 2 standard deviation (σ) thresholds for the respective experiment. Red and
green filled boxplots indicate significant up- or down-regulation respectively. The
p-values are included on the bottom of the plots.
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Figure 12.14: Boxplots comparing the log2 ratios for SS18, SS18L1 and SS18L2.
Each experiment has its own scale and the horizontal blue lines indicate the 2 stan-
dard deviation (σ) thresholds for the respective experiment. Red and green filled
boxplots indicate significant up- or down-regulation respectively. The p-values are
included on the bottom of the plots.
The reduction of esBAF proteins signifies a transition from esBAF to npBAF in hfNS
cells. esBAF appears to persists in hfNES cells and there is a transition towards npBAF as
they transform into hfNS cells. Removal of esBAF from hESC has been shown to reduce
their proliferation and pluripotency, thereby restricting their self renewal and forcing them to
differentiate.97 The effect on the core pluripotent markers is delayed by many cell divisions,
and there is an initial upregulation of pluripotent markers as esBAF has a repressive effect
on them. As these genes are being actively induced, their expression is merely modulated by
esBAF.97 esBAF also represses genes involved in differentiation, maintaining ESC pluripotency
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and perhaps that of hfNES cells. Some of the proteins found to be interacting with esBAF
were also upregulated in hfNES cells, namely SOX2 , SALL4 , RIF1 , DNMT3B , HELLS , and
JARID2 (Figure 12.15).
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Figure 12.15: SDE genes and proteins known to interact with esBAF
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12.1.2 Cellular components enriched in hfNS cells
perinuclear region of cytoplasm
actin cytoskeleton
hemidesmosome
actin filament
MHC class I protein complex
lumenal side of membrane
integral component of lumenal side of en...
caveola
pseudopodium
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costamere
basolateral plasma membrane
lysosomal membrane
Arp2/3 protein complex
plasma membrane
lysosomal lumen
phagocytic vesicle membrane
extracellular exosome
extracellular membrane−bounded organelle
focal adhesion
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log10(p value)
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LFQ_NES
LFQ_NS
Figure 12.16: Top twenty most highly enriched CC terms in the upregulated genes
or proteins from all the experiments. ESC dNES (red) refers to the Huang dNES
hESC
experiment, GE (orange) refers to the GE NS
NES
experiment, SILAC (yellow) refers
to the SILAC NS
NES
experiment, LFQ NES (green) refers to the hfNES cell differen-
tiation experiment, and LFQ NS (blue) refers to the hfNS cell differentiation ex-
periment. Enrichment p-values were log10 transformed. Down-regulated genes and
proteins have negative log10(p-values) while up-regulated genes and proteins have
positive log10(p-values), so that they can be plotted together to illustrate the differ-
ences in enrichment. Vertical blue lines represent the p-value cutoff of log10(0.01),
positive and negative.
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The down-regulated proteins of the GE NS
NES
and SILAC NS
NES
experiments representing those
most highly expressed in hfNES cells and were enriched for CCs of the nucleus responsible for
maintaining cell proliferation. The up-regulated proteins represent those most highly expressed
in hfNS cells. These proteins were enriched for CC terms from membranes and extracellular
regions of the cell, namely the plasma membrane , extracellular exosome , lysosome ,
endosome , and the actin filament (Figure 12.16). Enrichment of these terms indicates the
cells have moved from intrinsic to extrinsic control mechanisms. Instead of being primarily
focused on proliferation, they are now establishing their position within the neural tissue. The
neural tissue at this point in becoming more complex, and cells need to adhere to the control
mechanisms established in the layering during brain development.
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Figure 12.17: Venn diagram comparing the overlap of genes and proteins SDE in
the GE NS
NES
and SILAC NS
NES
experiments for the CC terms plasma membrane,
lysosome, endosome, and extracellular exosome
Most of these terms contain too many genes and proteins to illustrate their interaction
networks or to discuss their components meaningfully. Venn diagrams illustrating the overlap
of genes and proteins between terms, and provide insight into the level of uniqueness of the
enrichment. The uniqueness of many plasma membrane proteins from those within the vesi-
cles being produced is shown in Figure 12.17. Enrichment of the plasma membrane indicates
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changes to the cell surface and the relationship to its environment. Enrichment the lyso-
some , endosome , and extracellular exosome , may be in preparation for the astrocyte
degradation of extracellular compounds accumulating in the brain. Extracellular exosome
was down-regulated in hfNES cell differentiation experiment, perhaps because they are not re-
quired by neurons. Exosomes are also used in intracellular communication,6 further supporting
the notion that as the hfNS cells develop they are becoming more responsive and reactive to
their environment. Focal adhesion was already discussed in section 11.2.2, and was enriched
in hfNS cells both in KEGG and CC. As discussed, Focal adhesion interacts with the actin
cytoskeleton. Actin filaments were enriched in the up-regulated proteins in the SILAC NS
NES
experiment hfNS cells.
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Figure 12.18: Heatmap of the genes and proteins from CC actin filament SDE
across all experiments. Red and green indicates up- and down-regulation respec-
tively.
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proteins: 9
interactions: 7
expected interactions: 0 (p−value: 4.29162098192215e−07)
Figure 12.19: STRINGdb network for Genes SDE in the Huang dNES
hESC
experiment
from CC extracellular matrix. Red and green halos indicate up- and down-
regulation respectively.
Interestingly, the CC term extracellular matrix was upregulated in the Huang dNES
hESC
experiment. This up-regulation of ECM components as hESC develop into dNES cells may be
a means of producing the correct extracellular substrate for neuroepithelial cells in vivo and
later for the neural stem cells to develop within (Figure 12.19).
12.2 Molecular Function
The MF terms enriched in down-regulated genes and proteins from the GE NS
NES
experiment
and the SILAC correlate well with the enriched CC. The MFs relate to the cell cycle and
cell proliferation, namely DNA binding , chromatin binding , damage DNA binding
and helicase activity . Interestingly two signalling pathways, Wnt-protein bindins and
platelet-derived growth factor binding are enriched in the up-regulated genes in the
Huang dNES
hESC
experiment. The up-regulated genes in the Huang dNES
hESC
experiment represent
proteins being expressed as the hESC differentiate into dNES cell. These same pathways
are enriched in down-regulated genes in the GE NS
NES
experiment. This would mean that the
members of this pathways are more highly enriched in the hfNES cells vs the hfNS cells.
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Figure 12.20: MF Top 20 enriched terms across all experiments. ESC dNES (red)
refers to the Huang dNES
hESC
experiment, GE (orange) refers to the GE NS
NES
experiment,
SILAC (yellow) refers to the SILAC NS
NES
experiment, LFQ NES (green) refers to
the hfNES cell differentiation experiment, and LFQ NS (blue) refers to the hfNS
cell differentiation experiment.
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Part V
Discussion and Conclusion
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Chapter 13
Developmental epigenetics
13.1 Introduction
Figure 13.1: The Waddington landscape of cell fate trajectories (Takahashi and
Yamanaka 2015).
Differentiation according to the Waddington Landscape (Figure 13.1)213 is described as a cell
rolling down a landscape. ESCs would be at the top of a three-faced mountain, with each
face representing, one of the three layers formed during gastrulation. Each face consists of
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gullies, down which cells are sorted, that empty into valleys. Progenitors cells are formed in
the highest valleys, and as these valleys fill up the cells spill over running further down the
face until they reach the lowest valley, a stable state and become terminally differentiated.
During gastrulation, the epiblast separates into three layers, the endoderm, mesoderm and
ectoderm. BMP produced by the mesoderm, induces the ectoderm to become epithelia, but the
notocord or organiser produces BMP inhibitors, CHRD , FST NOG and CER1 , thereby en-
abling the neural plate to spontaneously form in the absence of BMP or any other stimulation.
In vitro, if ESCs are plated sparsely and in the absence of growth factors, they differentiate
into neurons. This may be due to dilution of the BMPs produced by the ESCs. Neuroepithe-
lial like cells can be derived from ESC65 or iPSC114 cells in vitro, using BMP inhibitors. This
indicates that the default differentiation trajectory is towards neurons, known as the default
model.158, 201
Neuroepithelial cells and hfNES cells would therefore represent cells present early in the
development trajectory of the embryo and are therefore possibly closely related to ESCs,
as they have been sheltered from the patterning stimulation that the rest of the embryo is
subjected to. When comparing the Huang dNES
hESC
experiment to the GE NS
NES
experiments, it is
evident that there are considerably more differences between the hfNES cells and hfNS cells
than between the hESC and the dNES cells.
In this study, we have used two different cell lines derived at different timepoints from the
human foetal hind-brain. The hfNES cells were derived at five weeks, while the hfNS cells were
derived at nine weeks. The cells were derived and cultured in identical conditions. The extrin-
sic environment of the cells was therefore identical. The cells, however, had vastly different
morphologies under proliferative conditions and different fates upon differentiation.206,211 The
differences in these cells are therefore likely to be intrinsic.60 The hfNS cells, however, may
be altering their environment though secretion of ECM components and through increased
cell-cell interactions.
Here, we show that these hfNES cells still maintain much of the pluripotent characteristics,
and they are mainly controlled by intrinsic factors. Only once they develop into hfNS cells do
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they become more receptive to their environment.
13.2 Epigenetics
During replication, DNA in chromosomes is tightly packed, but during interphase, it loosens
up to form heterogeneous chromatin. Euchromatic areas are open areas of chromatin, within
which most transcribed genes are found. Heterochromatin is more densely packed and can
be divided into two classes; facultatively and constitutive. Constitutive heterochromatin is
condensed in every cell type and usually does not contain genes. Facultative chromatin differs
according to cell type and these areas are condensed upon developmental cues. The density
of the chromatin affects transcription factor binding and thereby gene expression. Facultative
chromating can be further divided into two compartments: A and B.90 Compartment A con-
sists of accessible DNA that may be transcribed, while compartment B consists of condensed
chromatin. As cells differentiate, topological associated domains (TADs) move from one com-
partment to another. With this rearrangement, there are subtle changes in gene expression.
It was previously believed that these changes were irreversible and that once a cell had begun
its journey its course could not be altered. Recently with the advent of induced pluripotency
and direct programming, this belief has been overturned. Through induced pluripotency, cells
are pushed back up to the top of the pyramid and are allowed to start a journey of any trajec-
tory. Using direct reprogramming, pioneer factors enable sufficient plasticity to allow terminal
differentiation factors to push cells towards a new valley.
The state of a cell, is a reflection of the genes that are being transcribed, the journey
they go on to become mature proteins, and where these proteins find themselves within the
cell. Proteins, the building blocks of the cell, are transcribed in the nucleus, assembled by the
ribosome, then self-assemble into complexes to perform cellular functions or form the structural
components of cells. Each of these building blocks is part of a fractal, finding its perfect place
within the whole. If one changes the composition of the parts the nature of the whole is
transformed.
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The fate determination of a cell is defined by its intrinsic state, the genes that are currently
being transcribed, and those that are poised to be transcribed. ESCs have open chromatin,
and their transcription is mainly controlled by pluripotent factors that induce proliferation and
inhibit differentiation, thereby promoting rapid cell proliferation.62,82,224 Besides the strong
induction of pluripotent factors, transcription is not tightly regulated, and many genes are
expressed at low levels but have minimal effect on the cells, due to the dominant effect of
pluripotent factors.61 Upon differentiation, induction of the pluripotent factors is reduced and
the effect of differentiation factors can begin to take hold. This effect is usually mediated
by extrinsic factors, activating signalling pathways and inducing specific genes that guide
the direction of differentiation. Differentiation genes are often controlled by bivalent marks
on their chromatin.30 The genes have both repressive and activation marks but are usually
silenced. During differentiation one of these marks is removed, resulting in the genes being
either permanently activated or repressed.180
The intrinsic regulation of cells is based on their epigenetic and genetic differences, allowing
cells to maintain different states in homogenous environments.60 Epigenetic changes occur
as changes in DNA methylation, histone modification, and non-coding RNA. Differences in
transcription factor expression and the availability of signalling response elements can also be
viewed as intrinsic factors. This internal environment is the state of the cell. Its response
to the environment is therefore defined by this state. Changes in the environment need to
transverse the internal environment of the cell, to effect changes to the transcription factor
expression. Prolonged exposure to a new environment creates a new intrinsic state within the
cell, thus changing its nature and how it may respond to the environment in the future.
13.2.1 DNA methylation
DNA is methylated on cytosine mainly in CpG-rich areas except CpG islands. If these areas
occur in gene regulatory regions, the result is usually gene silencing.208 Active genes increase
methylation in gene bodies208 and this is thought to reduce spurious transcription from pseudo
TSSs. DNA methylation may have been introduced early in evolution as a means to control
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the activation of exogenous DNA inserted into the host genome. It is a effective means of
controlling transposable elements. DNA methylation is thought to repress transcription by
preventing transcription factors binding to DNA or by recruiting transcription depressors.
DNA methylation is erased during formation of the gametes and again after fertilisation.156
The genome is then globally methylated, although not all promoters of genes are rich in CpG,
and are therefore precluded from silencing. Genes required for housekeeping and possibly
those required for pluripotency are therefore able to be expressed ubiquitously. Methylation
patterns during development are stage- and tissue-specific, and changes define different cell
types. There are highly significant changes in DNA methylation patterns during foetal brain
development,197 particularly site-specific methylation patterns between neurons and glia.125
DNMT1 maintains methylation by methylating the newly synthesised DNA strand that
is not initially methylated during cell proliferation. De novo DNA methylases DNMT3A and
DNMT3B increase methylation as they are active in new areas previously not methylated.
DNMT1 can also function as a de novo methyltransferase.34
(a)
Process
−2 −1 0 1 2
maintenance of DNA methylation
log10(p value)
SILAC
(b)
proteins: 5
interactions: 5
expected interactions: 0 (p−value: 6.71281877406841e−06)
GE down & LFQ_NES down & SILAC down
SILAC down
Figure 13.2: BP Maintenance of DNA methylation, (a) Log10 enrichment
score and (b) STRINGdb network. The halo colours indicate the overlaps in SDE
between experiments, as per the legend, molecules without halos were not SDE.
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Figure 13.3: Boxplots comparing the log2 ratios for DNMT1. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
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llllllll
llllllll
llll
llllllllllllllll
llllllllllll
llllllll
llllllllllll
llllllllllllllllllllllllllllllll
llllllllllllllll
llllllllllllllllllll
llllllll
llllllllllll
llllllll
llllllllllll
llll
1
ll
lllll
lllll
llllllll
llllllllllll
lllll
llllllll
l
ll
5.44e−05
l
lll
ll
l
l
l
0.0164
ESC_dNES GE SILAC
−4
−2
0
2
4
−0.2
−0.1
0.0
0.1
0.2
−0.4
−0.2
0.0
0.2
0.4
lo
g2
(ra
tio
)
Significantly
up−regulated
down−regulated
HELLS
l
l
l
l
l
l
l
l
l
ll
l
l
l
ll
l
l
l
0.0128 0.363
−4
−3
−2
−1
0
0 1 2 4 8 12
Day
lo
g2
(ra
tio
 v
s 
D
ay
 0
) Significantly
up−regulated
down−regulated
experiment
LFQ_NES
LFQ_NS
HELLS
Figure 13.4: Boxplots comparing the log2 ratios for HELLS. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
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Figure 13.5: Boxplots comparing the log2 ratios for CTCF, UHRF2 and USP7.
Each experiment has its own scale and the horizontal blue lines indicate the 2 stan-
dard deviation (σ) thresholds for the respective experiment. Red and green filled
boxplots indicate significant up- or down-regulation respectively. The p-values are
included on the bottom of the plots.
The BP term maintenance of DNA methylation was significantly enriched in the
down-regulated proteins from the SILAC NS
NES
experiment (Figure 13.2). Within this term
DNMT1 and HELLS were SDE. DNMT1 was more highly expressed in hfNES cells than in hfNS
cells in the SILAC NS
NES
experiment and then decreased during differentiation of both cell types
(Figure 13.3). Knockout of DNMT1 in the cortex was shown to decrease the number of neurons
and induce precocious gliogenesis.141 HELLS was down-regulated in the GE NS
NES
and SILAC
NS
NES
experiments and the hfNES cell differentiation experiment (Figure 13.4). It is essential in
normal development and required for maintenance and de novo DNA methylation. All other
members of this term showed decreased trends in the GE NS
NES
and SILAC NS
NES
experiments,
although none were statistically significant (Figure 13.5).
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Figure 13.6: Boxplots comparing the log2 ratios for DNMT3A and DNMT3B.
Each experiment has its own scale and the horizontal blue lines indicate the 2
standard deviation (σ) thresholds for the respective experiment. Red and green
filled boxplots indicate significant up- or down-regulation respectively. The p-values
are included on the bottom of the plots.
In previous studies there was a difference in the time of expression between DNMT3A and
DNMT3B in the developing brain.197 DNMT3B was observed to be expressed during early
neurogenesis, while DNMT3A is observed in embryonic and postnatal CNS.69 DNMT3A and
DNMT3B appeared to be more highly expressed in hfNES cells, than in hfNS cells, but only
DNMT3B was SDE in the GE NS
NES
experiment. These de novo DNA methyltransferases may
promote DNA methylation in the hfNES cells, cementing their cellular fates.
There is a correlation between the binding of methylated DNA binding domain (MBD)
proteins and the density of DNA methylation.25 MBD proteins have been found in association
with chromatin remodelling complexes and may play roles in alternative splicing and in some
cases gene activation.25, 57
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Figure 13.7: Boxplots comparing the log2 ratios for MBD2. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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Figure 13.8: Boxplots comparing the log2 ratios for MECP2. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
Two MBD proteins MBD2 and MECP2 were SDE in this study. MBD2 was up-regulated
in the hfNES cells vs hfNS cells in the GE
NS
NES
experiment. It appears as two transcripts,
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NM 003927.3 and NM 014832.3, although only NM 015832.3 was SDE. MBD2 has previously
been associated with tissue-specific methylated gene repression during differentiation. MECP2
becomes up-regulated during hfNES cell and hfNS cell differentiation, and it may play important
roles here in the terminal differentiation of neural stem cells.
DNA demethylation may occur in a passive manner during the synthesis of new DNA
and through active removal of methylation. The mechanisms of demethylation are as of yet
unclear.113 It is believed that through oxidation, 5-methylcytosine (5mC) is converted to 5-
hydroxomethylcytosine (5hmC),79 5-formylcytosine (5fC), and 5caCl5-carboxylcytosine (5caC)
and then through deamination the oxidised base is converted to thymine or uracil, recognised
as an incorrect base-pair or mismatch and then replaced. 5hmC is abundant in ESCs113 and
its levels are critical to neuronal development.113
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Figure 13.9: Boxplots comparing the log2 ratios for TET1. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
Active DNA demethylation occurs through a series of oxidations of 5mC to 5hmC, 5fC,
and 5caC by the ten-eleven translocation (TET) proteins. In the GE NS
NES
experiment, TET1
was down-regulated while the others showed no significant changes.
There are a number of key genes and proteins involved in DNA methylation that were
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SDE in this study. This indicates that DNA methylation changes may be at play here to
direct the identity and fate specification of these cells. No direct DNA methylation data were
collected in this study, but future whole-genome DNA methylation analysis of this cell model
may provide valuable insights into the changes in DNA methylation and their effects on foetal
brain development.
13.2.2 Chromatin
Nucleosomes
A nucleosome consists of four dimers of four core histones, H2A, H2B, H3, and H4. A section
of 147bp of DNA is wound tightly around each nucleosome. Higher order structures are formed
through linking nucleosomes via linker H1 histones and varying lengths of linker DNA. This
enables the almost 2 m of DNA to be condensed enough to fit inside a 6µm nucleus.
Pluripotent cells usually contain more euchromatin. The chromatin becomes progressively
replaced by heterochromatin as development progresses. The change is usually permanent and
is visible via electron microscopy.
The density of the chromatin is affected by the composition of histones. Histone com-
position can be changed by exchanging histone variants or covalently modifying the existing
histones. There are multiple isoforms of each histones, most notably replication-dependent
and -independent isoforms. In yeast, these are synchronised with the cell cycle.20 In the mouse
eye, replication-dependent histones were recently detected in neurons, indicating more complex
control in mammals and perhaps the necessity for a more detailed re-classification.20 Many of
the histone isoforms appear to have redundant functionality, but some play distinct roles in
proliferation and gene expression. Different expression levels of these isoforms may affect the
nature and density of the chromatin.23
221
proteins: 13
interactions: 44
expected interactions: 2 (p−value: 0)
GE down
GE down & LFQ_NES up & SILAC down
LFQ_NES up
SILAC down
Figure 13.10: CC nucleosome. STRINGdb network for the SDE genes and pro-
teins. There are too many members of the nucleosome to illustrate all meaningfully.
The colour of the Halo’s indicate the SDE in the different experiments.
The CC term nucleosome was not enriched in this study, despite many of its components
being SDE (Figure 13.10). There are however, BPs related to the nucleosome significantly en-
riched in the SILAC NS
NES
experiment, namely nucleosome disassembly , DNA replication-
dependent nucleosome assembly , and CENP-A containing nucleosome assembly
(Figure 13.11).
Process
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nucleosome disassembly
log10(p value)
ESC_dNES
GE
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LFQ_NES
LFQ_NS
Figure 13.11: BP nucleosome-related terms, enriched in the SILAC NS
NES
experi-
ment. ESC dNES (red) refers to the Huang dNES
hESC
experiment, GE (orange) refers
to the GE NS
NES
experiment, SILAC (yellow) refers to the SILAC NS
NES
experiment,
LFQ NES (green) refers to the hfNES cell differentiation experiment, and LFQ NS
(blue) refers to the hfNS cell differentiation experiment.
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Figure 13.12: Heatmap of histones SDE across all experiments. Red and green
indicates up- and down-regulation respectively.
The following histones from each core histone class were down-regulated in the GE NS
NES
experiment.
H2A : H2AFX ,H2AFY2 , HIST1H2BH
H2B : HIST2H2AC
H3 : HIST1H3C , HIST1H3J
H4 : HIST1H4J , HIST1H4K
Interestingly only HIST2H2BE was up-regulated in the GE NS
NES
experiment (Figure 13.12).
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Figure 13.13: Boxplots comparing the log2 ratios for H2AFY. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
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Figure 13.14: Boxplots comparing the log2 ratios for H2AFY2. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
Most notably, H2AFY and H2AFY2 , which are more commonly known as macroH2As
were SDE. H2AFY showed little difference between hfNES cells and hfNS cells in the SILAC
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NS
NES
experiment and was then up-regulated during differentiation of both cell lines (Figure
13.13). H2AFY2 was up-regulated, although not statistically significantly, in the Huang dNES
hESC
experiment, and was then down-regulated in the GE NS
NES
and SILAC NS
NES
experiments and
up-regulated during differentiation (Figure 13.14). The macroH2A histone variants differ from
their canonical H2A counterparts. They are known to be epigenetic regulators of cell fate deci-
sions during development,38 and regulate dynamic chromatin formation possibly in conjunction
with the SWI/SNF complex.38 They are the histones known to be most up-regulated during
hESC differentiation, and have been shown to be upregulated in neural precursors which are
SOX9 -positive.23 SOX9 was up-regulated in the Huang dNES
hESC
and GE NS
NES
experiments (Figure
13.15).
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Figure 13.15: Boxplots comparing the log2 ratios for EZH2 and SOX9. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
MacroH2As have been linked to both passive and active transcription repression, and are
found at most transcriptionally inactive genes, most notably those containing the repressive
mark H2K27me3. Transcription is passively repressed by macroH2As, by impeding access of
transcription factors,23 SWI/SNF-induced nucleosome sliding, and repressing the initiation
of polymerase II transcription.38 Transcription is actively repressed through interaction of
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the macro domain with histone deacetylases,23 and the polycomb group (PcG).23 There is
a known overlap between EZH2 , a member of the PcG, and H2AFY2 localisation.23 EZH2
was down-regulated in the SILAC NS
NES
experiment (Figure 13.15), and thus co-expressed with
H2AFY2 .
MacroH2A’s are found to occupy regulatory regions in genes of transcription factors, partic-
ularly those of the pluripotent network and the epigenetic regulators, many of which were down-
regulated in the GE NS
NES
experiment, (CBX2 , DNMT3A, LIN28A, and RCOR2 ).23 MacroH2As
are usually linked to differentiation, being expressed at low levels in ESCs and neural stem
cells, and then being induced during differentiation, they are most often expressed at higher
level in somatic cells.23 Here, paradoxically, we observed a higher expression in hfNES cells
than hfNS cells, followed by an up-regulation during differentiation.
When macroH2As were knocked out in zebrafish, brain malformations were observed, par-
ticularly a reduction in the size of the hind-brain.38 Knock-down in ESC impaired differentia-
tion by delaying the silencing of SOX2 . Interestingly, the differentiation from ESCs to hfNES
cells requires delayed silencing of SOX2 . MacroH2As may be fundamental in inducing differ-
entiation towards hfNES cells, and then decrease in hfNS cells and are again up-regulated to
complete terminal differentiation.
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Figure 13.16: Boxplots comparing the log2 ratios for H1F0. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
None of the replication-dependent H1 histones were SDE in this study, but some of
the replication-independent H1 histones were, namely H1F0 and H1FX . The replication-
independent H1 histone H1F0 , known to accumulate in terminally differentiated cells, was
up-regulated during differentiation of both hfNES cells and hfNS cells, although not statisti-
cally significantly in the hfNS cells (Figure 13.16). H1FX was up-regulated in the SILAC
NS
NES
experiment (Figure 13.12)
In a recent study, Zhang et al. 2016 used proteomics to determine the distinct interaction
partners of two replication-dependent H1 linker histones (HIST1H1A and HIST1H1C ) and one
replication-independent histone H1FX . Interestingly many of the proteins interacting with only
the replication-dependent histones, were up-regulated in hfNES cells, namely CDC73 , CHD7 ,
CTR9 , DDX21 , EBNA1BP2 , SUPT16H , and TAF5 (Figure 13.17).
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Figure 13.17: Protein shown to interact with replication-dependent histones in
Zhang et al. 2016
Chromatin-remodelling
In addition to differences in histone composition affecting chromatin structure, changes in
histone modification can affect both chromatin structure and gene expression. Histones are
subject to a range of modifications, some serve as a means to facilitate chromatin compaction,
while others serve as binding sites for proteins, that then affect gene expression. The major
histone modifications are acetylation and methylation.
The animal transcription factor database (AnimalTFDB)242 provides a list of chromatin-
remodelling factors. Using the Fisher exact test the SDE genes or proteins from each ex-
periment were analysed against all genes or proteins detected in the same experiment. The
list of chromatin remodelling proteins were significantly enriched in the down-regulated pro-
teins from the SILAC NS
NES
experiment (p=0.00015). Using these, a STRINGdb network of
chromatin-remodelling factors SDE in the GE NS
NES
and SILAC NS
NES
experiments was generated
(Figure 13.18).
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proteins: 23
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GE down
GE down & SILAC down
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Figure 13.18: STRINGdb network of chromatin-remodelling genes and proteins
from the AnimalTFDB that were or SDE in the GE NS
NES
and SILAC NS
NES
experi-
ments. The halo colours indicate the overlaps in SDE between experiments, as per
the legend
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Figure 13.19: Boxplots comparing the log2 ratios for KDM3B and KDM4D. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
Two lysine demethylases, KDM3B and KDM4D , were down-regulated in the SILAC NS
NES
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experiment and the GE NS
NES
experiment respectively (Figure 13.19). Methylation of histones
is particularly important during differentiation. Many promoters of differentiation genes are
bivalently marked, with activation (H3K4me3) and repressive (H3K27me3) marks. This poises
them for transcription, but prevents their transcription in pluripotent cells. As the cells dif-
ferentiate, one of the marks is removed, thus establishing the genes expression pattern, and
thereby the fate of the cell. These demethylases may thus be playing an important role in
neural stem cell fate specification
Two major complexes control the regulation of bivalent chromatin marks: the polycomb
group PcG and the trithorax group (TrxG). The PcG was not enriched in the GO analysis
in this study, as too few of its members were SDE. The majority that were SDE were down-
regulated in the GE NS
NES
and SILAC NS
NES
experiments (Figure 13.20).
proteins: 6
interactions: 15
expected interactions: 1 (p−value: 1.97319938166659e−12)
GE down
GE up
SILAC down
Figure 13.20: STRINGdb network CC PcG protein complex. the halo colours
indicate the overlaps in SDE between experiments, as per the legend
The PcG and TrxG antagonise each other. The PcG represses transcription while the
TrxG activates transcription. PcG is known to overlap with macroH2A already seen to be
up-regulated in hfNES cells. Within the PcG, the subunits EZH2 , MTF2 , and SCML2 were
down-regulated in the GE NS
NES
experiment, whereas HDAC2 and RBBP4 were down-regulated
in the SILAC NS
NES
experiment, and CBX6 was up-regulated in GE NS
NES
experiment (Figure
13.20).
230
SWI/SNF forms part of the TrxG. Within the SWI/SNF are esBAF and npBAF. A change
from esBAF to npBAF was observed in hfNS cells and discussed in detail in section 12.1.1.
GE down & SILAC down
SILAC down
(a)
proteins: 13
interactions: 64
expected interactions: 6 (p−value: 0)
(b)
proteins: 13
interactions: 78
expected interactions: 1 (p−value: 0)
(c)
proteins: 10
interactions: 36
expected interactions: 1 (p−value: 0)
(d)
proteins: 12
interactions: 66
expected interactions: 4 (p−value: 0)
Figure 13.21: STRINGdb network of the ATP-dependent chromatin remodelling
complexes, (a) CHD-type complex, (b) INO80 complex, (c) ISWI-type com-
plex, and (d) SWI SNF complex. The halo colours indicate the overlaps in SDE
between experiments, as per the legend, molecules without halos were not SDE.
Chromatin structure often requires energy in order to be changed. ATP-dependent
chromating-remodelling complexes, change the chromatin structure by sliding nucleosomes,
dissociating core histone and re-locating entire nucleosomes. There are four families of ATP-
dependent chromatin-remodelling complexes: SWI/SNF, imitation switch (ISWI), chromod-
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omain (CHD), and INO80 complex (INO80). Of these only SWI/SNF was significantly en-
riched according to GO enrichment analysis. However, within some of the others, there were
key genes or proteins down-regulated in the GE NS
NES
and SILAC NS
NES
experiments (Figure 13.21).
13.2.3 Non-coding RNA
Non-coding RNA (ncRNA) refers to RNAs transcribed from DNA that are not translated into
proteins. Recently more and more regulation processes have been discovered for these RNAs.
There are multiple different types of ncRNA. Because ncRNA were not investigated in this
study, we do not have quantitative evidence of their presence or influence, but many proteins
involved in the regulation of ncRNA were however dysregulated here and warrant discussion.
Figure 13.22: Let-7 bio-genesis from Rehfeld et al. 2015.
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LIN28/let-7 Micro RNA (miRNA) are produced in the nucleus as long pri-miRNA’s. They
are processed in the nucleus by DROSHA and DGCR8 to approximately 70 nucleotide hairpin
structures and then exported by XPO5 . In the cytoplasm, DICER1 cleaves them into the
final active 22bp miRNA, after which they are loaded into argonaute (AGO) to induced silenc-
ing. miRNAs inhibit protein expression at the post-transcriptional level. miRNA, binds the
complementary 3’ untranslated region (UTR) regions of mRNA, thereby inhibiting translation
and inducing degradation. Binding is often imperfect, allowing them to regulate many targets.
The miRNA let-7 was one of the first miRNA to be discovered during the study of the
heterochronic pathway that controls developmental timing in Caenorhabditis elegans.179 There
are 12 isoforms of let-7 in vertebrates, and it is the most abundant miRNA in most adult tissues,
including the brain.174 In vertebrates levels of let-7 are low in pluripotent cells and high in
differentiated cells. It antagonises proliferation and supresses the self-renewal capacity of stem
cells.118 Levels of let-7 increase rapidly as neural stem cells differentiated into neurons.173
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Figure 13.23: Heatmap of the known let-7 targets from Rehfeld et al. 2014. Red
and green indicates up- and down-regulation respectively.
Among the known targets of let-7 ,173 (ASCL1 , HMGA2 , HSPD1 , IGF1R, IGF2BP1 ,
LIN28A, LIN28B , TRIM71 , MYC , MYCN , PAX6 , PRTG , SALL4 , and TLX3 ), most were
down-regulated in the GE NS
NES
and SILAC NS
NES
experiments and some were also down-regulated
in the hfNES cell differentiation experiment. Only ASCL1 and IRS2 was up-regulated in the
GE NS
NES
experiment (Figure 13.23).
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Let-7 is regulated by LIN28 and it in-turn represses LIN28 . LIN28 is an RNA-binding pro-
tein with two RNA-binding domains. It is highly expressed in the neural tube and co-localises
with SOX2 expression.238 LIN28 expression is high in ESCs and decreases during development
of the embryo, most significantly in the brain during neurogenesis. In vivo expression levels
in mice start declining at embryonic day 11.5 (Carnegie stage 13), the timepoint at which
the transition to RG begins, and it is virtually absent by embryonic day 14.5 (Carnegie stage
20).47 RG do not express LIN28 and its expression has been shown to regulate neurogenesis
and gliogenesis balance in early neural progenitors in vitro.19 LIN28 has also been shown to be
down-regulated by miR-145 which is upregulated during neuronal differentiation. Suppression
of neuronal differentiation by suppression of miR-145 by anti-miR0145 can also be recov-
ered through silencing of LIN28 , further supporting LIN28 ’s role in suppressing neural stem
cell differentiation.139 When LIN28 was overexpressed in mouse primary embryonic cortex at
Carnegie stage 23 and then harvested, mainly neurons survived and these showed suppressed
neurite outgrowth and increased expression of HMGA2 .31 This indicates that LIN28 impairs
neuronal maturation.
LIN28 binds to pre-let-7, inhibiting maturation of let-7 and maintaining pluripotency of
cells. There is a direct correlation between the reduction of LIN28 expression, an increase
of let-7 , and an increase in neurogenesis. In the SILAC NS
NES
experiment, there was a signifi-
cant reduction in LIN28A during transition from hfNES cells to hfNS cells and a subsequent
reduction during differentiation of hfNES cells. LIN28B showed a similar trend, however it
was not statistically significant, because of high variability and limited detection in the SILAC
NS
NES
experiment. In the GE NS
NES
experiment, both LIN28A and LIN28B were significantly
down-regulated (Figure 9.6 and Figure 9.7).
LIN28 expression is induced by SOX2 , which was down-regulated in the SILAC NS
NES
ex-
periment (Figure 9.4). LIN28 induces expression of MYCN, which was down-regulated in the
GE NS
NES
experiment (Figure 9.9). Proteins associated with LIN28 and those inhibited by let-7
were mostly down-regulated in the GE NS
NES
and SILAC NS
NES
experiments. The most notable
LIN28 -associated proteins that were down-regulated in the GE NS
NES
and SILAC NS
NES
experi-
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ments were CDK1 , HMGA2 , IGF2BP1 , LIN28A, LIN28B , and YAP1 (Figure 13.24). The
co-expression of LIN28 inducers and its effectors strongly support the likelihood that LIN28
is a key player in the differences observed in cellular identity between hfNES cells and hfNS
cells.
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Figure 13.24: Heatmap of LIN28 associated proteins that were SDE across all
experiments. Red and green indicates up- and down-regulation respectively.
YAP1 , the Hippo pathway effector is up-regulated by SOX2 .182 It is responsible for main-
taining organ size, it is highly expressed in neural stem cells, and suppresses differentia-
tion.236,243 Knockdown of YAP1 has been shown to aberrantly increase let-7 .46 Here it was
down-regulated in the SILAC NS
NES
experiment, (Figure 11.35) it may be a significant effector
in maintaining the stemness of hfNES cells, it and its effectors should be explored further. The
Hippo pathway was discussed in section 11.3.1.
13.3 Conclusion
In this study, key components of the three epigenetic mechanisms were shown to be more
highly expressed in hfNES cells. This would suggest that these mechanisms were more active
in hfNES cells. The core pluripotent transcription factors were reduced during transition from
ESC to hfNES cells, except for SOX2 and LIN28 . LIN28 expression maintains inhibition
of let-7 , thereby promoting self-renewal and proliferation of the hfNES cells. The de novo
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DNA methylases were more highly expressed in hfNES cells, suggesting that they are silencing
specific genes that are not longer required. Extensive chromatin remodelling may be occurring
as there were significant changes in histone composition of nucleosomes as well an up-regulation
of chromatin-remodelling complexes.
Inhibition of let-7 may permit the hfNES cells to maintain some of their stemness, while
the DNA and chromatin is being modified. Once LIN28 and SOX2 expression reduces, the
self-renewing factors would be reduced and the full effect of the epigenetic changes would come
into effect, bringing about the transition from hfNES cells to hfNS cells.
The mechanisms for altering epigenetic control are broad sweeping mechanisms. The speci-
ficity of these mechanisms is controlled by transcription factors. The transcription factors
recruit DNA methylation and chromatin-modifying enzymes to specific regions of the genome.
These regions can then be marked with activation or repressive marks. Despite the epigenetic
complexes making the changes it is really the transcription factors that decide the specificity
of where and how these changes, will be implemented. The transcription factors will therefore
be discussed next.
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Chapter 14
Transcription factors
14.1 Pioneer transcription factors
Pioneer factors are transcription factors that are able to bind to unmarked closed chromatin
compacted by H1 linker histones. Closed chromatin is usually inaccessible to transcription
factors. Pioneer factors adopt conformations that allow them to bind to DNA wrapped around
histones through their affinity for histones. Co-factors are then recruited to open the chromatin
and make it accessible for transcription, often through the displacement of H1 linker histones.
Pioneer factors make changes to specific areas of compacted DNA to prepare cells for cell fate
transition. In development, this is as a precursor step for differentiation.
A pioneer factor will facilitate the opening of chromatin and then additional transcription
factors will initiate transcription. These two processes are complimentary. Without the pioneer
factors, the chromatin will remain closed and additional transcription factors will have no effect.
Without the additional transcription factors, pioneer factors themselves are mostly unable to
initiate transcription.104, 140
During cell reprogramming, a cocktail of factors are used to produce iPSCs or convert one
cell type directly to another through direct reprogramming.90 Such reprogramming cocktails
must contain at least one pioneer factor. This pioneer factor gains access to chromatin, which
is otherwise inaccessible to other factors. The other factors then drive cell reprogramming
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in the required direction. To induce pluripotency, the pioneer factors POU5F1 , SOX2 , and
KLF4 are activated, together with MYC .
Morris (2016) proposed that genes are organised in gene regulatory networks. These gene
regulatory networks are activated in a hierarchical manner. ESCs are sparsely specified. During
gastrulation, body plan gene regulatory networks (GRNs) are activated, followed by activation
of the body part, body pattern, cell fate, and finally terminal differentiation GRNs. Pioneer
factors are responsible for the opening, and in some cases condensing, of chromatin during
development. The changes in chromatin can be visually observed as areas of different density
in the nucleus. There is a transition of compartments during differentiation. During mouse
ESC differentiation to neural progenitors, a 36% change in compartments was observed and
this was confirmed in human ESCs.90
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Figure 14.1: Heatmap of SDE pioneer factors from the literature90,103,240
From the thirteen pioneers factors identified in the literature,90,103,240 four were SDE across
the Huang dNES
hESC
, GE NS
NES
, and SILAC NS
NES
experiments (ASCL1 , POU5F1 , SOX2 , and SOX3 )
(Figure 14.1).
ASCL1 is used in direct-reprogramming to produce neurons from somatic cells.140 It was
up-regulated in the GE NS
NES
experiment (Figure 14.1) and may be one of the pivotal driving
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forces in turning hfNES cells into hfNS cells. It has already been discussed in section 9.3.4
14.2 SOX transcription factors
SOX transcription factor’s play critical roles during early development, controlling the forma-
tion of tissues and organs. Because they do not bind DNA with high enough affinity to initiate
transcription, they form dimers with other transcription factors thereby extending their func-
tions.30 SOX transcription factors are therefore able to play multiple roles in different contexts
depending on the expression of their binding partners. Changes in SOX expression have a
significant effect on cellular identity.129
SOX2 binds genes mainly expressed in ESCs. Genes bound by SOX2 and SOX3 are
mainly expressed in neural stem cells. Genes only bound by SOX3 are primarily expressed
in neurons. These genes are then activated by SOX11 binding, which usually displays an
expression pattern inverse to that of SOX3 .30
In this study, we observed a distinct difference in expression of SOX transcription factors
in the GE NS
NES
experiment, but because of the low levels of expression, few SOX proteins were
detected in the proteomic datasets.
SOX2 was down-regulated in the SILAC NS
NES
experiment (Figure 9.4) as it is more highly
expressed in hfNES cells, thereby maintaining their stemness and promoting proliferation.
SOX2 was down-regulated during hfNES cell differentiation, although this was not statistically
significant.
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Figure 14.2: Boxplots comparing the log2 ratios for SOX3. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
SOX3 showed an upward trend in the Huang dNES
hESC
experiment, although this was not
statistically significant, and was then up-regulated in the GE NS
NES
experiment and during hfNES
cell differentiation (Figure 14.2). Its up-regulation would confer neuronal identity upon the
hfNES cells and even more so upon the hfNS cells.
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Figure 14.3: Boxplots comparing the log2 ratios for SOX11. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
SOX11 was up-regulated in the Huang dNES
hESC
experiment and down-regulated in the GE NS
NES
experiment (Figure 14.3). This may mean that it is instrumental in initiating the neuronal
program within hfNES cells, but may not be as necessary in the hfNS cells. However, it was
once again up-regulated in the hfNES cells differentiation experiment, as it may be required to
activate neuronal genes during differentiation.
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Figure 14.4: Heatmap of the expression of all SOX2 genes and proteins across
all experiments. Red and green indicates up- and down-regulation respectively.
SOX9 was up-regulated in the Huang dNES
hESC
and GE NS
NES
experiments, and SOX8 and SOX18
were up-regulated in the GE NS
NES
experiments (Figure 14.4). The involvement of SOX3 , SOX8 ,
SOX9 , and SOX11 in neural stem cell development has previously been reported, but no
connection has been made between SOX18 and neural stem cells as of yet.4
SOX2 regulates LIN28 47 and YAP1 182 both of which show expression patterns that are
correlated with that of SOX2 . SOX2 forms part of three BPs significantly enriched in the
SILAC NS
NES
experiment, namely stem cell development , regulation of neurogenesis ,
and endodermal cell fate commitment (Figure 14.5). It is therefore supported by other
molecules to effect its function in maintaining development of the neuroepithelium.
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Figure 14.5: SOX2 was significantly down-regulated in the SILAC NS
NES
experi-
ment. These BP terms are significantly enriched and concern SOX2.
14.3 POU transcription factor family
SOX2 appears to be the principal driver of pluripotency in hfNES cells, as it is widely ex-
pressed in the neural plate soon after gastrulation, which is the origin of hfNES cells. As
SOX2 itself does not bind DNA strongly enough to effect change, it needs to work in complex
with other transcriptions factors, and its versatility in association with different transcription
factors enables them to perform different roles in different contexts. During nervous system
development, it complexes most favourably with the Pit-Oct-Unc domain transcription factors
(POUs).
In ESCs, SOX2 forms a complex with OCT4/POU5F1 ,129 and in neural progenitors, SOX2
forms a complex with BRN2/POU3F2 .129
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Figure 14.6: A heatmap of POU transcription factors SDE across all experiments.
Red and green indicates up- and down-regulation respectively.
POU5F1 (OCT4), a core pluripotent factor, was up-regulated in the Huang dNES
hESC
experiment
(Figure 9.3). This would account for a reduction in pluripotency as these cells move towards a
more differentiated state. POU2F1 , POU3F1 , POU3F4 , POU4F1 , and POU4F2 were down-
regulated in the GE NS
NES
experiment (Figure 14.6), and may be important in maintaining hfNES
cells.
Despite not being SDE, POU3F2 , showed substantial differential expression (Figure 9.5).
It appeared to be slightly more highly expressed in hfNES cells than in hESC and also slightly
more highly expressed in hfNES cells than in hfNS cells. It was also detected in the differen-
tiation experiments, indicating that it was fairly highly expressed in these cells despite not
showing much actual change. It is a marker of early neural commitment129 and co-operates
with SOX2 to promote a neural fate. When its expression was activated in ESCs using light
pulses it promoted their differentiation into neural tissue.192 POU3F2 also works in conjunc-
tion with ASCL1 and MYT1L to reprogram fibroblasts to a neural fate.213
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14.4 Developmental transcription factor families
14.4.1 Homeobox transcription factor family
ROR receptor transcription factors
C/EBP transcription factors
Runt transcription factors
GCR transcription factors
CTF/NFI transcription factors
POU transcription factors
COUP transcription factors
Homeobox transcription factors
−2 0 2 4 6
log10(p value)
ESC_dNES
GE
Figure 14.7: Transcription factor families from the AnimalTFDB significantly
enriched by Fisher exact test in the Huang dNES
hESC
and GE NS
NES
experiments, with
a p-value less than 0.05. The horizontal blue lines indicate a p-value threshold of
0.01. ESC dNES (red) refers to the Huang dNES
hESC
experiment, GE (orange) refers
to the GE NS
NES
experiment, SILAC (yellow) refers to the SILAC NS
NES
experiment,
LFQ NES (green) refers to the hfNES cell differentiation experiment, and LFQ NS
(blue) refers to the hfNS cell differentiation experiment.
Members of the homeobox transcription factors family are mainly responsible for directing the
development of structures during embryo development. The prefix homeo, originated from
homeosis, as when these genes are mutated, the results is often the replacement of discrete
organs with others. The family is larger than just the commonly known HOX genes that
control segmentation patterning in vertebrates. Enrichment analysis was done by Fisher exact
test against the transcription factors family lists from the AnimalTFDB. The homeobox tran-
scription factor family was the most significantly enriched transcription factor family (Figure
14.7).
ADNP is a homeobox transcription factor that is vital for brain formation157 and is highly
expressed in the embryonic brain during development and later throughout the nervous sys-
tem.134 Deficiency leads to defects in neural tube closures and early embryonic death.134 In
vitro, it has been shown to produce neurite outgrowth, as it protects neurons and is involved
in microtubule re-organisation, through interaction with tubulins.157
245
llll
llllllll
llllllllll
llllllll
llllll
1
llllll
llllllllllllllllllllllll
llllllllllllllll
llllllllllllllllllllllllll
llllllllllllllllll
ll
llll
0.778
l
l
ll
l
ll
l
0.042
ESC_dNES GE SILAC
−1.0
−0.5
0.0
0.5
1.0
−0.2
−0.1
0.0
0.1
0.2
−0.4
0.0
0.4
lo
g2
(ra
tio
)
Significantly
up−regulated
down−regulated
ADNP
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
0.834 0.977
−1
0
0 1 2 4 8 12
Day
lo
g2
(ra
tio
 v
s 
D
ay
 0
) Significantly
up−regulated
down−regulated
experiment
LFQ_NES
LFQ_NS
ADNP
Figure 14.8: Boxplots comparing the log2 ratios for ADNP. Each experiment
has its own scale and the horizontal blue lines indicate the 2 standard deviation
(σ) thresholds for the respective experiment. Red and green filled boxplots indicate
significant up- or down-regulation respectively. The p-values are included on the
bottom of the plots.
ADNP was down-regulated in the SILAC NS
NES
experiment and its expression was consis-
tent in the differentiation experiments (Figure 14.8). It showed little variance in the Huang
dNES
hESC
experiment, and this indicates that it is potentially already expressed in ESCs and may
be one of key molecules instigating the default model of ESC differentiation into a neural
fate. Down-regulation in the SILAC NS
NES
experiment indicates that it may be less necessary
once this trajectory is established. However, expression appeared to be maintained during
differentiation, perhaps with a slight decrease as the hfNES cells mature into neurons (Figure
14.8).
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Figure 14.9: Heatmap of the genes and proteins form AnimalTFDB that were
SDE in the Huang dNES
hESC
, GE NS
NES
, and SILAC NS
NES
experiments. Red and green
indicates up- and down-regulation respectively.
HOX genes are responsible for patterning in the embryo, and are usually expressed in
defined areas along the anterior/posterior axis of the embryo. HOXA2 , HOXA4 , HOXA5 ,
HOXB2 , HOXB3 , and HOXB5 were all up-regulated in the GE NS
NES
experiment (Figure 14.9),
indicating that their effect on embryo patterning is more important in the hfNS cells than the
hfNES cells.
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EN2 and GBX2 are both known to be involved in hind-brain patterning and both were
down-regulated in the GE NS
NES
experiment. GBX2 was also down-regulated in the SILAC NS
NES
experiment. These expression patterns indicate that their roles in neural development may be
more important in hfNES cells than hfNS cells.
TALE transcription factors The three amino acid loop extension (TALE) transcription
factors are important co-factors to the HOX proteins.104 They consist of six transcription
families, of which iroquois (IRX), myeloid ectropic viral integration site (MEIS), pre-B-cell
leukemia homeobox (PBX), and PBX/knotted homeobox (PKNOX) were SDE in the Huang
dNES
hESC
and GE NS
NES
experiments. IRX3 is known to be involved in SHH -mediated neural pattern-
ing. MEIS2 works in conjunction with ASCL1 for direct reprogramming of fibroblasts into
neurons. PBX1 is a potential pioneer factor,33 involved in chromatin remodelling.93 Further
study of the dynamics of the individual genes detected as SDE may provide important insights
into their roles in the fate specification of neural stem cells.
Many of the remaining homeobox transcription factors SDE in this work have previously
been shown to be involved in neurogenesis or astrogliogenesis.222 They have not been discussed
in this study, but further investigation into their effect upon this cell model may provide further
insight into the control mechanisms at play here.
14.4.2 COUP transcription factors
Nuclear receptor subfamily 2 or COUP transcription factors I/II (NR2) are known to regulate
neural stem cell temporal specification. In vivo, expression begins at Carnegie stage 16 and
diminishes with development. When NR2s are knocked down in vitro, the neurogenic potential
of neurospheres, which usually declines with successive passages, is maintained.143
NR2F1 was up-regulated in the Huang dNES
hESC
experiment but down-regulated in the GE
NS
NES
experiment, and this was further verified by one SILAC NS
NES
experiment sample (Figure
9.20). It also showed a strong upwards trend during hfNES cell differentiation. NR2F2 was
up-regulated only in the Huang dNES
hESC
experiment (Figure 9.21).
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There is evidence for their involvement in changes in GFAP promoter methylation from
poised to activated.143 They may in turn affect other gliogenic genes as well. This opens up
expression of these genes to extrinsic stimulation, which may enable gliogenic potential.
14.4.3 CTN/NFI
NFIX
NFIC
NFIB
NFIA
ESC_dNES GE SILAC LFQ_NES LFQ_NS
Experiments
G
en
e 
Sy
m
bo
ls
Significantly
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down−regulated
Figure 14.10: Heatmap of CTN/NFI transcription factor family SDE across all
experiments. Red and green indicates up- and down-regulation respectively.
NFIA and NFIB are induced at the onset of gliogenesis.143 Furthermore Tiwari et al. 2018
showed that NFIA and ATF3 are drivers of astrogliogenesis,222 by effecting changes to chro-
matin remodelling, thereby making poised gliogenic genes active for transcription. RUNX2
was also shown to be involved in the maturation of astrocytes.222
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Figure 14.11: Boxplots comparing the log2 ratios for ATF3 and RUNX2. Each
experiment has its own scale and the horizontal blue lines indicate the 2 standard
deviation (σ) thresholds for the respective experiment. Red and green filled boxplots
indicate significant up- or down-regulation respectively. The p-values are included
on the bottom of the plots.
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Chapter 15
Conclusion and future work
During nervous system development neuroepithelial cells proliferate rapidly to increase the cell
mass required for the nervous system development. These neuroepithelial cells are able to self
renew or differentiate into neurons. As development progresses neuroepithelial cells develop
into RG. RG are able to self-renew and further add to the cell mass required for development of
the nervous system. Unlike the neuroepithelial cells, RG are tri-potent, thereby able to form
neurons, astrocytes and oligodendrocytes. RG also go on to become the adult neural stem
cells responsible for maintaining the population of glial cells in the brain. No new neurons
are formed in most areas of the brain after birth, except in the SVZ and SGZ.80,137,194 These
neurogenic niches create environments which allow the adult neural stem cells to still take on
neuronal fates. The property is not inherent to the cells within these areas, but rather due the
micro environment created within these areas.48,99,106,107,122,123,194 This means that all adult
neural stem cells maintain the ability to differentiate into neurons, but the environment of the
adult brain suppresses this ability.
In this study we had access to human foetal neural stem cells derived from five week old
hindbrain (hfNES cells) and from 9 week old hindbrain (hfNS cells). The earlier timepoint
resembled neuroepithelial cells and differentiated into an almost pure population of neurons,
while the later timepoint resembled RG and differentiated into a mixed population of neurons
and astrocytes.
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A quantitative proteomic study was conducted comparing the relative abundance of pro-
teins being expressed in each of these cell lines while under proliferative conditions. Removal
of growth factor stimulation allowed the cells to spontaneously differentiate. Six timepoints of
early differentiation were isolated and a quantitative proteomics analysis was performed. The
aim of the study was to determine the control mechanisms at play that distinguished hfNES
and hfNS cells, with the hopes of discovering druggable targets, that could be used for brain
regenerative therapies.
Due to the subtle nature of the mechanisms at play here, it became evident that the depth of
coverage of proteomics analysis was not sufficient to deduce the answers required. Fortunately
the Smith lab who had derived the hfNES and hfNS cells had done a transcriptomic analysis
of these cells,211 which they kindly allowed us to use.
The cells from these two studies came from the same source, but had been cultured at
different times and in different labs. Interestingly there was a good overlap between the two
datasets. There were numerous genes and proteins found to be uniquely SDE in each of the
datasets, but there were no contradictions in those that were SDE. Not being SDE versus being
SDE was not seen as a contradiction, because often the trends, despite not being statistically
significant, were also correlated. The increased numbers of genes observed to be SDE in the
transcriptomic analysis resulted in a more detailed GO and KEGG pathway enrichment. This
allowed more detailed conclusions to be derived from the data. The proteomics data was then
used as validation of the transcriptomics data, rather than the basis of the analysis as was
previously intended.
While trying to make sense of the wealth of information gleaned from the datasets, it
also became evident that understanding the differences between hfNES and hfNS cells was
confounded by not knowing anything about the trajectory that the hfNES cells were on prior
to differentiating into hfNS cells. What had essentially been created was a data silo; data
standing independently of an origin. Fortunately dNES cells have previously been derived in
vitro from hESC, a dataset by Huang et al. 2016 contained a transcriptomic analysis of these
cells. This dataset was then added to the analysis as a means to establish a possible trajectory
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of hfNES cell differentiation.
The same statistical evaluation was applied to all three datasets in order to make them
most comparable. The data were analysed using R scripts wrapt in a R Shiny dashboard.
R Shiny produces a browser based interactive interface to R code. The data could then be
navigated graphically without needing to deal with complex code. A link to the Shiny interface
is available at https://www.shaungarnett.co.za/thesis.html.
In addition to the Huang dNES
hESC
, GE NS
NES
, and SILAC NS
NES
experiments, the hfNES and hfNS cell
differentiation experiments were also added to the Shiny interface. Thus far the differentiation
experiment was merely used to substantiate the findings observed in the GE NS
NES
and SILAC NS
NES
experiments. The differentiation dataset warrants it’s own detailed independent assessment,
which will be done in a subsequent publication.
hfNES cells appear to differentiate into an almost pure population of neurons, while hfNS
cells differentiate into a mixed population of neurons and glia. The focus of the study was
to identify molecules that would direct neural stem cells towards a neuronal fate rather than
a glial fate. As a premise to this search, it was assumed that molecules conferring cellular
identity on the hfNES cells, opposed to the hfNS cells, would be good candidates. Therefore,
the main focus of the analysis was to understand what maintained the cellular state of hfNES
cells.
With 1817 SDE genes and 473 SDE proteins, there were too many molecules to try and
deduce meaning through individual investigation. In order to identify important molecules
warranting further study, the lists of SDE genes and proteins were analysed by gene ontology
(GO) and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment. This
produced an overarching characterisation of the cells through, cell, tissue, cellular component
(CC), molecular function (MF), biological process (BP) and KEGG pathway enrichment. Once
major processes were identified, the SDE genes were visualised in STRINGdb networks to
identify those with the most interconnectedness within these processes. These molecules were
then researched in literature to understand the connections drawn between them. Many of
the genes traditionally implicated in literature as inferring neuronal fate were not SDE in the
253
comparison of hfNES and hfNS cells, due to both of the cell lines being neural stem cells. Some
of these were up-regulated in Huang dNES
hESC
experiment, indicating that they were possibly highly
expressed in both cells and therefore not SDE between them.
15.0.1 Summary of Findings
During the analysis it became evident that hfNES and hfNS cells were controlled by vastly
different mechanisms. The hfNES cells were controlled by the intrinsic default neural differen-
tiation program of ESCs. Key pluripotent factors SOX2 and LIN28 were maintaining these
cells in a more pluripotent state than the hfNS cells. In conjunction with the higher expres-
sion of these pluripotent factors, there were also higher expressions of DNA methylating and
chromatin modifying proteins; namely DNMT1 , DNMT3B , HELLS , TET1 , H2AFY2 , EZH2 ,
KDM3B and KDM4D . These could be executing epigenetic changes to the hfNES cells genome,
while the hfNES cells may be maintained in their current state, through the expression of the
pluripotent factors SOX2 and LIN28 . A number of other transcription factors are also at
play to maintain the hfNES cells cellular identity, ATF3 HMGA2 , NR2F1 , and PBX1 , and
warrant further study.
The molecules that are likely the most instructive in maintaining the hfNES cells cellular
identity are LIN28A and LIN28B . These molecules suppress the miRNA let-7 , which is instru-
mental in neural stem cell differentiation. LIN28 has previously been shown the be reduced
during nervous system development. Here we show clear persistence of expression in hfNES
cells. In addition to this, the Hippo pathway appeared to be active in the hfNES cells. It may
be the main control mechanism maintaining proliferation of the hfNES cells, until sufficient
cells mass has been created, and before induction of differentiation into hfNS cells. Supporting
this, the Hippo effector YAP1 was more highly expressed in the hfNES cells.
Once the expression of the pluripotent factors is reduced, the full effect of the epigenetic
changes would take effect, and the cells would then be established as hfNS cells. Furthermore
the transcription factors up-regulated in hfNS cells PAX3 , ASCL1 , HES4 , HES5 , INHBB ,
NFIA, NFIB , RUNX2 and SOX3 may further induce the transition from hfNES cells to hfNS
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cells. It was also evident from the GO and KEGG analysis that the hfNS cells were more
complex in their structure, metabolism and control mechanisms than the hfNES cells. The
plasma membrane of the hfNS cells undergoes significant changes as does the cytoskeleton.
This indicates a greater ability of these cells to interact with their environment. A number of
signalling pathways were enriched in the hfNS cells (Figure 11.26). This indicates that they are
able to interact more readily with their environment and transduce those signals more readily
within the cells, thereby being more responsive to their environment. As the nervous system
develops the nervous tissue would become increasingly complex, integration into this complex
tissue would require cells to become more responsive to their environment.
15.0.2 Novelty
Much of the information attained for neural tissue has been produced in mice and rats or
human neural stem cells derived from ESC. This study makes distinct comparisons between
human foetal neuroepithelial-like stem cell lines (hfNES cells) and human foetal neural stem
cell-like cell lines (hfNS cells). This is the most comprehensive comparison of these newly
derived cell lines to date. This study validates that discoveries made in animal models are
also at play in human cells derived directly from human foetal brain. It also produced novel
information for many of these molecules. Previously these molecules had only been observed
to change between ESC and neural stem cell. Here we observe more precise changes within
two neural stem cells populations, hfNES and hfNS cells. There are also a number of SDE
molecules within the dataset for which there is very little information in literature, so they
were not discussed, They may therefore be playing important roles in these cells, but are as of
yet uncharacterised, and warrant further study, such as POLQ
15.0.3 Future Work
This study has identified a number of candidate molecules that play roles in neural stem cell
fate specification. In order to validate and fully understand their effects, detailed biochemical
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characterisation of individual molecules would need to be performed.
Manipulating the expression levels of the identified hfNES and hfNS cell producing tran-
scriptions factors (Section 14) in either of the cell lines and observing the effect on their cellular
identity and differentiation potential may yield interesting information as to their roles in neu-
ral stem cell development and differentiation. Expression perturbations that would most likely
yield the greatest results would be that of SOX2 , LIN28A and YAP1 .
With the differences in nucleosomes (Figure 13.10), chromatin-remodelling (Figure 13.18)
and DNA methylation (Section 13.2.1) observed between hfNES cells than hfNS cells, this
cell model would be a good place to do follow-up epigenetic studies. Understanding the
changes in DNA methylation and chromatin compaction in these two cell types together with
the corresponding gene expression differences may offer valuable insights into the epigenetic
mechanisms at play here. Manipulating expression of key components in these mechanisms
may also provide more detailed information on there individual roles within these cells. In
particular, altered expression of DNMT1 , DNMT3B , H2AFY2 , EZH2 and KDM3B would be
most interesting.
Using this cell model there is also potential to learn more about the nature of the hfNS
cells. Detailed analysis of the signalling pathways enriched in the hfNS cells (Figure 11.26),
may yield information on how these cells decide to become neurons or glia, and the effect that
activation of these signalling pathways have on the hfNS cells.
The hfNS cells up-regulate numerous proteins that form part of the plasma membrane, most
notably those for focal adhesion (Figure 11.19). Furthermore understanding the changes to the
cell surface could be used to enhance cell culture conditions as well as identify new markers to
more clearly distinguish between these cells. The collagens and lamins (Figure 11.18) SDE in
this data could be used to design more appropriate tissue culture environments, which would
be better suited to directing the differentiation of iPSC. FABP7 , SLC1A3 and DPYSL2 are
often used as cell markers. There were a number of fatty acid binding proteins, solute carriers
(Figure 9.30) and dihydropyrimidinase like proteins (Figure 9.48) SDE in this data. For many
of these there is limited information in literature pertaining to neural stem cells, and they may
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potentially be novel markers for these cells.
There were a number of other molecules which were SDE, but whose functionality fell
outside of the scope of this study. Within the information held in this study, there may also
be information that could increase understanding of neurological developmental disorders.
Defective proteins more highly expressed in hfNES cells may explain reduced brain size, while
defective proteins in hfNS cells may explain more complex disturbances in the balance between
the number of neurons and glia. It is hoped that by making this data accessible, researchers
with defined questions about human foetal brain development may be able to identify particular
molecules that warrant further study within the context of their own research.
15.0.4 Final Words
As intended this study has provided a number of candidate molecules for further study. It is
hoped that more in-depth analysis on a molecule by molecule basis of these candidate molecules
could yield fundamental breakthroughs in the development of brain-regenerative therapies.
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